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 Summary 
 
Flagella, the helical propellers that extend from the bacterial cell surface, illustrate how 
complex nanomachines assemble outside the cell. The sequential construction of the 
flagellar rod, hook, and filament requires export of thousands of structural subunits 
across the cell membrane and this is achieved by a specialised flagellar Type III 
Secretion System (fT3SS) located at the base of each flagellum. The fT3SS imposes 
a crude ordering of subunits, with filament subunits only exported once the rod and 
hook are complete. This “export specificity switch” is controlled by the FlhB component 
of the fT3SS export gate in response to a signal from the exported molecular ruler 
FliK, which monitors the length of the growing hook. This study seeks to clarify how 
rod and hook subunits interact with FlhB, and how FlhB switches export specificity. 
 
Rod and hook subunits possess a conserved gate recognition motif (GRM; Fxxxϕ, 
with ϕ being any hydrophobic residue) that is proposed to bind a surface-exposed 
hydrophobic patch on the FlhB cytosolic domain. Mutation of the GRM phenylalanine 
and the final hydrophobic residue resulted in impaired subunit export and decreased 
cell motility. Isothermal titration calorimetry was performed to assess whether subunit 
export order is imposed at FlhB. These experiments showed that rod and hook 
subunits bind to FlhB with micromolar dissociation constants (5-45 μM), suggesting 
transient interactions. There was no clear correlation between subunit affinity for FlhB 
and the order of subunit assembly in the nascent flagellum. Solution-state nuclear 
magnetic resonance (NMR) spectroscopy supported prior data showing that rod and 
hook subunits interact with FlhB’s surface-exposed hydrophobic patch. NMR also 
indicated that residues away from the patch undergo a conformational change on 
subunit binding. 
 
FlhB autocleaves rapidly in its cytosolic domain, and the resulting polypeptides 
(FlhBCN and FlhBCC) are held together by non-covalent interactions between b-strands 
that encompass the autocleavage site. The autocleavage event is a prerequisite for 
the export specificity switch, but its function is unclear. Analysis of the cellular 
localization of FlhBCN and FlhBCC revealed that FlhBCC dissociated from the membrane 
export machinery, but only in the presence of FliK. Biochemical and biophysical 
5
 studies of FlhB variants that undergo export specificity switching in the absence of FliK 
showed that these FlhB “autonomous switchers” were less stable than wildtype FlhB 
and their FlhBCC domain could dissociate from the export machinery in the absence of 
FliK. The results suggest that the export specificity switch involves a FliK-dependent 
loss of FlhBCC from the export machinery, eliminating the binding site for rod and hook 
subunits. 
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 Chapter 1 
Introduction 
 
1.1 The bacterial flagellum 
Motility is a common feature of life. The ability of organisms to swim, to fly, or to walk 
to new, more favourable environments presents them with an advantage over their 
non-motile competitors. They can also avoid harmful chemicals like antibiotics, or 
evade predators, things their non-motile competitors must evolve defenses to combat. 
Organisms across the domains of life have evolved many features that impart motility 
or allow them to be moved by external physical forces. 
 
Bacteria have evolved long, self-assembling helical propellers called flagella to move 
through their environment. These elegant structures span the cell envelope and 
extend far into the environment, requiring the orchestration of dozens of genes and 
proteins to assemble the three substructures of the flagellum – the basal body, the 
hook, and the filament. Thousands of subunits must be exported from the cell to 
construct a single flagellum since bacterial flagella are assembled at the distal end of 
the growing structure. This poses a grand challenge, made even larger in bacteria 
possessing multiple flagella. How does a cell express thousands of protein subunits 
and energise their export? Just as important, how does a cell coordinate the export of 
so many proteins so that a competent structure is assembled? 
 
Long championed as a representation of irreducible complexity and the hand of a 
creator, the bacterial flagellum is an example of evolution at work over millions of 
years. Since its discovery in the late 19th century, the flagellum has been studied by 
bacteriologists, biophysicists, and others to demystify its complexity. Subunits vary 
across species, some lost, duplicated, or replaced as needed. Rather than providing 
proof of the hand of a creator, studying the bacterial flagellum has given us a strong 
example of natural selection leading to a diversity of forms while maintaining a unified 
function (1). Over 25 proteins must come together in a web of interactions to assemble 
and operate the final product. What sort of interactions must occur and how do these 
interactions produce a functional flagellum? 
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 1.2 Flagellar motility and arrangement 
1.2.1 Rotary works 
There are two types of flagellar motility – swarming and swimming. Swimming 
describes the movement through liquid environments, while swarming is the ability of 
bacteria to move across surfaces. This study investigated swimming motility, so that 
will be the focus of the following section. 
 
Flagellar swimming motility is often described as “tumble and run” (2). During run 
behavior, the flagellum can rotate clockwise (CW) or counterclockwise (CCW), 
converting rotary motion into thrust and leading to smooth swimming (2, 3). When the 
motor stops and begins to switch direction or slows down, the cell tumbles and ceases 
movement. Once the motor restarts and enough thrust is generated, the cell can return 
to a “run” and swim smoothly towards a chemotactic signal (2, 4, 5). 
 
Far from a random process, motility is guided by a response to chemotactic signals 
such as pH, temperature, and molecules sensed by methyl-accepting chemotaxis 
proteins (MCPs) (2, 6). Chemotaxis and rotational direction of the flagellar motor is 
controlled by the CheA-CheY two component system (7). MCPs modulate the 
autophosphorylation activity of CheA depending on whether they have sensed an 
attractant or repellent. Upon a MCP sensing a repellent, CheA undergoes 
autophosphorylation before transferring the phosphate group to CheY. 
Phosphorylated CheY then interacts with the flagellar motor and “switch” proteins, 
FliG/FliM/FliN. Phosphorylated CheY interacts directly with FliM, probably leading to 
a change in the interaction of FliM with the motor protein, FliG (2, 8). This cascades 
to alter the interaction between FliG and the stator subunit MotA, eventually altering 
the stator-motor complex to switch direction from CCW to CW rotation. If the MCP 
senses an attractant signal, CheA autophosphorylation is repressed. CheA cannot 
then phosphorylate CheY and the motor will not switch directions, allowing the cell to 
continue to move toward the attractant (2). 
 
Flagellar motility is driven by the proton motive force (PMF) via the MotA and MotB 
stator complex or the sodium motive force (SMF) via the PomA and PomB stator 
complex (9–11). Not all bacteria produce flagella with a single ion motor. Sodium and 
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 proton motive force flagella are simultaneously present in some marine bacteria. To 
slow down or switch direction in these cases, the bacterium can slow its proton-drive 
motor or switch the direction of its sodium-driven motor (12). Although their energy 
sources are different, functional chimeras containing parts of both stator complexes 
can also be engineered (13). This suggests the drive mechanism is shared amongst 
the various ion-driven motors. 
 
Each unit of the PMF motor complex is formed of a 2:1 ratio of MotA to MotB, with the 
most probable stoichiometry being MotA4MotB2 (14). At most, 11 complexes of 
MotA/MotB assemble at the base of each flagellum (15). The individual units in the 
complex are not fixed to the motor, but rather transiently engage with the motor with 
an average dwell time of 30 s. Any of the 22 units of MotB at the motor can be 
exchanged with a membrane pool of approximately 200 unbound stators, for example 
(16). This freely diffusing membrane pool of stators might be an insurance policy of 
sorts and suggests the MotA/MotB motor complex is not as static as previously 
claimed (16). As the stator complex in the flagellar motor wears down, its components 
may be exchanged for fresh ones from the membrane pool to continue the flagellum’s 
smooth, efficient operation. The cell can then continue to move through its 
environment with little mechanical impediment. 
 
Both stator proteins are inserted into the cell membrane and contain conserved, 
charged residues necessary for torque generation and motor rotation (2). In 
MotA/PomA, these charged residues are located on a cytoplasmic loop between the 
second and third transmembrane domains where they can interact with the motor 
protein, FliG (17–19). MotB/PomB only contains one transmembrane domain where a 
conserved aspartate is required for proton or sodium translocation across the cell 
membrane (20–23). The C-terminus of MotB/PomB sticks into the periplasm and 
contains a peptidoglycan-binding motif to anchor the stator complex (24, 25). 
Together, these stator complexes form the ion channels that drive rotation by 
harnessing the energy provided by protons or sodium ions moving across the cell 
membrane. 
 
20
 The electrostatic interactions between the motor protein, FliG, and the stator complex 
ultimately drive the rotation of the flagellum. The full picture of torque generation by 
the flagellar motor is still unclear, but there is some information on the speed at which 
the motor can operate and the amount of torque generated. A low estimate of the 
proton-driven flagellar motor suggests it can rotate at approximately 63 Hz, generating 
1300 pN×nm of force, although higher estimates of 1.5 x 105 pN×nm s-1 of power have 
also been observed (15, 26). Speeds up to 1700 Hz have been recorded for the 
sodium-driven motor (27). These rotary speeds translate into a range swimming 
speeds. Peritrichous organisms such as Salmonella, which utilise the PMF, have been 
measured swimming at 55 µm s-1 at 35°C, or over ten-times their body length per 
second (28). This is a casual jog compared to organisms with single, polar flagella 
powered by the SMF such as Vibrio alginolyticus, which has been clocked at 116 µm 
s-1 at 35°C (29). 
 
1.2.2 Flagellar arrangement 
The number and arrangement of flagella varies greatly by cell and by species. It isn’t 
clear why some species assemble more than one flagellum when a singular flagellum 
is sufficient to swim through a liquid environment (30, 31). Although this topic isn’t as 
well studied as flagellar subunit export and assembly, recent research has begun to 
explore the mechanisms that determine flagella positioning in the cell. 
 
As the flagellum structure crosses the cell envelope, flagella are immobilised in the 
cell wall. Once assembly has proceeded through the cell wall, the position of that 
particular flagellum has been settled, but the exact mechanism behind this choice is 
largely unknown. Broadly, flagellar arrangement can be classed in four groups. 
Flagella can be singular and polar or singular and situated along the length of the cell. 
They can also be multiple and polar, called lophotrichous, or multiple and spread 
across the cell, called peritrichous. The biological importance of flagellar patterning 
and arrangement is poorly understood, but we do know that positioning and number 
of flagella is not a random process (31). 
 
This patterning is under the control of two subunits, with slight variations made for the 
arrangements found across bacteria. FlhF and FlhG have been shown to dictate basal 
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 body positioning. FlhF is a GTPase and FlhG serves as its ATPase antagonist (31–
33). Although much of their function remains unknown, it’s clear that FlhF and FlhG 
co-localise at the base of the flagellum (34, 35). 
 
How may the FlhF-FlhG pairing regulate flagellar patterning and number? In species 
with polar flagella, the loss of FlhF causes flagella to be inserted along the length of 
the cell rather than at the poles (33, 34, 36). The loss of FlhG increases the number 
of assembled flagella in species with a single flagellum (32, 35, 36). In peritrichous 
bacteria, however, the loss of FlhF leads to polar flagellar and the loss of FlhG 
contributes to the aggregation of basal bodies along the cell (31). In addition to their 
role in determining flagellar placement and number, FlhF and FlhG may serve to 
determine the number of flagella daughter cells receive after binary fission is complete, 
therefore determining the motility of individual cells, although not necessary the 
motility of the population (31, 35). So, although the FlhF-FlhG relationship and control 
is maintained across species, it is fluid enough to allow for the range of flagellar 
arrangement seen in bacteria (31). 
 
Bacteria have evolved a variety of arrangements, numbers, and modifications to their 
flagella. Flagella, in any arrangement or number, can generate substantial thrust and 
propel the organism into new frontiers. These frontiers often include the guts of 
mammals, where flagella play important roles in pathogenesis. 
 
1.3 Motility in pathogenesis 
Pathogens that can swim have an inherent advantage over their non-motile 
counterparts; namely, they do not have to rely on Brownian motion or mechanical 
forces to reach a potential site of infection (37). The same chemotaxis system that 
leads bacteria to a favourable environment is also used by pathogens to sense their 
preferred niche. Helicobacter pylori can detect sites of stomach injury to establish 
infection and Campylobacter jejuni detects mucins and glycoproteins to find the 
intestinal mucus-filled crypts it preferentially colonises (38, 39). Salmonella enterica 
serovar Typhimurium requires flagella with an active chemotaxis system to swim 
through the mucosal layer to reach the murine intestinal epithelium, allowing it to 
contact host cells and begin to inject effector molecules (40). 
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 The flagellum is not simply employed to move from point A to point B. It plays a 
complex role in the pathogenesis of many bacteria including S. enterica, C. jejuni, 
Pseudomonas aeruginosa, and Escherichia coli (41). Beyond swimming, flagella have 
been shown to be important for adhesion, biofilm formation, effector molecule 
secretion, and modulating the immune response (37). 
 
The filament, the largest of the flagellar substructures, is important for adhesion to 
host cell membranes during infection (37). In Enteropathogenic E. coli (EPEC), flagella 
are highly induced upon interaction with epithelial cells to adhere the pathogen to the 
host cell. Girón and colleagues noticed that the number of flagella was reduced when 
EPEC was cultured with methanol-fixed cells, suggesting that some soluble molecule 
secreted by living cells is responsible for the increase in flagella number. They further 
went on to show that motility medium preconditioned by the growth of HeLa cells could 
induce motility in a strain previously unable to swim in the motility medium (42). 
Enterotoxigenic E. coli (ETEC) secretes EtpA, an adhesion exoprotein, that interacts 
with flagellin, the filament subunit. This interaction between the two ETEC proteins is 
crucial for adherence to the host cell and eventual colonisation (43). Adherence by 
flagella to the host cell has also been identified in other pathogens such as P. 
aeruginosa and C. jejuni (44, 45). Recently, work by E. Wolfson and colleagues 
suggests that the filaments of Enterohaemorrhagic E. coli (EHEC) can interact with 
components of the host cytoskeleton and might even penetrate host cell membranes, 
although it is unclear by what mechanism (46). Once contact is established, pathogens 
like Salmonella and Shigella can induce the cell to engulf them to continue with 
infection and either stay hidden in specialized vesicles or move into the cytosol for 
growth and replication (47). 
 
Of course, reaching the site of infection or invading a host cell is only the beginning of 
infection. To survive, the pathogen must evade the immune system. Having a long 
filament made up of many repetitive regions invites immune detection and response, 
stymying infection. Motile pathogens have evolved a few strategies to avoid death by 
host immunity (37). A common strategy pathogens employ is the downregulation of 
flagellar gene expression. Salmonella Typhimurium greatly downregulates flagellar 
and chemotaxis gene expression once inside macrophages (48). EHEC 
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 downregulates flagellar gene expression after attachment to and formation of 
microcolonies on host intestinal epithelial cells (49). Legionella pneumophila actively 
senses its external temperature and begins to downregulate flagellar expression at 
37°C (50). In continuing infection, these pathogens actively sense their external 
environment and dispense with flagella production to evade the immune system. 
 
Pathogens have also evolved subtler means than downregulating gene expression to 
evade the immune system. Salmonella Typhimurium expresses two flagellins, FliC 
and FljB, with different antigenicities (51, 52). This leaves the bacterium exposed to 
an immune response, but it also makes it harder for the host immune system to detect 
and react to the pathogen (37). Salmonella cells are also known to exhibit bistability, 
or maintaining a population ratio of motile to non-motile cells depending on 
environmental conditions. Individual motility, then, can be sacrificed to allow the 
population to survive (53). Another method pathogens have evolved to survive in a 
host is to alter their flagellin sequence to avoid detection by host toll-like receptor 5 
(TLR5) (54). Although mutations present a risk to the cell’s survival, natural selection 
may well favour a pathogen that can avoid immune detection while maintaining its 
ability to swim and colonise its host. 
 
Clearly, flagella are vital to the pathogenesis of many bacteria. The following sections 
provide further detail into Salmonella enterica serovar Typhimurium, its flagella, and 
the complex molecular interactions that are required for the cell to produce a 
competent flagellum. Comparisons will continue to be made to other organisms, where 
appropriate, but as this study focuses on the Salmonella Typhimurium flagellum, it will 
be the focus of the remaining sections. 
 
1.4 Salmonella enterica serovar Typhimurium 
550 million people, and 220 million children under the age of five, contract diarrhoeal 
diseases each year. About 33 million people eventually die from their disease. 
Salmonella is one of the leading causes of these diarrhoeal diseases globally, 
affecting those in developed and developing countries. Salmonella is genus of 
common Gram-negative, motile, rod-shaped pathogens. They readily survive in the 
soil or water for weeks and can colonise different mammalian species, allowing them 
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 to spread from animals to humans. Transfer of Salmonella is often due to poor hygiene 
after direct contact with infected individuals or food. 
 
Salmonella enterica serovar Typhimurium, like most Salmonella serovars, mostly 
causes sporadic diarrhoeal disease in humans that is faeco-orally spread, usually self-
limiting, and typically lasts less than a week. It can, however, cause severe disease in 
the young, the elderly, and those with compromised immune systems (55). 
Additionally, in mice, it causes a disease similar to typhoid fever in humans. This 
makes Salmonella Typhimurium a suitable model organism to study the much more 
severe typhoid fever without the risk of contracting the disease. 
 
Prevention requires efforts across the food supply chain such as better hygiene, 
prevention of faecal contamination of meat, fruit, and vegetables, and keeping 
processing surfaces clean and dry. International efforts to track and reduce 
Salmonella outbreaks are ongoing. They include giving national health organisations 
the tools to monitor food processing, educating consumers and industry on better 
hygienic procedures, and establishing improved safety standards (55). 
 
The most common treatment of salmonellosis is rehydration and, if the patient 
experiences severe dehydration, electrolyte replacement. Antibiotics are only 
recommended for those patients with severe disease or in whom the bacterium has 
spread from their gut to the blood stream. This is because of the growing concern of 
antibiotic resistance and the self-limiting nature of most salmonellosis (55). According 
to the National Antimicrobial Resistance Monitoring System in the United States, 
Salmonella Typhimurium is more likely to be resistant to antibiotics and to possess 
resistance against more classes of antibiotics than other Salmonella serovars (56). 
Data varies from nation to nation and year to year, but Salmonella Typhimurium is 
either the most common or second-most common serovar of Salmonella enterica to 
cause foodborne disease in humans (55, 57). This ubiquity only makes the spread of 
antibiotic resistance among Salmonella Typhimurium more troubling. There is a clear 
need for better surveillance and faster treatment of humans and animals with 
salmonellosis coupled with a greater understanding of Salmonella Typhimurium 
biology. 
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 The flagellum is an important component of Salmonella Typhimurium pathogenesis. 
By understanding its structure, and how the cell goes from flagellar gene expression 
to subunit assembly, we will be better equipped to develop novel, rational therapies to 
combat this global menace. The strain used in this study as a wild type motility model, 
SJW1103, is a Salmonella Typhimurium strain originally described in 1984. It is phase-
locked, meaning it only expresses FliC flagellin and assembles a homogenous 
filament (58). 
 
1.5 Bacterial secretion systems 
Gram-negative bacteria have evolved a multitude of highly specialised systems to 
secrete substrates into the extracellular environment or a host cell (Figure 1.1). These 
substrates, which can include small molecules like antibiotics or large proteins, are 
typically secreted as a response to some external stimuli. Secreted substrates may 
lead to the assembly of an intricate nanomachine, like the flagellum or a pilus, or could 
remove a harmful molecule from the cytoplasm. They can also cause host cells to 
react in such a manner as to initiate or prolong infection (59). Current work has 
identified over a dozen secretion systems in Gram-negative bacteria, although more 
certainly remain to be identified (60). The diversity of secretion systems give Gram-
negative bacteria a veritable arsenal of options to regulate their internal and external 
environments. 
 
Secretion systems can be broadly described with two mechanisms. In one-step 
secretion, substrates are secreted directly from the bacterial cytoplasm to outside the 
cell. Type I, III, IV, and VI secretion systems all work in this manner (59). Other 
secretion systems, like Type II and V, use a two-step mechanism. In this case, 
substrates are first secreted into the periplasmic space before being secreted outside 
the cell. These systems require an inner membrane transporter to secrete substrates 
into the periplasm or insert them into the inner membrane (61). The SecYEG 
translocon is often used to transport unfolded polypeptides across the inner 
membrane, while the twin-arginine translocation (Tat) system is employed to transport 
folded proteins across the inner membrane (59, 62). 
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Figure 1.1 Bacteria have evolved many systems to export molecules
Different secretion systems serve many different functions. Some are used to remove harmful
molecules, such as antibiotics, from the cell, whilst others are used to transport effector
molecules from the bacterial cell into the host cell in order to cause infection. Others secrete the
subunits necessary to assemble intricate nanomachines for use in adhesion, motility, and more.
Secretion systems can also be used to share genetic material, spreading genes useful in host
colonisation, nutrient utilisation, and antimicrobial resistance. Some notable systems missing
from this figure are the Sec system, flagellar type III secretion system (shown in figure 1.2A),
type VII secretion system, and the newly characterised type IX secretion system found in the
Bacteroides phylum.
RND pump is the resistance-nodulation-division pumps; T1SS is the type I secretion system;
T2SS is the type II secretion system; T3SS is the injectisome type III secretion system; T4SS is
the type IV secretion system; and T6SS is the type VI secretion system.
CM is the host cell membrane; OM is the bacterial outer membrane; PG is the peptidoglycan
cell wall; and IM is the bacterial inner membrane.
Figure adapted from Costa et al., 2015.
Host environment
RND 
pump T1SS T2SS T3SS T4SS T6SS
Bacterial cytosol
CM
OM
IM
PG
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 Energy sources for substrate secretion vary by system. Some, like type IV secretion 
systems, energise secretion by ATP hydrolysis at dedicated ATPases (63). Others, 
like RND pumps, use proton gradients to power secretion (64). And in other cases, 
like type V secretion systems, energy is provided by the protein substrate folding in 
the extracellular environment, leading these systems to be termed “autotransporters” 
(65). 
 
In many cases, secretion systems must adopt different conformations to control 
substrate secretion. The TolC outer membrane channel of Type I secretion and RND 
tripartite pumps, for example, assumes an open conformation when in complex with 
the inner membrane component and periplasmic adaptor proteins. This complex, 
creating a channel that spans the cell envelope, is only able to form upon substrate 
binding (59). In the absence of this complex, the TolC channel is closed at the 
periplasmic side to prevent substrates from inadvertently entering the channel (66). 
 
Proteins pose a challenge that small molecules do not. Many of these secretion 
systems have very narrow central channels, restricting the size of molecules that can 
pass through. The injectisome type III secretion system in Salmonella has an inner 
channel diameter of ~25 Å, much too small for folded protein to pass through (67, 68). 
Some secretion systems are capable of secreting folded protein; however, they 
usually begin secretion with unfolded polypeptides. The usher of the chaperone-usher 
pathway used to construct type I pili can mediate secretion of folded protein. In this 
pathway, unfolded polypeptides are first secreted by SecYEG into the periplasm (69). 
There, a pilus chaperone folds the subunit, thereby stabilising it against periplasmic 
proteases, and delivers it to the usher for secretion and polymerisation into the 
growing pilus (70). 
 
Bacterial flagella are assembled at the distal end, necessitating the secretion of 
thousands of subunits from the cell. Flagella use dedicated type III secretion systems 
(T3SS) to overcome this challenge. The following section discusses type III secretion 
in greater detail and how these systems manage to export proteins up to 20 µm away 
from the cell. 
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 1.5.1 Type III secretion systems 
One of the most common secretion systems found in bacteria is the type III secretion 
system. There are two evolutionary-related T3SSs which secrete subunits across the 
cell envelope for the assembly of two nanomachines – the flagellum and the 
injectisome. 
 
The injectisome is used by many Gram-negative pathogens to inject effector 
molecules across the cell membranes of eukaryotic host cells (71). These injectisomes 
are major players in the infection of animal and plant cells. The injectisome is made 
up of the core needle structure, a needle tip assembly for the construction of the 
translocation pore, and an assortment of secreted effector molecules (72). The range 
of effector molecules and their targets, often implicated in disease but also in 
symbiosis between bacterium and host, varies greatly across bacterial species (73). 
These effector molecules transit the central channel of the needle structure and enter 
the host cell through a pore formed by translocon subunits once contact with the host 
cell has been made (74). Once inside the host cell, these effector molecules are free 
to bind to their targets to elicit a favourable response from the host cell (71). 
 
Many proteins necessary for type III secretion are found in both systems, sharing 
structural and functional similarities, although not always significant sequence 
homology (Figure 1.2A). The flagellar and injectisome basal bodies are surrounded by 
ring structures that are embedded in the bacterial cell envelope (74). The export 
machinery of both systems contains a dedicated ATPase to separate subunits from 
their chaperones and begin to unfold subunits prior to export (75, 76). Export gates 
serve to coordinate export by recognising subunits via N-terminal secretion signals or 
chaperone-subunit complexes and directing the subunits to the export channel (76–
89). Both systems use the proton motive force to begin to translocate subunits across 
the cell envelope, either to be assembled into the nascent structure or to be secreted 
into the environment (90–92). 
 
The evolution of the two T3SSs has been hotly debated for some time. It was once 
thought that the two systems shared a common ancestor or even that the injectisome 
came first, but recent work advocates for a flagellum-first hypothesis. Flagellar genes 
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strains have the genes for the Ysc T3SS expressed in animal
cells at 378C and the Ysa T3SS which is not expressed under
these conditions. Recently, the Ysa system was shown to be
involved in intracellular survival and to be required for the
infection of Drosophila S2 cells at lower temperatures,
suggesting a role in an alternative insect host [62,63].
4. Transcriptional and post-transcriptional
regulation of the T3SS
It appears obvious that both the expression and the function
of T3SS must be regulated. Environmental inputs control not
only whether a bacterium needs a flagellum, but also how
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Figure 1. Structural model of the flagellar and injectisome T3SS, and comparison with structurally related parts of the F0F1-ATP synthase. Components present in
both T3SS are listed in the centre, flagellum-specific and injectisome components on the left and right side, respectively. An alternative location for FliH/SctL [27,28]
is indicated by dashed lines. Subunits of the F0F1-ATP synthase are listed on the far right side, components that are structurally related to T3SS components are
coloured correspondingly. The c-ring of the F0F1-ATP synthase spans the IM, but has been drawn as corresponding to the FlhA/SctV ring in this image [28,29].
Flagellar model based on the study of Minamino & Imada [30]; injectisome model modified from [31]; based on cryo-electromicroscopic data [32]; F0F1-ATP synthase
and structural homologies based on Ibuki et al. [33]. Scale bar and relative size of flagellum/injectisome based on Kawamoto et al. [27].
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allowed the formation of contact-dependent injectisome-type T3SS. In addition to the depicted gene acquisitions and losses, family-specific changes occurred,
leading to the eight injectisome subfamilies indicated—the more ancestral Chlamydia T3SS and the Rhizobia, Hrp1, Hrp2, Ysc, Desulfovibrio, SPI-1 and SPI-2 injecti-
somes. In the rhizobial family, a Tad-like secretin has been acquired independently. Gene acquisition is depicted by incoming arrows and solid lines, gene loss is
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rstb.royalsocietypublishing.org
Phil.Trans.R.Soc.B
370:20150020
5Fl gellum Inj ctisome
L-ring
P-ring
FliE, FlgB,C,F,
ctF
MotB
MotA
FliO
FliG
li / ctJ
FliH/SctL
l / ctV
liI/
liJ
,N/SctQ,QC
l / ctU
/FliP,Q, / ctR, ,
ctD
SctC
SctI
ctK
A
B
T3SS genes
flgBCDEHK
fliEG, motAB
T3SS genes
Flagellum InjectisomesNeedle-less Injectisom -lik  
T3SS
sctFJLNQRSTUV
flgBCDEHK, fliEG, motAB
Flagellum-specific genes
sctDI sctC
sctDFIJLNQRSTUV sctCDFIJLNQRSTUV
T3SS genes
Chlamydia T3SS
lost sctI
Myxococcus T3SS
lost sctF
Figure 1.2 Type III secretion systems (T3SSs) are closely related
(A) Comparison between the flagellum and injectisome basal structures. Subunits found in
both systems are listed in the middle of the two structures. The unified sct nomenclature for
the injectisome is used. Adapted from Diepold and Armitage 2015.
(B) Current hypothesis of T3SS evolutionary history. SctC was acquired multiple times by
different subfamilies of injectisomes. The Chlamydia subfamily is ancestral to the other animal
and plant pathogen T3SSs. Adapted from Abby and Rocha 2012 and Diepold and Armitage
2015.
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 are commonly found on the chromosome, while injectisome genes are found on 
pathogenicity-islands or virulence plasmids, supporting the flagellum-first hypothesis 
(74). Modern large-scale genomic analysis has revealed that the flagellar T3SS is 
closer to the ancestral system than the injectisome T3SS (Figure 1.2B). This data 
uncovered that more bacteria possess flagella than possess injectisomes. Flagella are 
found in 14 Gram-positive and Gram-negative bacterial taxa, while injectisomes have 
only been found in three Gram-negative bacterial taxa (93). 
 
This genomic analysis gave clear evidence, via the shared ATPase found in both 
T3SSs, that the injectisome evolved from an ancestral flagellar system in three major 
steps. The injectisome was first adopted as a secretion system in free living bacteria. 
This first adaption occurred when the injectisome ancestor lost its motility genes, 
retaining the core T3SS genes. Secretins were then recruited from other secretion 
systems, allowing the injectisome to further evolve in animal and plant pathogens for 
association with a range of host cells (Figure 1.2B) (93). 
 
Because of their homology and commonality among human pathogens, the T3SS is 
an attractive target for designing novel therapeutics, especially in the wake of growing 
antimicrobial resistance and a dry antibiotic development pipeline (94). Potentially, a 
compound that targets one of the core T3SS subunits could cripple both the flagellum 
and injectisome. Pharmacological inhibitors have been discovered for some 
injectisomes, ranging from targeting gene regulation and transcription to components 
of the injectisomes themselves (95). The Salmonella Typhimurium flagellum was 
identified as a therapeutic target as early as the 1950s, with efforts concentrating on 
how to prevent its formation and, therefore, keep Salmonella populations non-motile 
(96). These experiments were conducted on bacterial cultures and in host models, 
such as mice. More recent work has shown it is possible to target the Salmonella 
flagellum using antibodies to enhance the immune response to pathogenic bacteria 
by phagocyte-like cells in culture (97). High-throughput screens to find new classes of 
flagellar inhibitors have shown some promise against the sodium motor of Vibrio but 
were less successful in finding compounds with anti-motility activity in Salmonella (98). 
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 Type III secretion systems can also be hijacked as protein translocation pumps to 
deliver specialised protein cargo. They offer attractive opportunity for the 
biotechnology industry as these systems are capable of rapidly exporting a lot of 
protein into the environment, eliminating the need to harvest proteins from cells. The 
flagellar type III secretion system (fT3SS) is remarkably fast, capable of exporting up 
to 1,700 amino acids per second (99). For comparison, the haemolysin A type I 
secretion system exports roughly 17 amino acids per second and the Sec machinery 
is capable of exporting around 220 amino acids per second (100, 101). Protein 
engineering is relatively simple as well. By adding the specific N-terminal signal for 
fT3SS recognition and export or fusing the target protein to a secreted flagellar 
subunit, protein can be exported into the supernatant so long as it can be unfolded by 
the fT3SS for transit through the channel. 
 
The fT3SS has been used to export peptides derived from snails, snakes, and spiders 
by fusing them to FlgM, a secreted subunit not assembled into the final flagellum 
structure (102). Dobó and colleagues were able to use the fT3SS system to secrete 
different proteins such as GFP and maltose-binding protein by placing a disordered 
N-terminal portion of flagellin (residues 26-47) at the N-terminus of fusion protein 
(103). Early flagellar subunits are not chaperoned and possess a five-residue 
recognition sequence that could be used in biotechnology (86). The injectisome has 
been used to deliver vaccines or cytokines into host cells and spider silk into the 
culture supernatant for harvesting (74). These are only a few ways in which T3SS can 
be targeted or hijacked for our imaginative purposes. 
 
The complexity of type III secretion systems requires fine coordination beginning with 
gene expression. These systems are not constitutively expressed (59). Gene 
expression, therefore, is often controlled by environment signals to manage the energy 
cost to the cell of building these nanomachines. The next section discusses how the 
cell reaches the decision to begin flagellar and type III secretion gene expression and 
efforts to tune gene expression to various cues. 
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 1.6 Flagellar gene arrangement and expression 
Salmonella flagella require over 60 genes for proper structure and function (104). 
Flagellar gene expression can be broadly classed into three promoter classes that 
matches structural hierarchy (Figure 1.3) (105). The entire system is under control of 
the class I FlhD4C2 heterohexameric master regulator complex, but not individual FlhD 
or FlhC subunits (106). 
 
The FlhDC complex is activated and regulated by many different cell signals based on 
the environment and life stage (motile vs non-motile). Examples of positive regulators 
of flhDC transcription in Salmonella include cAMP-CRP and Fis (107, 108). An 
example of a negative regulator is RflM, which acts to control the FlhD4C2 complex’s 
own autoinhibitory effect on its transcription (109). The Salmonella cell cycle is also a 
strong transcriptional regulator, both positive and negative, of flhDC. Flagella 
production is energetically costly and is therefore reduced in favour of other cell 
processes during most growth phases. Flagellar gene expression is highest in mid-
exponential phase (110). The FlhD4C2 complex is further regulated post-translationally 
by the ClpXP ATP-dependent protease to control the level of class II and III transcripts. 
ClpXP can recognise and regulate the heterohexameric complex, but not individual 
FlhD or FlhC proteins (111). 
 
Once FlhDC is activated, it binds to the chromosome upstream of the fliA, fliL, and 
flhB operons and promotes the transcription of class II genes with s70 and RNA 
polymerase (112, 113). This activation requires an interaction with the C-terminal 
domain of the RNA polymerase a subunit (113). Class II genes include those of the 
hook-basal body (HBB) and flagellar motor complex (105). Upon HBB completion, 
transcription of class III genes by the class-specific s28 RNA polymerase is activated 
(114, 115). The shift between class II and class III gene expression is regulated by 
FlgM, the first of the “late” subunits (115). FlgM is only secreted once the hook has 
reached a mature length and the fT3SS has switched export specificity from “early” to 
“late” export, thereby coupling gene expression control to structure assembly (105). 
 
FlgM serves as an anti-sigma factor to FliA (the s28 factor), thus inhibiting class III 
gene expression by tying up FliA in the cytoplasm and actively causing it to dissociate 
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 from the RNA polymerase (116–118). After the fT3SS export specificity switch and 
FlgM secretion, FliA is free to associate with the RNA polymerase and activate class 
III gene expression, resulting in flagellin expression (105). FliT, the chaperone for the 
filament cap FliD, also serves to regulate gene hierarchy (119). Once the fT3SS 
system begins to export FliD, FliT is free to interact with the FlhD4C2 complex and 
reduce both its ability to activate class II genes and the autoinhibition of its own 
transcription (105, 120). 
 
In this way, FliT suppresses class II gene expression by inhibiting the FlhD4C2 global 
regulator complex. Interestingly, the repression of the autoinhibitory effect of FlhD4C2 
serves to re-initiate class I flagellar expression (105). It is not fully understood why this 
happens, but it may be connected to the genetic regulation interplay between flagellar 
motility and host cell invasion by the injectisome. FliT serves to repress the expression 
of the Salmonella Pathogenicity Island 1 (SPI1) injectisome that is essential for 
Salmonella to invade host intestinal epithelium and cause disease (121). Additionally, 
the FlhD4C2 complex is one of many factors that activate SPI1 expression. Therefore, 
FliT-mediated suppression of FlhDC and SPI1 may serve to coordinate motility to first 
find a host cell to invade and then eventual invasion by controlling the expression of 
the different Salmonella T3SS (122). 
 
Complicating gene expression is that some late subunits, such as FlgM, FlgK, and 
FlgL, are under the control of class II and class III promoters (105). But flagellin is 
strictly under class III control, so the filament cannot begin export and assembly until 
the HBB and junction proteins are assembled (104, 123, 124). This regulatory regime 
is made even more difficult in peritrichous bacteria like Salmonella where many 
flagella may be in different stages of assembly. How Salmonella regulates each 
individual flagellum, and the contribution of local and global control, is still being 
investigated. 
 
Gene expression is only one way by which Salmonella cells regulate the assembly of 
the flagellum. The fT3SS and its interactions with various subunits also controls when 
subunits are exported for assembly. Before discussing how the fT3SS imposes order 
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 on subunit export, it is important to understand the structure and proposed assembly 
mechanisms of the Salmonella flagellum. 
 
1.7 Flagellar structure in Salmonella 
The basic architecture of the flagellum is shared across bacterial species with 
adaptions made for Gram-positive and Gram-negative organisms and the periplasmic 
flagella of the spirochetes. The flagellum is formed of three helical substructures – the 
basal body, the hook, and the filament – requiring the export and assembly of over 
different 20 protein subunits. Each substructure has a unique capping protein that 
direct subunits to the site of assembly (125). The hook and basal body are often 
grouped as one larger substructure called the HBB (hook-basal body) as they 
assemble in the same phase. 
 
Each substructure is responsible for a different function that, in a perfect example of 
the whole being greater than the sum of its parts, allows the bacterium to move through 
the environment. The Salmonella flagellum is presented as a model structure (Figure 
1.4). Running through the three substructures is a narrow channel through which 
subunits are exported for their assembly at the distal tip of the nascent flagellum (126). 
Recent work using cryoelectron microscopy (cyroEM) revealed the rod and hook 
central channel, with a diameter of only 13 Å, to be narrower than that of the filament, 
with a diameter of 20 Å (Figure 1.5) (127, 128). 
 
1.7.1 The basal body 
The basal body spans the cell envelope, hosting the “drive-shaft” rod, a series of rings, 
and the motor-stator complex (126). The cytoplasmic (C) ring is a bell-shaped 
structure inside the cell made up of FliG/FliM/FliN, which, as previously discussed, 
serves as the motor and directional “switch” for rotation. The C ring is attached to the 
membrane-supramembrane (MS) ring, made up of the FliF subunit (126). The MS ring 
rests in a closed conformation until FliE is assembled, at which time the channel is 
opened to allow for proximal rod assembly (129). At the base of each flagellum, 
aligned with the export channel, is the dedicated flagellar type III secretion system 
(fT3SS), which sits inside the MS ring and bulges into the cytoplasm as a sort of cage. 
Type III secretion and its role in subunit assembly will be discussed in greater detail in 
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Figure 1.4 The structure of the flagellum is an elegant example of millions of years of
evolution
Structure of the Salmonella flagellum, a model for Gram-negative bacteria flagella. The
flagellum spans the cell envelope and extends far into environment, reaching lengths of 15-20
µm. Each subunit must be exported from inside the cell to the distal site of assembly through
the narrow central channel. Figure adapted from Evans, Hughes, and Fraser, 2014.
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Figure 1.5 Flagellar subunits must travel through a narrow channel to reach the distal
site of assembly
(A) The rod channel has a diameter of only 13 Å. Figure adapted from Fujii et al., 2017.
(B) The hook channel has a diameter of only 13 Å. Figure adapted from Fujii et al., 2017.
(C) The filament channel is wider than the rod and hook channel and has a diameter of 20 Å.
Figure adapted from Yonekura et al., 2003.
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 the following sections, but, briefly, the fT3SS serves to unfold and export subunits 
through the narrow central channel of the flagellum and to separate subunits into two 
export phases, “early” and “late” (126). 
 
There are two additional rings in Gram-negative organisms. The lipopolysaccharide 
(L) ring is made up of FlgH subunits and the peptidoglycan (P) ring is made up of FlgI 
subunits. These rings serve as bushings to allow the rod to rotate freely in the cell 
envelope (126). The gap between the distal rod and the L ring is not great, only around 
10 Å, and it is proposed that the rod rotates freely without lubricant against the L ring 
due to repulsive forces between negative residues on the distal rod subunit, FlgG, and 
FlgH (128). As no atomic resolution structures for the P and L ring exist, this 
hypothesis is currently difficult to test. 
 
The rod can be separated into two parts – the proximal rod, made up of 5-6 copies 
each of FliE, FlgB, FlgC, and FlgF, and the distal rod made up of between 26 and 42 
copies of FlgG (128, 130). Unlike the other flagellar substructures, the rod is quite rigid 
because of the tight packing between the domains of FlgG during distal rod assembly 
(Figure 1.5A). This packing prevents flexing of FlgG, allowing the drive shift to remain 
rigid while rotating (128). 
 
Rod assembly order is presumed to proceed FlgB, FlgC, and FlgF to first assemble 
the proximal rod. Only after the assembly of the proximal rod does the rod form the 
tube-like structure that allows for FlgG to polymerise into the distal rod (129). Thus, 
there is clear separation between proximal rod subunit assembly and that of the distal 
rod. But the precise order of these subunits appears to vary in different species. 
 
Recent work has attempted to describe assembly order using a variety of methods. 
Zhao and colleagues used cryoelectron tomography to unpick the rod order in the 
spirochete Borrelia burgdorferi. Subsequent deletions of rod subunits in vivo revealed 
an order of FliE, FlgB, FlgC, FlhO (the spirochete FlgF homologue), and FlgG (129). 
In vitro work using rod subunits from Salmonella supports this order of rod subunits 
(131, 132). 
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 Work in the Gram-negative bacterium Rhodobacter sphaeroides, however, found 
previously unknown in vitro interactions between FlgF and FlgB and between FlgC 
and FlgG. No direct interactions between FlgC and FlgF were detected. The authors 
propose FlgC as a checkpoint between the proximal and distal rod that assembles 
only upon FlgF polymerisation into the structure (133). Even though the exact export 
and assembly order of FlgC and FlgF may vary by species, these data support the 
need for cooperation between FlgB, FlgC, and FlgF (FlhO) to assemble the proximal 
rod (129, 133, 134). 
 
What controls the transition between rod and hook assembly? A combination of 
physical length control and loss of the rod cap in Gram-negative organisms. FlgG 
polymerises until it reaches the outer membrane, the force of its polymerisation not 
enough to punch through the outer membrane (135). Next, the P ring assembles 
around the distal rod (128, 136). The L ring then assembles in the outer membrane, 
removes the rod capping complex, and allows the rod to span the cell envelope (136, 
137). FlgD, the hook cap subunit, finally assembles on the completed distal rod to 
begin hook subunit polymerisation (137). 
 
1.7.2 The hook 
The second substructure, the curved hook, serves as the universal joint, transferring 
the torque generated by the motors to the helical filament (3, 125). The hook is made 
up of approximately 120 subunits, named FlgE (130). FlgE contains four domains – 
D0, Dc, D1, and D2 (138). Each domain contributes to the overall flexibility of the hook. 
The tightly packed D0 forms the inner core, lining the flagellar central channel, and 
provides mechanical stability. The coiled coil a-helices of the hook D0 domain are 
tilted to allow for extension and compression of the universal joint (127, 138). The Dc 
and D2 domains provide twisting rigidity and the D1 domain allows the hook to adopt 
highly curved conformations (Figure 1.5B) (139). 
 
Whereas the rod and filament remain rigid during rotation, hook protofilaments roll 
during flagella rotation, occupying different places along the curve and changing their 
conformation and the distance between the repeating subunits (140). The 11 
protofilaments shorten while inside the hook bend and extend once on the outside 
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 (140). This innate flexibility is not vital to the swimming speed of the organism, but is 
critical to allow for flagella bundle formation in multi-flagellated bacteria (139).  
 
Hook length in Salmonella Typhimurium is controlled at 55 nm ± 6 nm for efficient 
operation (141). This length is measured intermittently throughout hook assembly by 
a secreted molecular ruler protein called FliK (142). The length of the hook is tied to 
the export and assembly phases of the flagellum. Once a mature length is measured, 
early subunit export ceases and hook-junction proteins are exported to assemble on 
top of the hook to prepare for filament export and assembly. This results in an export 
specificity switch at the fT3SS that sees “early” subunit export give way to “late” 
subunit export (105). The export specificity switch will be discussed in greater detail in 
section 1.9. 
 
Once the HBB is assembled, the “early” structure of the flagellum is considered 
complete and the “late” structure, primarily the filament, can begin assembly. Before 
the filament is assembled, however, the three hook-filament junction subunits must be 
exported and assembled. Two of these subunits, FlgK and FlgL, polymerise into a thin 
layer of approximately 11 subunits each, accounting for two turns of the helical 
structure (105, 143, 144). The third junction subunit is FliD, the filament cap subunit. 
FlgK and FlgL are the only assembled subunits that do not require a specialised cap 
to control their assembly into the distal hook. The reason why a cap is missing remains 
a mystery (125). 
 
1.7.3 The filament 
The filament represents the largest substructure of the flagellum, comprising tens of 
thousands of flagellin subunits, which account for ~1% of total cell protein. These 
subunits polymerise into supercoiled protofilaments that can extend up to 20 µm 
outside the bacterial cell (125, 126). Filament length does vary across the cell as 
longer filaments are often broken by physical forces, such as mechanical shearing, 
before being rebuilt by the cell (125, 145). The FliD cap is continuously exported, thus 
allowing for the rapid regrowth of sheared filaments (146). FliD assembles as a homo-
pentamer at the distal end of the filament, forming a flat cap with five legs (147, 148). 
The leg domains can accommodate the different positions of individual flagellin 
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 subunits as the helix grows outward, like stepping up a helical stairway. The FliD cap 
fills the place on the growing filament meant for next flagellin monomer. Once the next 
flagellin monomer reaches the site of assembly, the monomer replaces FliD and the 
legs of the cap move to the neighboring position where the process can restart once 
another flagellin monomer is delivered (125, 149). Each flagellin monomer is made up 
of four domains – D0, D1, D2, and D3. The D0 and D1 domains form the inner and 
outer tube, respectively, that creates the central channel through which subunits are 
exported. The D2 and D3 domains form the external surface of the filament (Figure 
1.5C) (150–152). 
 
As the motor rotates the entire structure, the filament moves through the liquid 
environment like an Archimedean screw to propel the cell (153). When multi-
flagellated bacteria switch from a run to a tumble, the handedness of the 11 
protofilament supercoils can switch between two straight filament types, left and right 
(L- and R-type), releasing the bundle quickly and stopping motion (154, 155). The 
repeat distances between L- and R-type protofilaments are similar, 52.7 Å and 51.9 
Å, respectively. Therefore, this 0.8 Å difference requires flagellin to switch between 
types with a sub-ångstrom scale of precision (156, 157). Quite a remarkable feat! 
 
This lengthwise mechanical switch is controlled by the outer-tube D1 domain. D1 
domains interact within each protofilament, but not laterally across protofilaments. This 
allows each protofilament to switch between the L- and R-types independently, 
although cooperation is still needed among the protofilaments for a properly 
functioning filament (157). This cooperation comes from shearing forces between 
protofilaments caused by the twisting force generated by a switching motor complex. 
These shearing forces cause a conformational change at the D1 domain, causing 
them to slide upwards and to tighten the interaction between two of the domain’s a-
helices. These changes ripple through the D1 domains in the 11 protofilaments and 
result in the shift from L-type to R-type filaments (158). In such a manner, the 
otherwise rigid filament can change conformations to accommodate the different 
physical forces at work when the cell is swimming and when it needs to slow down or 
switch direction. 
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 The structure of the flagellum is a beautiful example of a complex structure formed by 
inter- and intra-subunit interactions working in concert to self-assemble into a 
functioning nanomachine. Other than the initial structures that require the Sec pathway 
to integrate into the inner membrane, the structure is completely self-assembling 
through the fT3SS (125). Flagellin monomers, for example, must transit an extremely 
narrow channel that may be up to 20 µm long. How, then, does the cell power subunit 
transit? What steps are necessary to move a subunit from inside the cell to the distal 
site of assembly? 
 
1.8 Mechanisms of flagellar assembly 
Before subunits can transit through the channel, they must be prepared for export. 
This process can be separated into early subunit export of the rod and hook subunits 
and late subunit export, that of the hook-filament junction proteins and flagellin. Export 
of the early and late subunits is dependent on the fT3SS, which itself must be 
assembled within the MS ring. 
 
The MS ring, the L and P rings, and the fT3SS are assembled via the Sec pathway, 
while the C ring self-assembles on the MS ring via interactions with FliG. These 
structures probably coordinate assembly amongst themselves to ensure proper 
spacing and base structure (125, 130, 159). The fT3SS contains six transmembrane 
proteins – FlhA, FlhB, FliO, FliP, FliQ, and FliR – and a dedicated ATPase made up 
of three subunits – FliH, FliI, and FliJ (126). The FliH/FliI/FliJ ATPase is homologous 
to the F1 domain of the F0F1 ATP synthase (160). Once these structures are 
assembled, the real show can begin. 
 
Flagellar subunits must be targeted in a step-wise process to the fT3SS, either through 
an N-terminal signal sequence or a specialised chaperone, in the case of late subunits 
(Figure 1.6) (84, 85, 161–165). First, the ATPase recruits the (chaperone-)subunit 
complexes to the appropriate export gate. The cytoplasmic domain of FlhA serves as 
the export gate for late subunits (126). FlhA forms a homononameric ring aligned with 
the central export channel (166). The central stalk of the ATPase, FliJ, interacts with 
the cytoplasmic domain of FlhA, providing a link between the export gate and the 
ATPase, and acts to bring chaperones to the export gate (76, 167). There at the gate, 
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Figure 1.6 Flagellar subunits interact with the fT3SS in a step-wise process prior to
export
The flagellar type III secretion system (fT3SS) shown in an active state with the ATPase (FliHIJ)
engaged with one of the export gate components, FlhA. Flagellin (FliC) provides an example of
the steps chaperoned subunits must go through prior to export. Figure adapted from Evans,
Hughes, and Fraser, 2014.
cleaved, the resulting FlhB polypeptides remain associated
[45,46]. Cleavage is critical for full export function, as
mutation of the cleavage site locks FlhB in a conformation
that permits export of only rod and hook subunits, abolish-
ing export of filament subunits [47]. This structural flexi-
bility appears to be an important feature of FlhBC as other
mutations that similarly limit flexibility also reduce sub-
unit export [48,49].
Recruitment of subunits to the export gate requires a
surface-exposed hydrophobic pocket on the cleaved FlhBC
C-terminal polypeptide (FlhBCC) [36]. This pocket could
provide a binding site for a conserved hydrophobic gate-
recognition motif (with sequence Fxxxf, where f is any
hydrophobic residue) in the N-terminal region of rod and
hook subunits that is essential for FlhB binding and export
[36]. Binding of subunits to FlhBC in vitro appears to be
relatively weak, with dissociation constants in the micro-
molar range, reflecting the transient nature of subunit
interactions at the export gate [36].
In addition to binding structural subunits of the rod and
hook, the FlhBC export gate is bound by FliK, an unusual
export substrate that senses the length of the flagellar
hook and, when the hook has reached its mature length,
switches the specificity of the export machinery to recog-
nise subunits for the flagellar filament (Figure 3) [50]. FliK
contains a canonical N-terminal gate-recognition motif
that binds the surface-exposed hydrophobic pocket on
FlhBC [36], but also contains a highly conserved C-termi-
nal region with an acidic loop (residues 294–300,
LHPEELG) that is proposed to bind to a basic patch
adjacent to the FlhBC autocleavage site and thus control
export-specificity switching [51]. The precise mechanism of
specificity switching is not fully understood, although sev-
eral models have been proposed (and are discussed in
recent commentaries [52,53]). The available data are, per-
haps, best explained by FliK acting as an infrequent
molecular ruler that is exported intermittently during
rod and hook assembly [54–56]. In this model, as hook
length increases so does the probability that FliK will form
a productive interaction with FlhB to flip the export-spec-
ificity switch and promote export of filament subunits
(Figure 3).
Once docked at the export gate, how do subunits then
move across the membrane into the central channel in
the growing flagellum? Energy for membrane transloca-
tion seems to be provided, in part, by the PMF [16,17],
and the contributions of its two components – the elec-
trical potential difference (DC) and the proton gradient
(DpH) – appear to be separable [16,17,57]. Translocation
energised by DpH is postulated to be an intrinsic prop-
erty of the export gate, with a conserved aspartate
(Asp208) in FlhA suggested to be involved, perhaps
indirectly, in proton transport [58]. Harnessing the en-
ergy of DC, however, requires the ATPase complex
[57,58]. Specifically, interactions between the FliJ
ATPase central stalk with the FlhA export cage are
needed for the export gate to function as an efficient
DC-driven protein translocator [57]. Although the mech-
anism of PMF-powered membrane translocation remains
unclear, it is proposed that DC and DpH act together to
energise the export gate in its suggested function as a
proton–protein antiporter [57].
FliM
FliGMC
FliN
FliH
(puta!ve posi!on)
FlhB
(puta!ve posi!on)
FliI ATPase
FliS chaperone–
FliC subunit complex
1. Subunit unfolding
FliJ escort
FlhA
2. FliS chaperone
release
4. Subunit
linkage
3. Export gate
recogni!on
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Figure 2. Sequential interactions of flagellar subunits with the membrane export machinery. The rotary ATPase complex (FliI hexamer, 2DPY [67]; FliJ escort, 3AJW [28]) is
associated with the C ring (FliGMC, 1LKV [68]; FliM, 2HP7 [69]; FliN tetramer, 1YAB [70]) via FliH (proposed position indicated by broken lines). The chaperone–subunit
complex (FliS–FliC, 1ORY [71]) docks initially at the ATPase complex before entering the export cage, comprising a nonameric ring of FlhA (FlhAC, 3A5I [72]), and then
passing to the export gate component FlhBC (3B0Z [45]). Subunits are then translocated across the cell membrane into the export channel.
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 the ATPase can facilitate the release of chaperone and the unfolding of subunit prior 
to export (126). In the case of late subunits, affinity of chaperone-subunit complex for 
their export gate reflect the order of the final structure. This gate-chaperone-subunit 
interaction may serve as a checkpoint to impose order onto the late structure, 
preventing export of flagellin before the hook-filament junction proteins have been 
exported (168). 
 
The export gate FlhA complex is a proton-protein antiporter that can make use of the 
PMF to translocate protein across the cell envelope. FlhA contains a charged residue, 
Aspartate-208, on its transmembrane a-helix5 that is directly involved in protein export 
(169). The efficiency is increased in the presence of the ATPase, suggesting the need 
for two energy sources (170). 
 
Early subunits are not chaperoned to the export gate, but rather possess a secretion 
signal that allows them to bind directly to their export gate, FlhB (165). This signal and 
the role of FlhB will be discussed in section 1.9.1. Early subunits are still exported at 
least partially unfolded, although FlhB does not seem to have a proton channel in its 
transmembrane a-helical domains as FlhA does. Most research into early subunit 
export has studied how early subunits contact FlhB. Early subunit interactions with the 
ATPase, if any, remain unknown. 
 
A picture emerges of subunits reaching the fT3SS, interacting first with the ATPase 
before being handed off to the export gate. How are subunits exported through the 
channel? For some time, it has been shown that subunits must be at least partially 
unfolded by the PMF with help from the ATPase before being exported (75, 90, 91). 
The central channel diameter, 13 Å for the rod and hook and 20 Å for the filament, is 
not wide enough to accommodate folded protein, although it is predicted that limited 
secondary structure may be able to pass through (127, 128). Radics and colleagues 
used cryo-EM to investigate the structure of subunits during export through the 
Salmonella injectisome T3SS. Their work mapped the path an exporting subunit 
follows and found that subunits must be unfolded during export to follow the export 
path (68). As the flagellum has a narrower channel than the injectisome, flagellar 
subunits are probably also exported fully unfolded. 
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 Now that the subunit has reached the fT3SS and docked at the gate, how does it reach 
the distal site of assembly? Especially as there is no apparent source of energy in the 
flagellar channel to power subunit transit (171). Recent work suggests two 
mechanisms. 
 
Evans and colleagues proposed that subunits travel to the site of assembly as a 
subunit chain (Figure 1.7A). Subunits link into chains via their termini as parallel a-
helical coiled coils. The N-terminus of an export gate docked-subunit can be captured 
by the C-terminus of a channel subunit. Subunits then transit through the channel 
without the addition of an external energy source because of the inherent entropic 
force of the unfolded subunits. Once they reach the site of assembly, subunits 
polymerise into the growing structure, anchoring the chain. This anchor provides 
directionality to the chain, pulling it from the fT3SS at the base to the distal tip. As each 
subunit assembles into the growing structure, the subunit chain tightens. The chain 
can then generate enough force to pull the next docked subunit off the export gate, 
which causes the chain to relax and restarts the process. In this way, the chain tightens 
and relaxes in rapid succession as subunits polymerise into the structure, capable of 
delivering subunits to the site of assembly at a constant rate (165). The chain 
mechanism, then, explains another recent observation that flagellum growth rate is 
independent of length, something diffusion alone cannot account for (165, 172). 
 
For the chain mechanism to work, there are a few conditions that must be met. 
Subunits must be able to link head-to-tail via their termini, this complex must be able 
to move through the channel, and subsequent forces forming the chain must be strong 
enough to hold the chain together but weak enough to break upon subunit 
polymerisation into the structure. 
 
The authors showed by in vitro capture assays and in vivo crosslinking experiments 
that early and late subunits can link up by their termini, and that this linkage was 
specific to the termini. Importantly, they showed that different early subunits could link 
their termini, leading to the possibility of a mixed subunit chain. Late subunits could 
not capture early subunits into a chain, so a mixed export “phase” chain is not possible. 
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Figure 1.7 Mechanisms for subunit transit and flagellum growth
(A) The proposed chain mechanism for flagellum assembly. Subunits are unfolded at the
fT3SS, leaving the terminus of a docked subunit free to interact with a channel bound subunit to
form a coiled coil domain. These head-to-tail links form a subunit chain that travels the length of
the structure. Transit is self-powered, the entropic force of the subunits enough to power transit,
and unidirectional as subunit folding into the structure or the environment prevents the chain
from moving back into the cell. Upon a chain break, the next subunit can diffuse to the site of
assembly to restart subunit chaining. The subunit chain is capable of delivering subunits at a
constant rate, independent of flagellum length (Evans et al., 2013). Figure adapted from Evans
et al., 2013.
(B) The injection-diffusion model of subunit transit. Subunits are injected into the channel by the
fT3SS using energy provided by the PMF. Subunits then travel through the channel via single-
file diffusion. The channel is too narrow to allow for overlapping interaction, so any subunit-
subunit interactions are primarily ballistic. Growth slows as the length of the filament grows
(Renault et al., 2017). Figure adapted from Evans et al., 2013.
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 They also showed that subunits lacking termini could not pull docked subunit from the 
export gate (165). 
 
The subunit chain relies on three core forces – the force holding the subunit to the 
export gate (FM), the force between the subunit termini forming the links of the chain 
(FL), and the anchoring force as subunit polymerises into the flagellar tip (FA). FlgD 
was found to bind the FlhB export gate weakly, with a Kd about 40 µM, resulting in a 
weak FM of about ~30 pN for FlgD. This force is weaker than FL, which is predicted to 
be between 400-700 pN. Finally, the FA is at least an order of magnitude greater than 
FL, approximately 11 nN when subunit polymerises into the structure. The FA is weaker 
when subunit refolds in the external environment, only ~6 nN, but it is still strong 
enough to pull the chain through the channel. Each of these forces are successively 
stronger than the last, meaning each successive force can break the last but cannot 
be broken by the prior force, allowing the chain to move quickly and unidirectionally 
through the channel (165). 
 
Unfortunately, Evans and colleagues did not discuss the width of the proposed coiled 
coils and whether they could fit through the channel. Another parallel coiled coil dimer 
found in nature is the leucine zipper. These zippers have a width of ~30 Å, much too 
large to fit through the HBB or filament channel. Leucine zippers are twisted, which 
causes them to bulge (173). It is reasonable to assume that straightened parallel 
coiled coils as proposed by Evans and colleagues would be narrower. Another 
example of the structure subunit termini may adapt is an a-helical hairpin. These 
hairpin structures are still wider than the narrowest part of the channel, just over 14 Å 
at their narrowest point (174). 
 
How could termini interact in the channel? That question now becomes more important 
to the viability of the chain mechanism. The two examples provided aren’t of flagellar 
subunits, so it is possible that flagellar subunit termini make different coiled coil 
structures. Even if narrower than the channel, there is not much room for overlapping 
domains to pass through. The wider the coiled coils are, the more likely they would 
get stuck in the channel, requiring a very large force to push or pull them through, or 
could interact with the residues lining the channel and possibly slow down the chain. 
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 Of course, this assumes termini do adopt secondary structure in the channel, which 
may not be the case. The termini structure of flagellar subunits during export needs to 
be investigated further to determine if they can fit through the channel. 
 
If not a chain mechanism, then what? Renault and colleagues present evidence for an 
injection-diffusion model of subunit transit (Figure 1.7B). In their model, subunits do 
not form a chain to transit outside the cell. Rather, they propose subunits are injected 
into the channel with energy provided by the PMF and diffuse individually to the site 
of assembly. They note that the growth rate of filament length is not independent of 
the length of the filament by elegantly labelling in situ different stages of filament 
growth in living cells. During flagellum growth, they exchange the fluorescent dyes to 
detect the different filament fragments. This allowed Renault and colleagues to track 
filament growth accurately and precisely over time. They watched the elongation rate 
hasten when filaments were made shorter by mechanical forces. They conclude that 
the growth rate is inversely proportional to filament length and slows drastically from 
an initial rate of roughly ~83-100 nm min-1 until the growth rate becomes negligible in 
very long filaments. When they disrupted the PMF by using carbonyl cyanide m-
chlorophenyl hydrazone (CCCP), they found the growth rate slowed to ~18 nm min-1 
and became linear, similar to the previously report independent growth rate of ~13 nm 
min-1 (99, 172). Thus, they concluded that PMF is used to inject unfolded monomers 
into the channel (99). 
 
How may subunits diffuse to the site of assembly? In the injection-diffusion model, 
subunit monomers must diffuse in single file. The authors reason the channel is too 
narrow to allow for end-to-end binding, so they predict any interaction between 
monomers to be ballistic. As the channel fills with monomers, diffusion would slow 
accordingly because monomers would be unable to pass one another in the channel 
(99). 
 
These two models do leave questions unanswered. Can subunits chain? It certainly 
seems so for early subunits, where robust in vivo and in vitro evidence was presented. 
For late subunits the picture is murkier (165). There is other evidence that a subunit 
chain may not drive subunit transit. Hook-filament junction proteins (FlgK, FlgL) and 
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 the filament cap (FliD) are secreted in relatively high levels throughout filament 
assembly (175). But flagellin does not appear to bind to the hook-filament junction 
proteins. It can, however, bind to FliD, which can bind to the junction proteins (176). It 
is possible, then, that if the subunit chain is broken by a junction subunit, FliD can 
restart the chain by acting as a bridge between flagellin and the junction proteins. The 
chances of this would depend on subunit expression level and the export gate’s ability 
to discriminate subunits. 
 
Can subunits interact in and with the channel? The injection-diffusion model makes a 
fair assumption that the channel is too narrow to allow for any monomers to interact 
end-to-end during transit (99). No one has observed a subunit trapped in the flagellar 
channel, so it is hard to conclusively say what structure subunits adopt in the channel. 
But, if subunits were to interact in the channel, they could act as a cork and prevent 
subunit travel, effectively killing that flagellum until the interaction weakened or the cell 
spent enough energy to push the subunits through. In a long flagellum, this would grow 
costly. The chain mechanism pre-empts this by claiming that subunits must interact to 
transit to the site of assembly. Although both models support that friction is not the 
rate-limiting step in pulling subunits, they do not discuss in detail whether subunits 
might interact with the channel wall at any step (99, 165). If subunits travel through the 
chain unfolded, as is the case in the injectisome, that would leave all their residues to 
interact with available channel residues (68). In this case, subunit transit could be 
significantly slowed depending on the strength and kinetics of these interactions. 
 
As with so many things in nature, the true subunit transit mechanism is probably closer 
to a combination of both the chain mechanism and the injection-diffusion mechanism. 
In fact, Evans and colleagues proposed diffusion as the necessary restart whenever 
the chain breaks due to inability of subunits to chain or a sheared filament 
necessitating a new cap (165). This could also explain why, although the chain is 
capable of delivering subunits at a constant rate, this would not be the case in nature 
(99, 165). So, although these two models are much more advanced than past 
proposals, more research is needed into subunit structure in the channel and inter-
subunit interactions to elucidate the true mechanism of subunit transit. 
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 Subunit transit and assembly are only part of the story, of course. Flagellar structure 
is tightly ordered by a combination of gene expression hierarchy discussed in section 
1.6 and protein-protein interactions at the fT3SS. The fT3SS imposes a strict order on 
subunit export and assembly via many interactions between fT3SS components and 
other flagellar subunits. This control is tied to gene expression via the fT3SS 
monitoring the phases of flagellar assembly. Without this level of feedback and control 
between the export machinery and gene expression, a competent structure cannot be 
produced. The following section discusses the roles of a few fT3SS components in 
imposing order on subunit export and assembly. 
 
1.9 Ordered assembly 
A shared and notable feature among T3SSs is the ability to discriminate between 
subunits and impose order onto subunit export. T3SS systems operate in phases – an 
early phase and a late phase for the fT3SS and an early, intermediate, and late phase 
for the injectisome. The early phase sees the export and assembly of basal body and 
hook subunits in the flagellar system and basal body and needle structure in the 
injectisome system (105, 177). The length of this early structure is measured by a 
secreted molecular ruler (178–181). Once a mature hook or needle length has been 
measured, a signal is sent to the export machinery, leading to a switch in export 
specificity to the second hierarchy of subunits (105, 177). Late flagellar subunits, those 
that assemble into the filament, or intermediate injectisome subunits, those that make 
up the translocon, are now made ready for export (126, 182). 
 
The export specificity switch remains one of the greatest outstanding questions in type 
III secretion. Much work over the past few decades has uncovered two key proteins 
for the switch found in T3SSs – a membrane-anchored subunit export gate, FlhB/SctU, 
and the aforementioned secreted molecular ruler, FliK/SctP. How do these proteins 
work together to cause the switch? 
 
A brief note on nomenclature. Unlike flagellar subunits nomenclature, injectisome 
subunit nomenclature is not unified. There are efforts by some groups to unify 
injectisome nomenclature using the secretion and cellular translocation (Sct) 
nomenclature (183). In the following sections, injectisome components will be 
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 identified with their Sct names unless otherwise specified. Where both names are 
used (e.g. FlhB/SctU), the information pertains to both T3SSs. 
 
1.9.1 The early subunit export gate, FlhB 
The early subunit export gate FlhB/SctU is a core member of the dedicated type III 
secretion export apparatus (Figure 1.8A-D), integrated into the membrane via the Sec 
pathway. FlhB/SctU contains two domains – a transmembrane domain comprising 
four alpha-helices through the inner member and a cytosolic domain (126). These two 
domains are connected by a linker (184). Although usually considered disordered, the 
linker domain of Yersinia SctU was shown to adapt a helical conformation when near 
a negatively-charged membrane, directly interacting with the membrane via a lysine 
and arginine on the membrane-face of the helix. Mutating the positively-charged, 
solvent exposed residues in the helix did not affect the interaction with the membrane, 
but affected effector molecule secretion, suggesting that this helical linker may serve 
to position the early subunit export gate to function appropriately (185). 
 
One copy of Salmonella pathogenicity island 1 (SPI-1) SctU was found at the export 
machinery by using mass spectrometry of peptide concatenated standards and 
synthetic stable isotope-labeled peptides (186). Genetic fusions observed in the 
flagellum of other species (like the Clostridia) and biochemical work completed in 
Salmonella show that a fusion between flhB and another export apparatus protein, 
dubbed fliR in flagella, is motile. These data support the hypothesis that FlhB is located 
in association with FliR near the export channel at the inner membrane (186, 187). 
Purification of full length FlhB and HBB showed that FlhB is able to dimerise, certainly 
in vitro in detergent micelles and possibly in vivo (188). The FlhB cytoplasmic domains 
were not found to interact, suggesting that the transmembrane domains were 
responsible for dimerization, if it were to occur at all in the cell, and may force the 
cytoplasmic domains into close proximity (188, 189). Further, deletion of flhB did not 
substantially alter the T3SS as measured by electron cryo-tomography (166). These 
data suggest that only one copy, two at most, of FlhB/SctU are present within the 
T3SS, although it may be system-dependent. 
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Figure 1.8 The early subunit export gate and secreted molecular ruler share features in
both flagellar and needle T3SSs
(A) Atomic resolution structure of autocleaved Salmonella FlhBC. FlhBCN is in blue, FlhBCC is
in yellow. The autocleavage site is in red.
(B) Atomic resolution structure of autocleaved Yersinia pestis YscUC (SctUC). YscUCN is in
blue, YscUCC is in yellow. The autocleavage site is in red.
(C) Surface-exposed hydrophobic patch where flagellar rod and hook subunits are proposed
to bind prior to export (Evans et al., 2013).
(D) Surface-exposed binding site for the Yersinia molecular ruler YscP (SctP) (Ho et al.,
2017).
(E) Sequences of putative GRMs of type III molecular rulers that may bind to FlhB/SctU.
Sequences in red are confirmed to interact with the early subunit export gate, FlhB/SctU.
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 The cytosolic domain of FlhB/SctU (FlhBC/SctUC) contains a highly conserved NPTH 
loop found in both the flagellar and injectisome T3S export apparatus. This loop 
undergoes rapid succinimide-mediated autocleavage with a half-life of approximately 
five minutes, resulting in two, non-covalently interacting cytoplasmic domains – the 
cytosolic N-terminal domain (FlhBCN/SctUCN) and the cytosolic C-terminal domain 
(FlhBCC/SctUCC) (Figure 1.8A and 1.8B) (184, 189–191). After autocleavage, the two 
polypeptides remain tightly associated with one another, although the exact magnitude 
of this association is unknown (190, 192). 
 
The autocleavage of the early subunit export gate is necessary for the proper 
functioning of the type III export machinery. A single residue mutation at the FlhB 
NPTH loop resulting in a loss of or inefficient autocleavage leads to the polyhook 
phenotype, where the cell continues to export and assemble flagellar hook subunit 
instead of controlling hook length. These flagella are therefore locked into early 
subunit export and are not motile (193). Similar results have been shown for SctU in 
a variety of pathogens (194–197). Autocleavage-deficient mutants of flhB are, 
however, still capable of exporting early subunits (193). Autocleavage appears only 
critical, then, to switch export specificity to intermediate injectisome or late flagellar 
subunits. 
 
As previously discussed, early flagellar subunits are not chaperoned to the export 
machinery. Rather, they possess an N-terminal, hydrophobic, five-residue secretion 
signal, dubbed the gate recognition motif (GRM) (86). This motif has also been 
reported in the injectisome molecular ruler, an early subunit secreted during needle 
assembly in the injectisome T3SS (Figure 1.8E) (88, 89). FlhBCC contains the putative 
surface-exposed, hydrophobic binding pocket for the early subunits (Figure 1.8C) (86). 
Recently, a similar binding pocket was uncovered for needle rod subunits in Yersinia 
pseudotuberculosis SctUCC (Figure 1.8D) (89). 
 
What might happen to FlhB after the switch? In Yersinia, it has been shown that 
SctUCC can dissociate from the rest of the SctU export gate after autocleavage and 
that it may be secreted from the cell after the switch is triggered (198). It was later 
determined that this domain may carry a secretion signal in the last 15 residues (199). 
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 Whether SctUCC is secreted into host cells has not been investigated, so its ultimate 
fate is unknown. It also remains unclear if other FlhB/SctU-type proteins share this 
feature. 
 
1.9.2 The molecular ruler, FliK 
In addition to the early subunit export gate, the secreted molecular ruler, FliK/SctP, is 
required to switch export specificity at the export machinery. The type III secreted 
molecular ruler is classed as an early subunit, possessing a GRM like other flagellar 
subunits, but does not assemble into the final structure (Figure 1.8E) (86, 88, 89). 
Instead, the N-terminal domain of FliK measures the length of the nascent hook or 
needle structure before being secreted into the environment (200). 
 
The C-terminal domain of FliK/SctP was dubbed the type III secretion substrate 
specificity switch (T3S4) (201). Genetic studies confirmed that 50 residues located in 
the core T3S4 domain and the last five residues of FliK were critical to the export 
specificity switch. These deletions had some effect on expression level, but did not 
affect export of the molecular ruler (202). 
 
FliK/SctP share low sequence homology across species, but do share structural and 
functional features. FliK/SctP proteins possess a “ball and chain” structure, consisting 
of an extended N-terminal ruler domain and a folded C-terminal T3S4 domain (88, 89, 
203). These domains are connected by a disordered linker, which can be lengthened 
or shortened to correspondingly lengthen or shorten the flagellar hook (204). Thus, 
the length of the hook is not dependent on any inherent polymerisation feature of FlgE, 
like is the case with the distal rod, but under the direct control of the length of the 
molecular ruler’s N-terminus and linker. Atomic force microscopy revealed that the 
FliK N-terminal domain could form a stable ball in solution, although it is not structured 
enough for structural studies using NMR or crystallography (205). This suggests that 
the N-terminal domain of the molecular ruler is easily unfolded by the type III export 
machinery prior to export so that the unfolded N-terminus can serve as a measuring 
stick as it transits through the export channel. 
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 The number of molecular rulers secreted by the injectisome or the flagellar T3SS 
varies. In the injectisome, SctP is secreted once; thus, a single N-terminal domain of 
the molecular ruler must measure the growing needle and trigger the export specificity 
switch at the injectisome export machinery (206). Yersinia SctP was observed to have 
two secretion signals in the N-terminal domain, supporting the notion that the N-
terminus is secreted first (207). The Yersinia molecular ruler has been observed at the 
tip of the needle by immunogold electron microscopy (208), hinting that the single 
molecular ruler may continue to associate with the needle as it is assembled. 
 
In contrast, FliK is secreted intermittently over the course of hook assembly (142). 
Unlike the injectisome which does not have a needle cap, FliK can interact in vitro with 
the hook cap, the protein found at the tip of the nascent hook (209). The N-terminal 
domain of the molecular ruler must follow the growing hook throughout assembly 
before being secreted into the environment by the hook cap, again supporting that the 
N-terminal domain is secreted first. To study the distribution of FliK prior to export, 
Hirano and colleagues fused the cyan fluorescent protein (CFP) to the N-terminus of 
the FliK molecular ruler. Although this fusion may be assumed to have masked the 
FliK N-terminal GRM, they found that cells expressing the CFP-FliK fusion swam 
comparable to wild type. Their results demonstrated that FliK is homogenously located 
throughout the cell after expression and that it presumably only interacts with the T3SS 
in preparation of export (210). Therefore, the secretion of the FliK N-terminal domain 
serves to place the FliK C-terminal T3S4 near the export machinery long enough to 
lead to the export specificity switch. 
 
It is well-studied that the early subunit export gate and secreted molecular ruler must 
communicate to switch export specificity at the type III export machinery. This has 
been observed from genetic studies and biochemical studies using full length protein 
(88, 89, 191, 202, 204). Genetic studies suggest the C-terminal T3S4 domain of the 
molecular ruler may interact with the cytoplasmic domain of the early subunit export 
gate to cause the export specificity switch (202). But subsequent biochemical analysis 
of an interaction between FliKC/SctPC and FlhBC/SctUC are crucially lacking. Only a 
handful of studies have investigated the possibility of the molecular ruler T3S4 binding 
in vitro to the early subunit export gate and have found mixed results (86, 88, 89, 211). 
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 Lorenz and colleague found that SctP N-terminus of Xanthomonas was unable to bind 
SctU without the C-terminal T3S4 present. They did not investigate if the T3S4 could 
bind the SctU on its own (211). Evans and colleagues found that FliK without the GRM 
(FliKDGRM) can bind GST-FlhBC weakly in vitro (86). Although, as FliKDGRM is missing 
only five residues from the N-terminus but is otherwise intact, it is difficult to determine 
if this weaker binding was due specifically to the FliKC T3S4 domain associating with 
FlhBC. Ho and colleagues found that Yersinia SctPC only associated with SctUC when 
the linker region was present with the C-terminal T3S4 region. The C-terminal T3S4 
region alone did not show evidence of an interaction, suggesting it is either very weak 
or non-existent (89). Similarly, in Pseudomonas, the SctPC T3S4 alone was unable to 
bind SctUC in vitro (88). 
 
Most biophysical studies measuring the affinity between the molecular ruler and early 
subunit export gate have used full length protein, rather than isolating individual 
domains for study (89, 191). It is therefore reasonable to suspect that these affinity 
measurements mostly relate to the GRM secretion motif near the molecular ruler’s N-
terminus. These data should not serve as demonstrative proof that the C-terminus 
binds to the early subunit export gate to trigger the export specificity switch, a 
hypothesis that remains in dispute. Further investigation should seek to isolate the 
domains of the molecular ruler to determine what domains may bind the early export 
gate and what the magnitude of binding may be. 
 
1.9.3 Other proteins contributing to the switch 
Whatever the interaction between FliK/SctP and FlhB/SctU may be, they are by far 
the most conserved players of the export specificity switch. But other proteins may 
play a limited role, depending on the species. 
 
Some organisms, like Salmonella, possess a “cork” at the base of the flagellum, a 
protein called Flk (pronounced fluke) that may work in association with FlhA to prevent 
premature switching by FliK (212). It has been proposed that FliKC could only interact 
with FlhBC once it has bypassed the Flk cork, as would happen when FliK is exported 
through a mature hook (105). The location of Flk in the export machinery has not been 
determined, so it is hard to say if this may be the case. We do know that Flk faces the 
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 cytoplasm, anchored via a C-terminal hydrophobic transmembrane tail, and prevents 
premature switching (213). Flk seems to manage the export specificity switch by 
coupling translation of flgM mRNA with P- and L-ring assembly (214). As Flk is found 
in only a handful of organisms, it remains poorly studied. But since it provides some 
control over the export specificity switch in Salmonella and other enteric bacteria, 
further investigation is merited. 
 
FlhE is a conserved flagellar subunit in Salmonella and other peritrichous bacteria that 
is required for swarming motility, but not swimming motility (215). As it is not involved 
in flagellar biogenesis and found only in flagellar systems in a limited number of 
species, FlhE is also not a well-studied protein and it is the last member of the flhABE 
operon without a clearly established function. The loss of FlhE causes a proton influx 
into the cytoplasm, suggesting that it may serve to modulate proton flow through the 
fT3SS (216). When FlhE was deleted from a Salmonella strain defective in P- and L-
ring assembly, the export specificity switch still occurred (212). At the moment, FlhE’s 
exact role in the switch is pure conjecture. The structure of the protein has been 
solved, so further biochemical and biophysical work on FlhE is possible to elucidate 
its true function in flagella regulation (217). 
 
Mutations in other proteins, such as FlhA, FlgG, and the C ring, have also been shown 
to affect the export specificity switch (212, 218). These mutations probably interfere 
with the FlhB-FliK control of the export specificity switch, either directly or by changing 
flagellar structure to allow for spontaneous switching. 
 
1.9.4 State of the export specificity switch 
The beginnings of a mechanism emerge when we piece together individual data on 
the early subunit export gate and secreted molecular ruler. The most basic mechanism 
requires the export and assembly of hook or needle subunits. During this stage, the 
molecular ruler binds to the autocleaved early subunit export gate through an N-
terminal, hydrophobic gate recognition motif, the GRM. The molecular needle is 
secreted to measure the length of the nascent hook or needle. Once a mature length 
has been determined, the C-terminal T3S4 domain triggers the export specificity 
switch at the early subunit export gate. These facts are not disputed. But, due to some 
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 quirks between the two type III systems and some gaps in our knowledge, the exact 
mechanism remains unknown. There are two recent hypotheses that seek to collate 
the most robust evidence for the export specificity switch in each type III system. 
 
Erhardt and colleagues proposed a mechanism for the flagellar export specificity 
switch in 2011. In their model, the molecular ruler is secreted intermittently during hook 
assembly. In short hooks, the molecular ruler is secreted into the environment where 
it begins to refold, pulling the rest of the protein with it, before the T3S4 domain can 
trigger the switch at the early subunit export gate. This process continues until the 
hook has reached the desired physiological length. When another molecular ruler 
molecule is secreted to measure the completed hook, the interactions between the 
molecular ruler and assembled hook subunits slows secretion long enough to allow 
for the C-terminal T3S4 domain of the molecular ruler to trigger the switch at the early 
subunit gate (142).  
 
In the injectisome, Bergeron and colleagues proposed a model that saw the T3S4 
domain of Pseudomonas SctPC anchor at the tip of the nascent needle and the SctPN 
domain remain associated with the early subunit export gate. In this model, the 
disordered N-terminal domain is stretched while within the channel as the needle 
assembles. Once the ruler measures a mature needle length, the N-terminus domain 
docked at the early subunit gate triggers the switch, dislodges from the needle tip and 
the export gate, and is fully secreted (88). 
 
This latter model has been challenged for two main reasons. The first, affinity 
measurements between the molecular ruler GRM and the early subunit export gate 
are micromolar, strongly suggesting transient interactions (89, 191). The affinity 
between Yersinia SctP and SctUC, for example, was calculated by NMR to be 430 ± 
293 µM in vitro. This interaction alone is doubtless not strong enough to hold the SctP 
N-terminus at the early subunit export gate as Bergeron and colleagues proposed, 
unless, in vivo, there are further partners yet to be discovered or the membrane is 
involved in stabilising the interaction (89). 
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 Secondly, the flagellar and needle channel diameter is narrow, on the order of 20-25 
Å at its widest (88, 127, 219). This channel only allows for unfolded subunits, and 
possibly partially unfolded subunits, to transit through. Observing subunits in the 
channel is technically challenging, but recent work has demonstrated the physical 
limitations of having multiple parallel subunits in the channel at any one time (68, 86, 
99, 220). Even if SctP were not structured in the needle channel, it could interact with 
moving subunits and pose another barrier to efficient subunit transit. 
 
It should be noted that the molecular ruler may not need to be secreted to trigger the 
export specificity switch. In one published example, hook length was indirectly 
controlled by the number of available C-terminal domains of FliK at the flagellar export 
apparatus, with overexpression of the truncated protein ultimately leading to near wild-
type motility in the absence of any hook length measurement (210). This argues for a 
temporal element to the FliK-FlhB interaction that causes the export specificity switch. 
FliKC must be able to interact with FlhBC, or trigger other interactions, just long enough 
to lead to the subunit switch. It’s probable the timing of this interaction is equal to the 
rate of travel of FliKN through a mature hook. The FliK truncation, residues 100-405, 
that can switch export specificity in the absence of secretion left much of the FliK N-
terminus intact. None of the truncations without the N-terminus were capable of 
secretion or switching (210). This truncation may, then, be sufficiently long enough to 
correctly time the interaction between the FliK T3S4 and FlhBC to trigger the switch. 
What further role, if any, the FliK N-terminus and disordered linker region plays in the 
export specificity switch besides measuring hook length is unknown. 
 
It is reasonable to suggest that the two systems will have slightly different mechanisms 
because of the difference between secretion patterns of the molecular ruler, the 
additional phase of assembly in the injectisome, and the possibility that the fT3SS has 
two copies of the early subunit export gates instead of one as was found in the 
injectisome. Additionally, the export specificity switch often requires the orchestration 
of other cytoplasmic or membrane-anchored proteins beyond the molecular ruler and 
early subunit export gate, although that is highly system- and species-dependent. The 
shared evolutionary history between the flagellum and injectisome means that the two 
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 mechanisms will have much overlap, even when accounting for species-specific 
idiosyncrasies. 
 
1.10 Aims 
Many bacteria, including pathogens like Salmonella, require type III secretion in order 
to colonise a host and cause infection. What is clear about the nanomachines utilising 
type III secretion is the amount of coordination extending from protein-protein 
interactions to controlled gene expression needed for the final product. This study will 
investigate some of the protein-protein interactions that must occur if a bacterium 
hopes to move through its environment to find a suitable site of infection or an 
environment better suited to growth and proliferation. 
 
The fT3SS export specificity switch divides subunit export, and therefore overall 
assembly, into two phases. It intimately ties gene expression to flagellar substructure 
assembly through secretion of FlgM only after FliK has measured a mature hook and 
triggered the switch at FlhB. But it remains unclear how the export specificity switch 
occurs, particularly what conformational changes FliK may activate at FlhB to switch 
export specificity.  
 
This study seeks to further examine FlhB’s dual role as an early subunit export gate 
and the arbiter of the export specificity switch. In vivo techniques were used to 
investigate mutational effects on swimming motility, subunit export, and the fate of 
proteins in the cell in order to understand the interactions between early subunits and 
FlhB. In vitro techniques, such as circular dichroism (CD) and nuclear magnetic 
resonance (NMR) spectroscopy, were used to determine structural changes at FlhB 
post-autocleavage upon subunit binding and during the export specificity switch. 
 
This combination of molecular microbiological, biochemical, and biophysical 
techniques was applied to answer the following outstanding questions in type III 
secretion: 
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 1. What are the binding affinities of early subunit GRM interactions with FlhB? Do 
the affinities of these interactions impose order on early subunit export? If these 
affinities do impose order, this would be similar to late subunit export order. 
2. Where do early subunits bind on FlhBC and what conformational changes may 
this cause at FlhBC?  
3. Is the early subunit binding site on FlhBC similar to sites found on early subunit 
export gates in other T3SS? 
4. Why is FlhB autocleavage important to the export specificity switch? 
5. What changes, if any, does FlhB experience to switch the export specificity of 
the flagellar type III export machinery? 
6. How might FliK interact with FlhB to trigger the switch? 
 
It is hoped that the results from this study provide a clearer picture of the early phase 
of flagellar subunit export and the transition between the early and late export phases. 
Early subunit binding to the export gate FlhB and the export specificity switch have 
great potential to help us understand how bacteria coordinate protein export to 
assemble intricate nanomachines. Efforts are already underway to engineer T3SSs to 
pump out biotechnologically relevant substrates. The GRM is short secretion signal 
that could easily be added to substrates to facilitate their export via the rapid fT3SS. 
Knowing the various binding affinities of early subunit GRM to FlhB could lead to more 
efficient substrate export. Finally, understanding how T3SSs operate in phases will 
open a pipeline for scientists to design rational, novel therapeutics against a wide 
variety of bacteria as we are faced with the rising challenge of antimicrobial resistance 
and persistence. These cases make it even more crucial that we understand how type 
III secretion systems impose order on subunit export. 
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 Chapter 2 
Materials and Methods 
 
2.1 Reagents, buffers, and media 
A full list of all reagents, buffers, and media used can be found in Table A1.1. 
 
2.2 Enzymes 
All enzymes were purchased from ThermoFisher Scientific and New England Biolabs 
and used according to manufacturer’s instructions. Enzymes were stored at -20°C. 
 
2.3 Oligonucleotides 
All oligonucleotides used in this study were designed using Serial Cloner and 
synthesised by Sigma Aldrich at desalt purification and without modification. Primers 
were stored in deionised water (MilliQ) at -20°C. Table A1.2 provides a full list of 
primers used in this study. 
 
2.4 Bacterial Strains 
Table A1.3 lists the name, description, and source of all strains used in this study. 
Strains were grown in Luria-Bertani (LB) broth (Formedium) or agar (1.5% agar, 
Formedium) with appropriate antibiotic at 30°C or 37°C. Cells were harvested at 
various intervals during the growth cycle as measured by absorbance at 600nm (A600) 
using a Cecil CE 2041 spectrophotometer. All strains were kept in 25% v/v glycerol at 
-80°C. 
 
2.5 Plasmids 
Plasmids used in this study can be found in Table A1.4. All plasmids were stored in 
deionised water (MilliQ) at -20°C.  
 
2.6 DNA isolation, manipulation, and analysis 
2.6.1 Isolation of DNA 
Plasmids were isolated from 6 ml of overnight broth culture using the QIAprep spin 
miniprep kit (Qiagen) or PureLink quick plasmid mini kit (Life Technologies, 
ThermoFisher Scientific) following manufacturer’s instructions. Plasmids were eluted 
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 from supplied columns with 50 µl pre-warmed (50°C) deionised water for use in the 
polymerase chain reaction (PCR), restriction digests, or sequencing. DNA 
concentration and purity was measured using a nandrop ND1000 (Thermo Scientific). 
 
Genomic DNA from an overnight culture of Salmonella enterica serovar Typhimurium 
SJW1103 was purified using the GeneJET genomic DNA purification kit 
(ThermoFisher Scientific) following manufacturer’s instructions. 
 
2.6.2 Analysis and extraction of DNA from agarose gels 
Analysis of DNA was carried out using agarose gel electrophoresis with 1% w/v 
agarose (Sigma Aldrich) gels in 1x Tris-Acetic Acid-EDTA (TAE) buffer containing 5 
µg ml-1 ethidium bromide. Samples were resuspended in gel loading buffer, purple 
(NEB) before being loaded into the gel. DNA was visualised using UV illumination and 
fragment size was estimated compared to a 2-log DNA ladder (NEB). QIAquick gel 
extraction kit (Qiagen) or GeneJET gel extraction kit (Life Technologies, ThermoFisher 
Scientific) were used to excise DNA from 1% w/v agarose gel in 1x TAE buffer 
following manufacturer’s instructions. DNA was eluted from supplied columns with 
50µl pre-warmed (50°C) deionised water for use in downstream applications. 
 
2.7 Construction of bacterial strains 
2.7.1 Scarless mutagenesis or deletion within the Salmonella chromosome 
Salmonella enterica serovar Typhimurium strains were constructed using a modified 
method from the one described by Blank, Hensel, and Gerlach (Figure 2.1) (221). 
Briefly, oligonucleotides were designed to target the appropriate gene with 
replacement by a kanamycin resistance cassette containing a I-SceI endonuclease 
recognition site (encoded on plasmid pWRG717). PCR using pWRG717 as template 
was performed to amplify the resistance cassette flanked on its 5’ and 3’ ends by 45 
nucleotides homologous to the gene region of choice. The lambda red recombinase, 
controlled by heat shock-inducible promoter, was used to knock in the resistance 
cassette (pWRG730, chloramphenicolR). 
 
Salmonella enterica serovar Typhimurium SJW1103 was transformed with pWRG730 
per the method outlined in 2.10.2. Cells were plated on LB agar with chloramphenicol 
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Figure 2.1 Scarless mutagenesis or in-frame deletion within the Salmonella
chromosome using the lambda red (λ Red) recombinase
Briefly, a kanamycin resistance cassette (kan) and the I-SceI recognition site (yellow) are
amplified by PCR from pWRG717 plasmid using primers with 45 base pair homology
extensions (red and pink). This construct is integrated into the Salmonella Typhimurium
genome at orfX (any gene of interest) using λ Red-mediated recombination induced by
incubating the cells at 42°C. A second round of λ Red-mediated recombination with synthetic
double-stranded DNA (dsDNA, ~1000 base pairs in length) can be used to remove orfX,
resulting in an in-frame deletion (black and green), or to mutate a specific region of orfX (red
and pink). This results when the synthetic dsDNA with homologous regions recombines with
the chromosome. Unsuccessful recombinants are selected against by the I-SceI endonuclease
induced with the addition of anhydrotetracycline to the growth medium, resulting in double
stranded breaks (DSB). The plasmid encoding both the λ Red recombinase and I-SceI
endonuclease could be removed from the cell by incubation at 42°C without antibiotic. Figure
adapted from Blank, Hensel, and Gerlach, 2011.
kan
orfXʹ
λ Red
orfX
kanorfXʹ
dsDNA
λ Red + I-SceI
In-frame deletion Site-directed mutagenesis
orfXʹorfXʹ
Unsuccessful recombinants
orfXʹkanorfXʹ DSB
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 10 µg ml-1 and allowed to grow at 30°C overnight. A single colony was inoculated into 
5 ml LB broth with chloramphenicol 10 µg ml-1 and incubated with 200 rpm shaking at 
30°C overnight. 
 
Overnight culture was diluted 1:100 into 100 ml LB broth with chloramphenicol 10 µg 
ml-1. Cultures carrying the pWRG730 plasmid were incubated at 30°C with 200 rpm 
shaking until an A600 of 0.3. The lambda red recombinase was then induced by 
incubation at 42°C, 100 rpm, for 12.5 minutes. Cultures were chilled on ice for 15 
minutes before being washed three times with deionised water and once with 10% v/v 
glycerol as described in 2.10.2. Strains were resuspended in 10% v/v glycerol used 
immediately or stored at -80°C for later use. Successful recombinant strains were 
selected by growth on LB agar containing chloramphenicol 10 µg ml-1 and kanamycin 
25 µg ml-1. Strains were confirmed by phenotype assays and sequencing. pWRG730 
carrying the lambda red recombinase and I-SceI endonuclease was cured from the 
cell by overnight incubation at 42°C. The loss of pWRG730 was confirmed by plating 
colonies on LB agar and LB agar with chloramphenicol 10 µg ml-1 and selecting only 
strains which grew exclusively on LB agar overnight at 37°C. 
 
To remove the kanamycin resistance cassette, electrocompetent cells of kanamycin-
resistance strains carrying active lambda red recombinase and tetracycline-inducible 
I-SceI endonuclease on pWRG730 were transformed with a DNA insert produced 
synthetically (Sigma Aldrich) or by PCR. Cultures were incubated and the 
recombinase was induced as described above and electrocompetent cells prepped as 
in 2.10.2. PCR was used to generate a 1000 base pair DNA insert. This insert was 
homologous to the surrounding region of the appropriate gene. The insert could be 
used to knock out the gene of interest, leaving a scarless deletion, or to mutate the 
chromosomal copy of the gene depending on desired strain characteristics. Cells were 
plated on LB agar containing 100 ng ml-1 of anhydrotetracycline (AHT) to induce the 
expression of the I-SceI endonuclease. The I-SceI endonuclease cut the chromosome 
of any cells still carrying the kanamycin-resistance cassette, killing those cells and 
leaving only colonies of recombinant strains. Successful recombination was confirmed 
by phenotype assays and sequencing. pWRG730 carrying the lambda red 
recombinase and I-SceI endonuclease was liberated by plating confirmed strains on 
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 LB agar and incubating them overnight at 42°C. The loss of pWRG730 was confirmed 
by plating colonies on LB agar and LB agar with chloramphenicol 10 µg ml-1 and 
selecting only strains which grew exclusively on LB agar overnight at 37°C. 
 
2.8 Polymerase Chain Reaction (PCR) 
2.8.1 Amplification of DNA by PCR. 
DNA of interest was amplified using Q5 hot start high-fidelity DNA polymerase (New 
England Biolabs) following manufacturer’s recommendations in a MJ Mini Personal 
thermocycler (Bio-Rad) using thin-walled, flat-capped tubes. Q5 hot start high-fidelity 
DNA polymerase was chosen as it allows for room temperature setup, has 3’®5’ 
exonuclease activity, and an error rate lower than Pfu or Taq polymerase. Extension 
time was adjusted based on the length of the target gene and Tm was adjusted based 
on the chemistry of the primer pair. Salmonella enterica serovar Typhimurium strain 
SJW1103 genomic DNA or previously constructed plasmid served as templates for 
the reactions. Reaction conditions and an example reaction are below. 
 
Reaction mixture 
Polymerase buffer (5X)    10 µl 
10mM dNTPs     1 µl 
10µM primer pair (forward and reverse)  5 µl 
Template DNA (50ng)    1 µl 
Q5 hot start high-fidelity polymerase (2U) 0.5 µl 
Q5 GC enhancer (5X)    10 µl 
Nuclease-free water    22.5 µl 
Total reaction volume    50 µl 
 
PCR reaction setup 
1. Initial denaturation    98°C, 30 sec 
2. Denaturation     98°C, 10 sec 
3. Annealing     50-72°C, 30 sec 
4. Extension     72°C, 20 sec kb-1 
5. Final Extension    72°C, 2 min 
6. Hold      4°C, ¥ 
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 Steps 2-4 were cycled 25 times. QIAquick gel extraction kit (Qiagen) or GeneJET gel 
extraction kit (Life Technologies, ThermoFisher Scientific) were used to clean up PCR 
products following manufacturer’s instructions. 
 
2.8.2 Overlap extension PCR 
Overlap extension PCR is often used to splice together DNA molecules or to introduce 
mutations into a target DNA molecule. Here, it was mainly used for the latter purpose. 
Overlap extension PCR was performed with the reagents and protocol described in 
2.9.1 with slight modification. Two rounds of PCR were used, the products of the first 
round serving as the templates for the second round (Figure 2.2). 
 
Primer sets were designed so that the mutation being introduced fell in the middle of 
each mutagenesis primer. In total, four primers were designed for each reaction. 
Primers A and D flanked the gene of interest. Primers B and C, reverse 
complementary to one another, included the desired mutation and flanking region. In 
the first round of PCR, two reactions were carried out. Primers A and B were mixed 
as a pair, as were primers C and D. Agarose gel electrophoresis was used to confirm 
that only a single PCR product of proper length was amplified. This product was then 
excised from the agarose gel and purified, removing any background template from 
the first reaction which could contaminate the second round of PCR. 
 
In the second round of overlap extension PCR, primer pair A and D were used to 
amplify the overall gene region by mixing the two templates generated in the first 
round. Again, the PCR product was confirmed to be a single product of correct length 
using agarose gel electrophoresis and excised from the agarose gel. This final 
product, containing the desired mutation, was then used in the construction of 
recombinant plasmid or bacterial strains. 
 
2.9 Construction of recombinant plasmids 
2.9.1 Preparation of vector and insert DNA 
Vector and insert DNA were digested with restriction enzymes (NEB) at 37°C for 2 
hours in a MJ Mini Personal thermocycler (Bio-Rad) to generate compatible termini 
for ligation. Vector DNA was also incubated at 37°C for 2 hours with 1 U calf intestinal 
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Figure 2.2 Overlap extension PCR
Overview of overlap extension PCR. The blue circles represent a point mutation, but overlap
extension PCR can also be used to introduce short deletions or insertions as well.
PCR round 1
PCR round 1
a
d
a c
b d
AB
CD
AD
PCR round 2
Overlap extension
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 alkaline phosphatase (NEB) to dephosphorylate the 5’ end and prevent vector self-
ligation. If insert DNA was not purified by extraction from a TAE agarose gel, 10 U of 
restriction enzyme DpnI was included in the restriction digest mixture to degrade any 
remaining methylated template DNA. Sample from both digestions was mixed with gel 
loading buffer, purple, and analysed for proper and complete digestion on a 1% w/v 
agarose gel in TAE buffer. Digest reactions were cleaned using the QIAquick gel 
extraction kit (Qiagen) or GeneJET gel extraction kit (Life Technologies, ThermoFisher 
Scientific) following manufacturer’s instructions. 
 
2.9.2 Ligation of vector and insert DNA 
DNA concentration was calculated using a nanodrop ND1000 (Thermo Scientific). 
Vector and insert DNA were mixed in a 1:3 molar ratio with 1 U T4 DNA ligase 
(ThermoFisher Scientific) and reaction buffer containing adenosine triphosphate 
(ATP) and MgCl2. The ligation reaction was incubated at 20°C for 1 hour in a MJ Mini 
Personal thermocycler (Bio-Rad). The T4 DNA ligase was inactivated by heating the 
reaction mixture to 70°C for 5 minutes. 
 
2.9.3 Confirmation of recombinant plasmid 
The ligation mixture (3.5 µl) was transformed into 45 µl XL-1 blue or DH10b cells in 
10% v/v glycerol. Colonies appearing after overnight incubation at 37°C on LB agar 
with appropriate antibiotic were selected for colony PCR using Reddymix PCR Master 
Mix 2x (Thermo Scientific) with a primer pair specific to the vector and desired insert. 
Standard reaction conditions as recommended by the manufacturer were used, the 
Tm and extension time adjusted per the primer pair and length of insert. Plasmid was 
prepped as above from strains carrying the correct sized insert on the recombinant 
plasmid and sent to Source Bioscience or the University of Cambridge Department of 
Biochemistry sequencing facility for confirmation by Sanger sequencing. DNA 
sequence alignment was performed using the Multalin online tool (Corpet, F. 1988). 
Glycerol stocks with a final concentration of 25% v/v glycerol were made for each 
strain carrying a confirmed recombinant plasmid and stored at -80°C.  
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 2.10 Preparation and transformation of electrocompetent cells 
2.10.1 Escherichia coli strains C41 (DE3), XL-1 blue, and DH10b 
Overnight culture of E. coli strains was diluted 1:100 in 500 ml of sterile LB broth. 
Culture was incubated with 200 rpm shaking at 37°C to an A600 of 0.5. Cells were 
chilled on ice for 15 minutes before being collected by centrifugation at low speed 
(3000 xg, 10 minutes) to minimise cell lysis. Cells were resuspended twice in 250ml 
chilled deionised water and then collected by centrifugation. A final resuspension and 
wash in 25 ml of chilled deionised water was performed. Cells were collected by 
centrifugation and resuspended in 25 ml of chilled sterile 10% v/v glycerol before a 
final centrifugation step. Prepared cells were resuspended to a final volume of 2 ml of 
chilled sterile 10% v/v glycerol and aliquoted in 100 µl into 0.5 ml tubes (Starlab). Cells 
were immediately stored at -80°C. 
 
Electrocompetent cells were thawed on ice before use. Cells (45 µl) were incubated 
on ice with 1 µl recombinant plasmid for 1 minute in a 1 mm cuvette (VWR). Cells were 
transformed by electroporation with the following settings: 1.25 kV, 200 Ω, 25 µF. Cells 
were quickly resuspended in 500 µl super optimal broth with catabolite repression 
(SOC) and recovered at 37°C for 1 hour with 200 rpm shaking. Transformed cells were 
then selected for by plating on LB agar with appropriate antibiotics. Cells containing 
recombinant plasmids encoding ampicillin resistance were selected for on LB agar 
with carbenicillin to reduce the prevalence of satellite colonies. 
 
2.10.2 Salmonella enterica serovar Typhimurium SJW1103 and JR501 
Overnight culture of Salmonella strains was diluted 1:100 in 500 ml of sterile LB broth. 
Culture was incubated with 200 rpm shaking at 37°C to an A600 of 0.5. Cells were 
chilled on ice for 15 minutes before being collected by centrifugation at low speed 
(3000 xg, 10 minutes) to minimise cell lysis. Cells were resuspended twice in 250 ml 
chilled deionised water and incubated on ice for 30 minutes before collection by 
centrifugation between washes. A final resuspension and wash in 25 ml of chilled 
deionised water was performed. Cells were collected by centrifugation after incubation 
on ice for 30 minutes and resuspended in 25 ml of chilled sterile 10% v/v glycerol. 
Cells were immediately collected by centrifugation. Prepared cells were resuspended 
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 to a final volume of 2 ml of chilled sterile 10% v/v glycerol and aliquoted in 100 µl into 
0.5 ml tubes (Starlab). Cells were immediately stored at -80°C. 
 
Electrocompetent cells were thawed on ice before use. Cells (45 µl) were incubated 
on ice with 1 µl recombinant plasmid for 1 minute in a 1 mm cuvette (VWR). Cells were 
transformed by electroporation with the following settings: 1.25 kV, 200 Ω, 25 µF. Cells 
were quickly resuspended in 500 µl (SOC) and recovered at 37°C for 1 hour with 200 
rpm shaking. Transformed cells were then selected for by plating on LB agar with 
appropriate antibiotics. Cells containing recombinant plasmids encoding ampicillin 
resistance were selected for on LB agar with carbenicillin to reduce the prevalence of 
satellite colonies. 
 
Before transformation in SJW1103, recombinant plasmids were transformed into and 
purified from JR501 to allow for higher transformation efficiency. 
 
2.11 Expression of recombinant protein 
2.11.1 Expression of intein-chitin binding domain fusion protein 
E. coli C41 (DE3) cells were transformed with recombinant expression plasmid DNA 
and plated on LB agar containing appropriate antibiotic. LB broth (1 L) with appropriate 
antibiotic was inoculated with colonies and incubated at 37°C with 200 rpm shaking 
until an A600 of 0.7. Protein expression under the control of the T7 promoter was 
induced with the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG, Generon) 
to a final concentration of 1 mM. Cells were incubated at 30°C with 200 rpm shaking 
for a further 4-5 hours. 
 
2.11.2 Expression of His-tagged proteins 
E. coli C41 (DE3) cells were transformed with recombinant expression plasmid DNA 
and plated on LB agar containing appropriate antibiotic. 2x Yeast Tryptone broth (1 L) 
(2xYT, Formedium) with appropriate antibiotic was inoculated with colonies and 
incubated at 37°C with 200 rpm shaking until an A600 of 0.7. Protein expression under 
the control of the T7 promoter was induced with the addition of IPTG to a final 
concentration of 1 mM. Cells were incubated at 30°C with 200 rpm shaking for a further 
4-5 hours. 
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 2.11.3 Expression of proteins in M9 minimal medium 
E. coli C41 (DE3) cells were transformed with recombinant expression plasmid DNA 
and plated on LB agar containing appropriate antibiotic. Plates were incubated 
overnight at 37°C. Ammonium chloride was used as the nitrogen source and D-
glucose was used as the carbon source. 
 
2.11.3.1 M9 minimal medium containing 15N-ammonium chloride and/or 13C-
labeled glucose 
M9 minimal broth (10 ml) containing appropriate antibiotic was inoculated with 3-4 
colonies overnight at 37°C. Multiple colonies were used to increase cell growth in the 
minimal medium. Overnight cultures were diluted 1:100 in 500 ml M9 minimal broth 
containing appropriate antibiotic and 15NH4Cl, 98 atom %, and/or D-glucose-13C6, 99 
atom % (Sigma). Cultures were incubated at 37°C with 200 rpm shaking until an A600 
of 0.7. Protein expression under the control of the T7 promoter was induced with the 
addition of IPTG to a final concentration of 1 mM. Cells were incubated at 20°C with 
200 rpm shaking for a further 16 hours. 
 
2.11.3.2 M9 minimal medium containing 15N-ammonium chloride, deuterated 13C-
labeled glucose, and 99% D2O 
M9 minimal broth (10 ml) containing appropriate antibiotic was inoculated with 3-4 
colonies overnight at 37°C. Cells were passaged via a 1:20 dilution in 10 ml of M9 
minimal broth containing appropriate antibiotic and increasing amounts of D2O (0%, 
50%, 70%, 90%, 90%, 99%, 99%, 99%). Each passage was incubated overnight at 
37°C with 200 rpm shaking. Final overnight cultures were diluted 1:100 in 500 ml M9 
minimal broth containing appropriate antibiotic and 15NH4Cl, 98 atom %, D-Glucose-
13C6,1,2,3,4,5,6,6-d7, 99 atom %, and 99% D2O (Sigma). Cultures were incubated at 
37°C with 200 rpm shaking until an A600 of 0.7. Protein expression under the control 
of the T7 promoter was induced with the addition of IPTG to a final concentration of 1 
mM. Cells were incubated at 20°C with 200 rpm shaking for a further 16 hours. 
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 2.12 Protein purification 
2.12.1 Purification of FlhBC-intein-chitin binding domain fusion protein 
FlhBC residues 219-383 G383A fused to the intein-chitin binding domain (FlhBC-
inteinCBD) was used in isothermal titration calorimetry, crystallography, and nuclear 
magnetic resonance spectroscopy experiments. Purification of FlhBC-inteinCBD was 
performed as previously described with slight modifications (222, 223). InteinCBD was 
chosen as an expression and purification partner because prior studies successfully 
purified FlhB using this system and for its cost-effectiveness and ease of use. Briefly, 
cells were resuspended in 25 ml buffer A with 2 U DNaseI (ThermoFisher Scientific) 
and 1 tablet of cOmplete protease inhibitor cocktail, EDTA-free (Roche). The 
resuspension was homogenised using a glass tissue homogeniser (VWR). Cells were 
lysed by cell disruption at 30 kpsi (Constant Systems Ltd). The soluble fraction was 
collected by centrifugation at 100,000 xg, 4°C for 1 hour and filtered through a 0.2 μm 
Minisart hydrophilic cellulose acetate filter (Sartorius). The soluble fraction was then 
bound to pre-equilibrated chitin resin (NEB) and washed with 10 column volumes (CV) 
buffer A. FlhBC was cleaved from the resin-bound inteinCBD tag by incubating the 
proteins with buffer A supplemented with 100 mM dithiothreitol for 16 hours at 4°C 
(DTT, Melford Laboratories). 
 
Eluate containing FlhBC was dialysed against 5 L buffer B (50 mM Tris-HCl, pH 7.4, 
150 mM NaCl) for two hours using a 5 kDa cutoff regenerated cellulose dialysis 
membrane tubing (Spectrum Labs). Purification continued using an Äkta Express 
system (GE Healthcare) and a pre-equilibrated Hitrap SP HP 5 ml cation exchange 
column (GE Healthcare). The column with bound protein was washed with 10 CV 
buffer B. Protein was eluted using a gradient of up to 1.2 M NaCl. Fractions with FlhBC 
were determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) stained with Coomassie R250 and were collected for further purification using 
a Superdex 75 size exclusion column (GE Healthcare) pre-equilibrated with buffer B. 
The final FlhBC concentration was measured using a DC Protein Assay (Bio-Rad) with 
known Bovine Serum Albumin (BSA, GE Healthcare) standards. Protein was stored 
at 4°C or -80°C depending on application. If stored at -80°C, protein was frozen 
immediately in liquid nitrogen. 
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 2.12.2 Purification of intein-chitin binding domain tagged proteins 
FlhBC residues 211-383 G383A and variants fused to the intein-chitin binding domain 
(FlhBC211-inteinCBD) were used in circular dichroism scanning and thermal melt 
experiments. Cells were resuspended in 25 ml buffer A with 2 U DNaseI and 1 tablet 
of cOmplete protease inhibitor cocktail, EDTA-free. The resuspension was 
homogenised using a glass tissue homogeniser. Cells were lysed by cell disruption at 
30 kpsi. The soluble fraction was collected by centrifugation at 60,000 xg, 4°C for 1 
hour. The soluble fraction was then bound to pre-equilibrated chitin resin and washed 
with 10 CV buffer A. FlhBC variants were cleaved from the resin-bound inteinCBD tag 
by incubating the proteins with buffer A supplemented with 100 mM DTT for 16 hours 
at 4°C. 
 
Eluate containing FlhBC was dialysed twice against 5 L buffer C for 8 hours at 4°C 
using fresh 3.5 kDa cutoff SnakeSkin dialysis membrane tubing (ThermoFisher 
Scientific) each time. FlhBC211 purity was determined by SDS-PAGE stained with 
Instant Blue. If protein was determined to be less than 95% of the fraction, FlhBC211 
was further polished using a pre-equilibrated Superdex 75 size exclusion column (GE 
Healthcare) with buffer C. The final FlhBC211 concentration was measured using a 
nanodrop ND1000 set to 280 nm, an extinction coefficient of 22460 M-1 cm-1, and a 
molecular mass of 19651.66 g/mol. Protein was stored at 4°C until use. 
 
2.12.3 Purification of HexaHis-tagged proteins 
Cells expressing HexaHis-tagged proteins were resuspended in 25 ml buffer D with 2 
U DNaseI and 1 tablet of cOmplete protease inhibitor cocktail, EDTA-free. The 
resuspension was homogenised using a glass tissue homogeniser. Cells were lysed 
by cell disruption at 30 kpsi. The soluble fraction was collected by centrifugation at 
60,000 xg, 4°C for 1 hour. The soluble fraction was then bound to a pre-equilibrated 
HisTrap Excel 1 ml column (GE healthcare) attached to a BioLogic DuoFlow fast 
protein liquid chromatography (FPLC) machine (Bio-Rad) and washed with 10 CV 
buffer D. HexaHis-tagged proteins were eluted using buffer E. Fractions were 
analysed by SDS-PAGE stained with Instant Blue and those fractions containing the 
hexaHis-tagged protein of interest were pooled. HexaHis-tagged proteins were 
dialysed against buffer conditions required for the relevant experiment using fresh 3.5 
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 kDa cutoff SnakeSkin dialysis membrane tubing. Dialysis was carried out overnight at 
4°C to ensure removal of imidazole. Final protein concentration was measured using 
a DC Protein Assay against known BSA standards. Protein was used immediately or 
stored at 4°C until use. 
 
2.12.4 Purification of co-expressed FlgB and FlgC 
Recombinant pTXBI plasmid containing HexaHis-3xFLAG-FlgB and FlgC was 
expressed in E. coli C41 cells at 20°C overnight with 180 rpm shaking. This condition 
allowed for optimal expression of both proteins. Cells were collected by centrifugation 
and resuspended in 25 ml of buffer F with 2 U DNaseI and 1 tablet of cOmplete 
protease inhibitor cocktail, EDTA-free. The resuspension was homogenised using a 
glass tissue homogeniser. Cells were lysed by cell disruption at 30 kpsi. The soluble 
fraction was collected by centrifugation at 60,000 xg, 4°C for 1 hour. The soluble 
fraction was then bound to a pre-equilibrated HisTrap Excel 1 ml column (GE 
healthcare) attached to a BioLogic DuoFlow fast protein liquid chromatography (FPLC) 
machine (Bio-Rad) at a low flow rate of 0.5 ml min-1. The column was then washed 
with 10 CV buffer F at the same low flow rate. Proteins were eluted using buffer F 
supplemented with 300 mM imidazole in 1 ml fractions. Fractions were analysed by 
immunoblotting (Section 2.14) using mouse anti-FLAG M2 (1:5000) and mouse anti-
CBD (1:2000) for co-elution of FlgB and FlgC. 
 
2.13 Electrophoresis and staining of proteins 
Proteins were analysed by size separation on SDS polyacrylamide gels using the 
Laemmli method and were visualised using Coomassie Brilliant Blue R250 (Sigma 
Aldrich) or Instant Blue (Expedeon). Samples were resuspended in SDS loading buffer 
containing 140 mM b-mercaptoethanol (bME, Sigma Aldrich) and vortexed vigorously 
to remove any aggregates. Samples were then boiled at 95°C for 7 minutes to 
denature the proteins. Once cooled, samples were loaded onto 12.5-15% v/v 
polyacrylamide (Bio-Rad or Severn Biotech) resolving gels based on the predicted 
molecular weight of the protein(s) of interest. Stacking gels were 10% v/v 
polyacrylamide. After electrophoresis, usually 140 V for 65 minutes, gels were stained 
in Instant Blue and destained in deionised water or stained and fixed with 0.25% 
Coomassie Brilliant Blue R250, 10% acetic acid (Fisher Scientific), and 50% methanol 
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 (Sigma Aldrich) for 10 minutes before destaining in 20% methanol and 7% acetic acid 
for an hour. 
 
2.14 Immunoblotting of proteins 
Samples separated by SDS-PAGE were transferred onto nitrocellulose membrane, 
0.45 µm pore size (GE Healthcare), at 400 mA and 100 V for one hour in transfer 
buffer in a TE22 wet transfer tank (Hoefer). After transfer, membrane was blocked 
overnight at 4°C with 20 ml phosphate buffered saline (Hutchison Media Unit, 
University of Cambridge) with 0.05% v/v Triton X-100 (VWR) (PBST) and 5% w/v skim 
milk power (Marvel). Blots were then washed one time in 10 ml PBST to remove the 
skim milk. 
 
Fresh blocking solution (10 ml) with diluted primary antibody was added to the blot 
and allowed to incubate at room temperature for one hour. Primary antibody depended 
upon the protein sample being probed. A full list of antibodies and dilutions used in 
this study can be found in Table AI.5. Where FlhB or FlhBCT3xFLAG was being detected, 
0.5 ml of SJW1103DflhB soluble lysate (in PBS) was added to the blocking solution 
with primary antibody. The addition of the flhB null lysate greatly reduced the 
appearance of contaminating bands when analysing samples. 
 
After incubation with primary antibody, blots were washed three times, 5 minutes each 
in fresh blocking solution. Fresh blocking solution with 1:10000 IRDye 680RD donkey 
anti-mouse and/or IRDye 800CW donkey anti-rabbit infrared fluorescent secondary 
antibodies (Li-Cor) was then added and incubated at room temperature in the dark for 
one hour. Blots were washed twice, 5 minutes each in PBST before being washed 
twice, 5 minutes each in phosphate buffered saline (PBS). Blots were analysed with 
the Li-Cor Odyssey CLx system set to scan on both available infrared channels (680 
nm and 800 nm). 
 
2.15 Analysis of protein concentration 
2.15.1 Bio-Rad DC Protein assay 
Protein was diluted 1:10 in buffer. The same buffer served as a buffer absorbance 
control. BSA standards (0.25, 0.5, 1.0, and 2.0 mg ml-1) were stored in 0.9% w/v saline 
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 solution at -20°C. They were thawed at room temperature as needed. Deionised water 
was used as the absorbance blank. All samples were performed in duplicate. 
 
Sample (20 µl of protein, buffer, or BSA standard) was added to a 10x4x45 mm 
polystyrene cuvette (Sarstedt). Reagent A (100 µl) was added to each sample, 
followed by 800 µl of Reagent B. Samples were vortexed and incubated for 10 minutes 
in the dark. Sample absorbance was measured at 750 nm, or A750, with a 
spectrophotometer (Cecil). Any A750 from buffer was subtracted from the protein 
sample. The unknown protein sample was compared to the BSA standards using a 
best fit line to determine protein concentration. Protein purity was confirmed using 
SDS-PAGE and concentration was reassessed if needed. 
 
2.15.2 Nanodrop spectrophotometer 
Protein was diluted 1:10 in buffer. The same buffer served as an absorbance blank 
control. Sample (1 µl) was analysed by a scan from 200-400 nm. Concentration was 
determined by the absorbance at 280nm, or A280, using the protein’s predicted 
molecular weight and extinction coefficient. Protein purity was confirmed using SDS-
PAGE and concentration was reassessed if needed. 
 
2.16 Subunit export assay 
Export assays were performed as previously described with few modifications (86). S. 
enterica serovar Typhimurium strains were first transformed with relevant 
pBAD18amp plasmids as described above. The A600 of overnight cultures was 
measured and culture was diluted in 10 ml LB with appropriate antibiotics and 0.02% 
w/v L-arabinose (Acros Organics) to an A600 of 0.05. Cultures were incubated at 37°C 
with 200 rpm shaking until the culture reached an A600 of 0.2. Cultures were then 
washed and transferred to 10 ml fresh LB with appropriate antibiotics and 0.02% w/v 
L-arabinose. A 1 ml sample was taken and centrifuged at 17,000 xg, 4°C. The cell 
pellet was saved as the “whole cell” fraction. Supernatant was recovered and passed 
through a 0.2 μm Minisart hydrophilic cellulose acetate filter. Exported subunits were 
precipitated from filtered supernatant with 10% v/v trichloroacetic acid (TCA) and 1% 
v/v Triton X-100 overnight at 4°C. Precipitated protein was centrifuged at 17,000 xg, 
4°C for 20 minutes. Protein pellets were resuspended in 1 ml ice cold 100% acetone 
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 (Sigma Aldrich) and vortexed vigorously to remove any remaining TCA. Precipiated 
protein was pelleted by centrifugation at 17,000 xg, 4°C for 20 minutes. Remaining 
acetone was allowed to evaporate. Whole cell and supernatant samples were 
resuspended in SDS-PAGE loading buffer, standardised against culture A600 with a 
1:100 dilution for whole cell fractions and 1:50 for supernatant fractions. These were 
called time point “0” samples. 
 
The remaining 9 ml of cultures were incubated for one hour at 37°C with 200 rpm 
shaking. A 1 ml sample of culture was taken and culture density was recorded at A600. 
The sample was centrifuged at 17000 xg, 4°C for 5 minutes to pellet the cells. Whole 
cell and supernatant samples at 60 minutes, time point “60”, were treated the same 
way as time point “0” samples. Whole cell and supernatant samples were 
resuspended in SDS-PAGE loading buffer, volume standardized against culture A600. 
All samples were visualised with immunoblotting. 
 
2.17 Swimming motility assay (in null and wildtype strains) 
S. enterica serovar Typhimurium SJW1103 strains were transformed with 
pBAD18amp plasmids, if needed. The A600 of overnight cultures was measured and 
culture was diluted in 5 ml LB with appropriate antibiotics and 0.02% w/v L-arabinose 
to an A600 of 0.05. Cells were grown in LB broth with ampicillin 100 μg ml-1 at 37°C 
until the cultures reached an A600 of 1.0. Culture (2 μl) was then spotted into a pre-
warmed motility agar plate with L-arabinose (0.002%- 0.2% w/v) to induce protein 
expression under the control of the PBAD promoter. The control motility plate did not 
contain L-arabinose. Motility agar plates with SJW1103 and SJW1103DflgE::KanR, 
and SJW1103flhBCt3xFLAG variants were incubated for 4 hours at 37°C. Motility plates 
with SJW1103DflgC were incubated for 18 hours at 30°C. Motility plates with 
SJW1103DfliK flhBCt3xFLAG variants were incubated for 20 hours at 37°C. 
 
2.18 Design of synthetic gate recognition motif (GRM) peptides 
Synthetic peptides were ordered from Covalab (France). They were designed to be as 
hydrophilic as possible given the nature of the hydrophobic GRM to ensure they would 
resuspend well in a water-based, Tris buffer. All peptides in this study were N-
terminally acetylated and C-terminally amidated to prevent peptides from ligating 
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 together in solution. Peptides were synthesised to greater than 95% purity and 
confirmed by the manufacturer using HPLC and mass spectrometry. Upon receipt, 
peptides were resuspended in deionised water (MilliQ) to a final concentration of 5 
mM for later dilution into buffer and stored at -20°C. A full list of peptides can be found 
in Chapter 3. 
 
2.19 Isothermal titration calorimetry (ITC) 
ITC was performed at 25°C using a VP-ITC system and all ITC data were analysed 
using the provided Origin software (MicroCal, GE Healthcare). The reference cell was 
filled with water. FlhBC was purified as previously described and concentrated using a 
VivaSpin 20 Concentrator with a 5k molecular weight cutoff (MWCO) (Vivascience, 
Sartorius) to 50 μM in 1.4 ml of buffer B. Protein was added to the sample cell and 
mixed, throughout the experiment, at 300 rpm. GRM peptide samples were diluted to 
1 mM in buffer B and added to the syringe. All samples were degassed and heated to 
25°C before use. Peptide (2 μl) was initially injected into the sample cell. The cell was 
allowed to equilibrate for 150 s. Peptide (6 μl) was then injected into the sample cell 
in 250 second intervals for a final ligand (peptide) injection volume of 176 μl (1 injection 
at 2 μl, 29 injections at 6 μl). The heat generated by the addition of peptide to FlhBC 
was recorded as was the energy needed to maintain a constant temperature in the 
sample cell as compared to the reference cell. The heat of dilution generated by the 
addition of peptide into buffer B was subtracted from the heats generated by the 
addition of peptide to FlhBC. The integral of the calorimetric signal was calculated and 
a best fit line was used to determine the Kd of peptide to FlhBC. 
 
2.20 Crystallography of GRM peptides and FlhB 
Purified FlhBC was crystallised in the presence of a fivefold molar excess of GRM 
peptides using the sitting drop vapor diffusion method. The full list of the screen 
conditions can be found in Figure 2.3 and Figure 2.4. Reservoir liquid (1 μl) was added 
to 1 μl protein:peptide mixture in a 24-well plate. The plate was sealed and incubated 
at 20°C. Crystals were checked 1 day, 3 days, 1 week, and 2 weeks after initial 
incubation. In preparation for x-ray diffraction, crystals were removed from the drops 
using a microloop and stereomicroscope. As all screen conditions contained a 
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Well 
ID
Sodium
cacodylate
Zinc 
acetate
Propylene 
glycol
1 pH 4.70.1 M 0.15 M 25% 
2 pH 4.70.1 M 0.16 M 25% 
3 pH 4.70.1 M 0.17 M 25% 
4 pH 4.70.1 M 0.18 M 25% 
5 pH 4.70.1 M 0.19 M 25% 
6 pH 4.70.1 M 0.20 M 25% 
7 pH 5.00.1 M 0.15 M 25% 
8 pH 5.00.1 M 0.16 M 25% 
9 pH 5.00.1 M 0.17 M 25% 
10 pH 5.00.1 M 0.18 M 25% 
11 pH 5.00.1 M 0.19 M 25% 
12 pH 5.00.1 M 0.20 M 25% 
13 pH 5.30.1 M 0.15 M 25% 
14 pH 5.30.1 M 0.16 M 25% 
15 pH 5.30.1 M 0.17 M 25% 
16 pH 5.30.1 M 0.18 M 25% 
17 pH 5.30.1 M 0.19 M 25% 
18 pH 5.30.1 M 0.20 M 25% 
19 pH 5.60.1 M 0.15 M 25% 
20 pH 5.60.1 M 0.16 M 25% 
21 pH 5.60.1 M 0.17 M 25% 
22 pH 5.60.1 M 0.18 M 25% 
23 pH 5.60.1 M 0.19 M 25% 
24 pH 5.60.1 M 0.20 M 25% 
Well 
ID
Sodium
cacodylate
Zinc 
acetate
Propylene 
glycol
25 pH 5.30.1 M 0.18 M 20% 
26 pH 5.30.1 M 0.18 M 25% 
27 pH 5.30.1 M 0.19 M 20% 
28 pH 5.30.1 M 0.19 M 25% 
29 pH 5.30.1 M 0.20 M 20% 
30 pH 5.30.1 M 0.20 M 25% 
31 pH 5.30.1 M 0.21 M 20% 
32 pH 5.30.1 M 0.21 M 25% 
33 pH 5.30.1 M 0.22 M 20% 
34 pH 5.30.1 M 0.22 M 25% 
35 pH 5.30.1 M 0.23 M 20% 
36 pH 5.30.1 M 0.23 M 25% 
37 pH 5.60.1 M 0.18 M 20% 
38 pH 5.60.1 M 0.18 M 25% 
39 pH 5.60.1 M 0.19 M 20% 
40 pH 5.60.1 M 0.19 M 25% 
41 pH 5.60.1 M 0.20 M 20% 
42 pH 5.60.1 M 0.20 M 25% 
43 pH 5.60.1 M 0.21 M 20% 
44 pH 5.60.1 M 0.21 M 25% 
45 pH 5.60.1 M 0.22 M 20% 
46 pH 5.60.1 M 0.22 M 25% 
47 pH 5.60.1 M 0.23 M 20% 
48 pH 5.60.1 M 0.23 M 25% 
Figure 2.3 Crystal screens used to co-crystallise FlhBC and GRM peptides
Chemical composition of two crystal screens for co-crystallisation of GRM peptides with FlhBC.
Wells 1-24 are screen GT1 and wells 25-48 are screen GT2.
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Well 
ID
Sodium
cacodylate
Zinc 
acetate
Propylene 
glycol
49 pH 5.50.1 M 0.19 M 25% 
50 pH 5.50.1 M 0.19 M 28% 
51 pH 5.50.1 M 0.20 M 25% 
52 pH 5.50.1 M 0.20 M 28% 
53 pH 5.50.1 M 0.21 M 25% 
54 pH 5.50.1 M 0.21 M 28% 
55 pH 5.60.1 M 0.19 M 25% 
56 pH 5.60.1 M 0.19 M 28% 
57 pH 5.60.1 M 0.20 M 25% 
58 pH 5.60.1 M 0.20 M 28% 
59 pH 5.60.1 M 0.21 M 25% 
60 pH 5.60.1 M 0.21 M 28% 
61 pH 5.70.1 M 0.19 M 25% 
62 pH 5.70.1 M 0.19 M 28% 
63 pH 5.70.1 M 0.20 M 25% 
64 pH 5.70.1 M 0.20 M 28% 
65 pH 5.70.1 M 0.21 M 25% 
66 pH 5.70.1 M 0.21 M 28% 
67 pH 5.80.1 M 0.19 M 25% 
68 pH 5.80.1 M 0.19 M 28% 
69 pH 5.80.1 M 0.20 M 25% 
70 pH 5.80.1 M 0.20 M 28% 
71 pH 5.80.1 M 0.21 M 25% 
72 pH 5.80.1 M 0.21 M 28% 
Figure 2.4 Crystal screens used to co-crystallise FlhBC and GRM peptides
Chemical composition of additional crystal screen for co-crystallisation of GRM peptides with
FlhBC. Wells 49-72 are screen GT3.
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 cryoprotectant (propylene glycol), crystals were immediately frozen and stored in liquid 
nitrogen. 
 
FlhBC crystals were analysed using x-ray diffraction and resulting data was processed 
by Dr. Philip Hinchliffe. Diffraction data for FlhBC-peptide crystals were collected on 
beamline I24 at UK Diamond Light Source using a Pilatus 6M detector. Data were 
collected with an oscillation angle of 0.2°, an exposure time of 0.3 seconds, and a 
crystal-detector distance of 579.73 mm with resolution set at 2.8 Å. Resulting data 
were indexed and integrated with MOSFLM (224), and scaled with Aimless in the 
CCP4 suite (225). Molecular replacement was performed using Phaser (226) and 
structure refined using Refmac (227). 
 
2.21 Nuclear Magnetic Resonance (NMR) spectroscopy 
NMR spectroscopy experiments were performed on 15N labelled FlhBC and 15N,13C 
labelled FlhBC in buffer B purified as previously described. Sample was concentrated 
using a VivaSpin 20 Concentrator with a 5k MWCO to 200-300 µM in 450 µl and 
supplemented with a final concentration of 10% v/v deuterium oxide (D2O). 2D [1H, 
15N]-TROSY NMR experiments were recorded on a Bruker AV800 spectrometer (1H 
frequency 800 MHz) equipped with a 5 mm HFCN/z cryoprobe while 3D 1H, 15N, 13C 
triple resonance experiments were recorded on a Bruker AV600 spectrometer (1H 
frequency 600 MHz) equipped with a 5 mm HFCN/z cryoprobe. Both spectrometers 
are part of the biomolecular NMR facility in the Department of Biochemistry. All NMR 
experiments were recorded at 25°C. All data were recorded and processed by Dr. 
Daniel Nietlispach, who also assisted with the analysis. Raw data were processed 
using the Azara software package (W. Boucher, unpublished). Sequential backbone 
assignments were obtained using the CcpNMR analysis software based on the 
following NMR experiments: 3D HNCA, 3D HN(CO)CA, 3D HN(CA)CB, 3D 
HN(COCA)CB, and 3D 15N NOESY (228). 
 
Titration experiments with labelled FlhBC at a concentration of 300 μM were conducted 
by addition of GRM peptide at an initial concentration of 4.8 mM in buffer B. Peptide 
was added in 20 μl increments until 2D [1H, 15N]-TROSY spectra showed no further 
changes. All samples were monitored by 2D Selective Optimized-Flip-Angle Short-
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 Transient Heteronuclear Multiple Quantum Correlation (SOFAST-HMQC) 
experiments with a receiver gain of 128 and a total of 8 scans. Spectra at GRM peptide 
saturation were recorded and compared to the unbound FlhBC reference spectra to 
determine the different chemical shifts upon a subunit-binding event. The changes in 
chemical shifts (Δδ) were calculated by subtracting the peptide-bound shifts by the 
unbound shifts to yield ΔδH and ΔδN. Δδ was found using the following formula: Δδ= 
√((ΔδH)2+((ΔδN)2/6)) (229). Δδ was plotted in comparison to the FlhBC residue 
number. 
 
2.22 Bioinformatics 
2.22.1 Analysis of protein structure using PyMol 
Protein structures were downloaded from the Research Collaboratory for Structural 
Bioinformatics Protein Database (RCSB PDB) as .pdb files. FlhBC and FliKC from S. 
enterica serovar Typhimurium have the accession number 3B0Z and 2RRL, 
respectively (230). Structures were loaded into PyMol v1.5.0.5 Enhanced for Mac OS 
X. Where necessary, the PyMol measurement wizard was used to measure the 
distance between atoms and the PyMol mutagenesis wizard was used to mutate 
selected residues. 
 
2.22.2 Alignment of protein sequences 
Protein sequences were downloaded from UniProt (231). Sequences were aligned 
using the Clustal Omega multiple sequence alignment tool hosted by the European 
Bioinformatics Institute (232). Default parameters were used, except output of 
sequences was changed to “as aligned”. 
 
2.23 Circular dichroism (CD) of proteins 
All CD measurements were carried out with an AVIV 410 CD instrument (AVIV 
Biomedical) at the Biophysics Facility in the Department of Biochemistry of the 
University of Cambridge. Pure nitrogen gas was used to purge the xenon lamp of 
oxygen (below 5 parts per million). FlhBC211 and its variants were purified and dialysed 
into buffer C as previously described. Protein was concentrated to 0.1-0.2 mg ml-1 
using a VivaSpin 20 Concentrator with a 5k MWCO. 400 µl of protein was added to a 
1 mm glass cuvette. All data were collected using AVIV 410 software. Data were 
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 analysed using Kaleidagraph (Synergy Software). All CD experiments were planned, 
conducted, and analysed with Dr. Katie Kemplen. 
 
2.23.1 General CD scans 
Protein was scanned at 25°C. Each protein was scanned 3 times and the average 
taken. Scans were conducted in a range from 260 nm to 200 nm, in 1 nm intervals 
with 3 seconds averaging time at each interval. A reference scan using buffer was 
subtracted from the average protein scan. The resulting averaged protein curve was 
smoothed using standard settings in the AVIV 410 software. The mean residue 
ellipticity (MRE) was calculated using the following equation: !"# = %&'()''!*+,)	.*/.'/0),01*/ ∗ 3,0ℎ	+'/(0ℎ ∗ #	*6	,%1/*	,.1&7 
 
The averaged mdegree (mdeg) was used. Molar concentration was determined using 
methods described previously. Path length was set to 0.1 cm and each protein 
contained 173 residues, except for FlhBC211 W353T, which only had 143 residues. 
 
2.23.2 Analysis of protein melting temperature by CD 
Protein was scanned in a range from 25°C to 95°C to 25°C, in 1°C intervals with 3 
seconds averaging time at each interval. Protein was held at 95°C for 5 minutes before 
the scan from 95°C to 25°C was completed. All measurements were recorded at 222 
nm. 
 
To find the best fit line to the data, the following equation was used (233, 234):                                   8 = %3 + %5	×	%0 + (%4 −%3 + %6 −%5 	×	%0 )/	(1 + exp	(0.12	×	(%7	×ln ( MNO ×	%0)) − ( MNP − MNO ×	(%1 − MNO ×	%7))))	  
 
The terms for the equation are defined below. 
 m0   x variable 
 m1   DH (change in enthalpy) (Greenfield, 2007; 
Kemmer and Keller, 2010) 
 m2   melting temperature (in Kelvin) 
 m3   y-intercept for folded/native baseline 
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  m4   y-intercept for the unfolded baseline 
 m5   slope of the native/folded baseline 
 m6   slope of the unfolded baseline 
 m7   DCP (change in heat capacity) 
 
2.24 Whole cell samples of FlhB variants with and without FliK 
Salmonella enterica serovar Typhimurium SJW1103 strains carrying a chromosomal 
copy of flhBCt3xFLAG and its variants were plated on LB agar to isolate individual 
colonies. Strains with a kanamycin resistance cassette in place of fliK were plated on 
LB agar with kanamycin 50 µg ml-1. 
 
Single colonies were grown in 5 ml LB broth with appropriate antibiotic at 37°C with 
200 rpm shaking. The A600 of overnight cultures was measured using a CE 2041 
spectrophotometer set to 600 nm. Overnight cultures were diluted to an A600 of 0.05 
in 10 ml fresh LB broth without antibiotics. Cultures were incubated at 37°C with 200 
rpm shaking until they reached an A600 of 1.0. A 1 ml “whole cell” sample was taken. 
Cells were pelleted by centrifugation at 5,000 xg for 5 minutes. The supernatant was 
discarded and cells were resuspended in SDS-PAGE loading buffer with 140mM bME, 
standardised against culture A600 with a 1:75 dilution. This served as the late log phase 
sample. 
 
The remaining 9 ml of culture was incubated overnight at 37°C with 200 rpm shaking. 
A 1 ml “whole cell” sample was taken and the A600 was measured. Cells were pelleted 
by centrifugation at 5,000 xg for 5 minutes. The supernatant was discarded and cells 
were resuspended in SDS-PAGE loading buffer with 140 mM bME, standardised 
against culture A600 with a 1:75 dilution. This served as the late stationary phase 
sample. 
 
2.25 Small scale fractionation of cell extracts following osmotic shock 
Small scale fractionation was carried out as previously described with slight 
modification (163, 235). Cells were incubated overnight at 37°C with 200 rpm shaking 
in 5 ml LB broth with appropriate antibiotics. The A600 of the overnight culture was 
measured and diluted to an A600 of 0.05 in 10 ml fresh LB broth without antibiotics. 
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 Cells were incubated 37°C with 200 rpm shaking until they reach an A600 of 1.0. A 1 
ml sample was taken and marked “whole cell”. A second 1 ml sample was taken and 
marked “insoluble”. 
 
“Whole cell” fractions were centrifuged at 13,000 xg for 5 minutes to pellet the cells. 
Supernatant was collected and passed through a 0.2 μm Minisart hydrophilic cellulose 
acetate filter. Proteins in the supernatant were precipitated by the addition of 10% v/v 
TCA and 1% v/v Triton X-100 for 1 hour at 4°C. Precipitated protein was centrifuged 
at 17,000 xg, 4°C for 20 minutes. Protein pellets were resuspended in 1 ml ice cold 
100% acetone (Sigma Aldrich) and vortexed vigorously to remove any remaining TCA. 
Precipitated protein was pelleted by centrifugation at 17,000 xg, 4°C for 20 minutes. 
Remaining acetone was allowed to evaporate. “Whole cell” and “supernatant” samples 
were resuspended in SDS-PAGE loading buffer with 140 mM bME. The “whole cell” 
fractions were standardised against culture A600 with a 1:75 dilution. These fractions 
served to provide the total protein in the cell. The “supernatant” fractions were 
standardised against culture A600 with a 1:50 dilution. These fractions served as a 
control to monitor different levels of protein export and secretion. 
 
“Insoluble” fractions were centrifuged at 13,000 xg for 5 minutes to pellet the cells. The 
supernatant was discarded. Cells were gently resuspended in 250 µl of sterile 
resuspension buffer (0.5M sucrose, 40mM Tris-HCl, pH 7.4, 5mM EDTA). Lysozyme, 
chloride-free from chicken egg white (Sigma Aldrich) was added to a final 
concentration of 50 µg ml-1. Sterile deionised water (230 µl) was added and cells were 
mixed by inverting the tube. The fractions were incubated for 5 minutes at room 
temperature. MgCl2 (1 M, 10 µl) was added and the fractions were mixed gently. Cells 
were centrifuged for 10 minutes at 17,000 xg, 4°C. The supernatant was removed and 
protein was precipitated with 10% v/v TCA and 1% v/v Triton X-100 for 1 hour at 4°C. 
This was the “periplasmic” fraction. 
 
Osmotically-shocked cells were resuspended gently in 500 µl of buffer (20 mM Tris-
HCl, 5 mM EDTA, 1 tablet of cOmplete mini EDTA-free protease inhibitor cocktail 
(Roche)). DNaseI (1 U) was added and the tube was inverted gently on a rotary wheel 
(Fisher Brand) for 2 minutes or until viscosity decreased. MgCl2 (1 M, 10 µl) was added 
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 and the suspension was mixed by inversion. The fraction was centrifuged for 10 
minutes at 17,000 xg, 4°C. The pellet was the “insoluble” fraction containing insoluble 
membrane and proteins. The supernatant was removed and protein was precipitated 
with 10% v/v TCA and 1% v/v Triton X-100 for 1 hour at 4°C. This supernatant was 
the “cytosolic-soluble” fraction.  
 
The “periplasmic” and “cytosolic-soluble” fractions were centrifuged at 17,000 xg, 4°C 
for 20 minutes to pellet protein. Protein pellets were resuspended in 1 ml ice cold 
100% acetone (Sigma Aldrich) and vortexed vigorously to remove any remaining TCA. 
Precipitated protein was pelleted by centrifugation at 17,000 xg, 4°C for 20 minutes. 
Remaining acetone was allowed to evaporate. The “periplasmic”, “cytosolic-soluble”, 
and “insoluble” fractions were resuspended in SDS-PAGE loading buffer with 140 mM 
bME, standardised against culture A600 with a 1:50 dilution. 
 
2.26 FlhBCC CT3xFLAG secretion assay 
S. enterica serovar Typhimurium SJW1103flhBCT3xFLAG strains were inoculated into 10 
ml LB broth for overnight growth. Overnight culture was diluted 1:100 into 100 ml LB 
broth and incubated at 37°C with 200 rpm shaking. When cells reached an A600 of 1.0, 
cells were pelleted by centrifugation at 10,000 xg for 10 minutes. The cell pellet was 
saved as the “whole cell” fraction. Supernatant was recovered and passed through a 
0.2 μm Minisart hydrophilic cellulose acetate filter. Proteins in the supernatant were 
precipitated overnight at 4°C by the addition of 10% v/v TCA and 1% v/v Triton X-100. 
Precipitated protein was centrifuged at 17,000 xg, 4°C for 20 minutes. Protein pellets 
were resuspended in 5 ml ice cold 100% acetone (Sigma Aldrich) and vortexed 
vigorously to remove any remaining TCA. Precipitated protein was pelleted by 
centrifugation at 17,000 xg, 4°C for 20 minutes. “Whole cell” fractions were 
resuspended in 500 µl SDS loading buffer with 140 mM bME and “supernatant” 
fractions were resuspended in 250 µl SDS loading buffer with 140 mM bME. 
 
2.27 Proline aminopeptidase activity assay 
A previously described proline aminopeptidase activity assay was adapted for use with 
Salmonella cell lysate and protein (236). E. coli C41 (DE3) was transformed with 
pET15b and pET15b FliKWT. Protein expression and HexaHis-tagged FliK purification 
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 were as previously described. HexaHis-tagged FliKWT was dialysed overnight at 4°C 
against buffer G using 10 kDa cutoff regenerated cellulose dialysis membrane tubing 
(Spectrum Labs). C41 (DE3) cells with induced pET15b were resuspended in 1x PBS 
and lysed at 30 kpsi by cell disruption. Soluble fraction was collected by centrifugation 
at 40,000 xg, 4°C for 1 hour. The soluble fraction from induced C41 (DE3) pET15b 
served as the positive peptidase control for this experiment as E. coli harbors native 
proline aminopeptidases.  
 
L-proline p-nitroanilide trifluoroacetate salt (Sigma Aldrich) was resuspended to 2 mM 
in either PBS or buffer G. C41 (DE3) pET15b soluble lysate (500 µl) with or without 
overexpressed HexaHis-tagged FliKWT (500 µl) was mixed with 500 µl of 2 mM L-
proline p-nitroanilide trifluoroacetate salt. 500 µl of PBS or buffer G mixed with 500 µl 
of 2mM L-proline p-nitroanilide trifluoroacetate salt served as negative peptidase 
controls. Samples were incubated for 30 minutes at either 20°C or 50°C. The reactions 
were stopped with 1 ml 30% v/v acetic acid. Sample (1 ml) was added to a 10x4x45 
mm polystyrene cuvette and analysed using a Cecil CE 2041 spectrophotometer set 
to 405 nm. 
 
2.28 In vitro FlhBCC dissociation assay 
FlhBC Ct3xFLAG fused to inteinCBD was purified as described in 2.12.2, but dialysed into 
buffer B. FlhBC Ct3xFLAG was diluted in buffer B to 10 µM and frozen in liquid nitrogen 
for storage at -80°C. 
 
E. coli C41 (DE3) was transformed with pET15b or pET15b-FliK (HexaHis-FliK). 
Proteins were expressed as described in 2.11.1. Cell pellets from both were 
resuspended in 25 ml buffer B supplemented with 2 U DNaseI and 1 tablet of cOmplete 
protease inhibitor cocktail, EDTA-free. Cells were lysed at 30 kpsi using cell disruption. 
Soluble lysate was collected by centrifugation at 60,000 xg, 4°C for 1 hour. 
 
The soluble lysates were transferred to 50 ml falcon tubes (Greiner). FlhBC Ct3xFLAG 
was diluted to 1 µM. FlhBC Ct3xFLAG and soluble lysates were incubated at 20°C on a 
rotary wheel. Samples (1 ml) were taken at 0, 30, 90, and 180 minutes. Samples were 
precipitated for 1 hour at 4°C with the addition of 10% v/v TCA and 1% v/v Triton-
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 X100. Precipitated protein was resuspended by vigorous vortexing in 100 µl SDS 
loading buffer supplemented with 140 mM bME. Samples were analysed by 
immunoblotting. Mouse PentaHis antibody (Qiagen) was used to detect FliK (HexaHis-
FliK) and mouse anti-FLAG M2 antibody (Sigma) was used to detect FlhBC Ct3xFLAG. 
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 Chapter 3 
Early subunit interactions with the export gate component, FlhB 
 
3.1 Introduction 
Unlike the late flagellar subunits, early subunits for the rod and hook do not possess 
chaperones to traffic them to the flagellar export machinery (126). Recent work has 
shown that early subunits bind via their gate recognition motif (GRM) to the 
cytoplasmic domain of the export gate component, FlhB (86). 
 
The N-terminal GRM is highly conserved among early subunits and across bacterial 
species possessing a flagellum (86). The motif starts with a phenylalanine (F), a 
residue found across early subunits and bacterial species. This phenylalanine is 
followed by three residues of varying composition and a large hydrophobic residue in 
the fifth position (86). It is predicted that the phenylalanine and the large hydrophobic 
residue in the fifth position putatively interact with the surface-exposed hydrophobic 
residues on FlhBCC. The function of the three middle residues is unknown, but may 
serve to place the GRM properly in the binding pocket. 
 
Evans and colleagues identified four hydrophobic residues on FlhBC that are important 
for subunit binding in vitro. These residues – two alanines, a leucine, and a proline – 
were individually mutated into glutamates, replacing hydrophobic residues with a large 
charged residue to alter the binding site to prevent early subunit binding. Any individual 
replacement was enough to abolish subunit interaction with FlhB as observed by a 
protein pulldown assay (86). All four residues are located on FlhBCC. It isn’t clear how 
the surface-exposed hydrophobic residues on FlhBCC interact directly with subunit 
GRM or if they may play some other role in subunit export. 
 
Although we are not certain how tightly early subunits bind to FlhB, we know the 
interaction is relatively weak. Isothermal titration calorimetry data for one such early 
subunit, FlgD (the hook cap monomer), shows that affinity between the hook cap and 
FlhBC is only around 40 µM. This weak interaction between subunit and gate allows 
the subunit to be removed from FlhBC to be exported and transit to the distal site of 
assembly in the nascent flagellum (86). Morris and colleagues used surface plasmon 
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 resonance to observe the interaction between full length FliK and autocleaved and 
non-autocleaved variants of FlhBC. They also reported micromolar affinities, although 
on the order of 1-10 µM, with very little change in affinity or reaction kinetics between 
autocleaved and non-autocleaved variants of FlhBC (188, 191). This interaction 
between the flagellar molecular ruler and early subunit export gate is much stronger 
than the reported affinity (430 µM) of the Yersinia injectisome molecular ruler to the 
early subunit export gate (89). 
 
The hook cap must first assemble to coordinate hook assembly, but, as the hook is a 
relatively short structure, presumably only one capping structure is needed to control 
hook assembly. The molecular ruler, however, must measure the hook throughout 
assembly and keep the length within a narrow range if the flagellum is to function 
properly. The difference between affinities of hook cap and the molecular ruler for the 
flagellar early subunit export gate is approximately five-fold, but it is unknown why 
these two subunits, with such similar GRMs, bind differently to FlhB (86, 191). Our 
hypothesis is that these affinities may play a role in establishing export order and 
stoichiometry of exported subunit. 
 
The work in this chapter seeks to further analyse the role of early subunit GRMs for 
efficient subunit export. Early subunit binding affinities to FlhBC were evaluated in vitro 
to test whether these affinities may impose order on subunit export. Finally, 
crystallography and nuclear magnetic resonance (NMR) spectroscopy were used to 
characterise the binding pocket environment on FlhBCC upon early subunit binding and 
investigate any further structural changes at FlhBC caused by early subunit binding, 
but not detected by the published pulldown assay results. 
 
3.2 Mutations of the gate recognition motif impair early subunit export 
It is known that deleting the GRM from early subunits abolishes the in vitro interaction 
between early subunits and FlhBC and attenuates subunit export in vivo. Presumably, 
this is because subunit is no longer able to bind to the export gate and therefore cannot 
be exported efficiently, affecting the cell’s ability to swim (86). It is not known, however, 
which of the GRM residues are most important for subunit export and swimming 
motility. 
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 The hook subunit, FlgE, is unusual among Salmonella early subunits in that its GRM 
contains two phenylalanine residues (Figure 3.1A). Recombinant pBAD18amp 
plasmids carrying mutations of the GRM of flgE under the control of the PBAD promoter 
were constructed for expression in a flgE null strain of Salmonella Typhimurium to 
measure the mutants’ ability to swim and export hook subunit. Mutations were either 
conservative, replacing the first phenylalanine and fifth phenylalanine in the FlgE GRM 
with an alanine, or non-conservative, replacing these GRM residues with lysine 
(Figure 3.1A). All recombinant subunits contained a three-repeating FLAG tag 
(3xFLAG) sequence between residues 234 and 235 to allow for better detection of 
subunit export. 
 
A flgE null strain of Salmonella Typhimurium was transformed with the recombinant 
plasmids to measure the effect of GRM mutation on swimming motility. Some of the 
mutated GRMs could complement the loss of chromosomal flgE in trans (Figure 3.1B). 
Cells expressing the FlgE F43K and F43A variants were as motile as wild type cells, 
whereas cells expressing the F39K, F39A, and F39A, F43A (FFAA) variants of FlgE were 
only weakly motile. Cells expressing the FlgE DGRM and FlgE F39K, F43K (FFKK) 
variants were not motile. None of the mutations were dominant when expressed in 
wild type Salmonella SJW1103 (Figure 3.1C). 
 
Why do only some of the GRM mutations complement swimming motility? We 
hypothesised that the effect on swimming motility was due to inefficient subunit export. 
To measure this, a flgD null strain of Salmonella Typhimurium was transformed with 
the recombinant plasmids described above. This strain would not assemble hook 
monomers into a hook structure, but would still be capable of exporting them into the 
culture supernatant. FlgE wild type and the GRM mutants expressed similarly from the 
plasmid after induction with 0.02% w/v L-arabinose, confirming that the mutations did 
not affect protein expression (Figure 3.2). 
 
Only the FlgE F43A variant approached levels of export comparable to wild type cells, 
nearly 80% of wild type FlgE export, although that difference was not statistically 
significant (p-value 0.07). The F39K, F43K, F39A, and FFAA variants exhibited similarly 
impaired export, only around 40-50% of wild type export. In comparison, the GRM 
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Figure 3.1 Replacing the first and fifth residue of the GRM attenuates cell motility
(A) FlgE GRM mutants used in this study.
(B) Complementation of SJW1103ΔflgE transformed with pBAD18amp plasmids carrying
flgEmid3xFLAG wild type and GRM variants on swimming motility agar (0.25% w/v agar) with
0.02% w/v L-arabinose after incubation for four hours at 37°C. No motility was observed in the
absence of arabinose. Vector is empty pBAD18amp.
(C) Dominance of SJW1103 transformed with pBAD18amp plasmids carrying flgEmid3xFLAG wild
type and GRM variants on swimming motility agar (0.25% w/v agar) with 0.02% w/v L-
arabinose after incubation for four hours at 37°C. Vector is empty pBAD18amp.
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Figure 3.2 Replacing the first and fifth residue of the GRM attenuates subunit export
Export data of flgEmid3xFLAG wild type and GRM variants carried on pBAD18amp. Plasmids
were transformed into SJW1103ΔflgD and protein expression was induced by the addition of
0.02% w/v L-Arabinose. Whole cell fractions were collected by centrifugation and diluted 1:100
in SDS loading buffer based on culture density as measured by absorbance at 600 nm.
Supernatant fractions were collected by centrifugation, filtered to remove any cells, and TCA
precipitated to concentrate secreted protein. Samples were diluted 1:50 in SDS loading buffer
based on culture density as measured by absorbance at 600 nm. Mouse anti-FLAG M2
(Sigma) anitbody was used to detect FlgE in both fractions. Secondary infrared antibody,
Donkey anti-mouse (Li-Cor), was used to detect the anti-FLAG antibody.
The relative levels of export for each variant compared to wild type FlgE are shown. The error
bars represent the standard error of the mean, which was calculated in Excel from four
biological replicates and analysed using a Li-Cor Odyssey CLx and Image Studio Lite (Li-Cor).
Wild type FlgE export was counted as 1 in each replicate. ** indicates a p-value < 0.01. ***
indicates a p-value < 0.001.
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 deletion (DGRM) and the FFKK variant led to a remarkable decrease in export 
compared to wild type, around 20% of wild type export. The similarity between the full 
deletion of the GRM and the non-conservative replacement of the first and fifth 
residues suggests that it is these two residues which are most important for subunit 
export. 
 
Statistical analysis of the export data confirms that the reduction of subunit export due 
to the FlgE GRM mutations, except FlgE F43A, compared to wild type FlgE export is 
significant with p-values below 0.01. To determine this, export of the GRM mutants 
was compared to FlgE wild type, which was standardised to a relative export level of 
1.0 across all four biological replicates. The standard error of the mean was calculated 
for each sample and is represented by the error bars shown (Figure 3.2). An F test 
was performed to determine variance across samples before a Student’s t-test was 
performed. 
 
The in vivo results in this section expand on the previously reported findings that the 
first and fifth residues of the early subunit GRM are vital for subunit export and 
swimming motility. Next, I investigated the strength of the interaction between the FlgE 
GRM and FlhBC, incorporating the point mutants used in vivo to determine how they 
effected subunit binding affinity. 
 
3.3 The hook protein, FlgE, binds weakly to FlhBC 
To study the in vitro interactions between the FlgE GRM and FlhBC, FlhBC was first 
purified as described previously with slight modifications (Figure 3.3A and 3.3B) (223). 
After overnight elution from chitin resin, FlhBC was further purified by cation exchange 
chromatography using 50 mM Tris-HCl, pH 7.4, buffer and a gradient of NaCl (up to 
1.2M) to elute FlhBC from the column. 
 
Concentrated fractions from cation exchange chromatography were pooled and 
applied to a S75 10/300 superdex gel filtration column (GE Healthcare), pre-
equilibrated into the appropriate buffer. FlhBC eluted in two peaks (Figure 3.3C). The 
first peak contained both FlhBC and contaminating bands and was discarded. The 
second, large peak contained only wild type, cleaved FlhBC (Figure 3.3C), which was 
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Figure 3.3 Purification procedure of FlhBC residues 219-383, G383A using inteinCBD
(A) FlhBC is fused to an intein-chitin binding domain (inteinCBD) tag and initially purified on
chitin resin (NEB). FlhBC is cleaved from inteinCBD and eluted using Buffer A supplemented
with 0.1 M Dithiothreitol (DTT) after overnight incubation at 4°C.
(B) FlhBC after elution from chitin column. Most of the eluate was FlhBC, but there was
contamination with intein-CBD. FlhBC was further purified using cation exchange
chromatography and size exclusion chromatography.
(C) Fractions from the second elution peak were pooled and concentrated to desired molarity.
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 collected and pooled before being concentrated to appropriate molarity for subsequent 
experiments. As previously reported, the FlhBCC domain remains non-covalently 
associated with the FlhBCN domain in solution (190, 192). 
 
Synthetic peptides were then designed to mimic FlgE GRM binding to FlhBC in vitro 
(Covalab S.A.S, France) (Figure 3.4A). Each peptide contains the wild type or variant 
GRMs described above in the middle of the peptide, flanked by the native residues 
found in Salmonella Typhimurium FlgE. Peptides easily went into solution in deionised 
water (MilliQ) and stocks were frozen in liquid nitrogen and stored at -20°C. 
 
Isothermal titration calorimetry (ITC) was performed for peptides containing the wild 
type or variant FlgE GRM peptides to assess the affinity for hook subunit GRM to 
FlhBC. Peptide was applied in a ten-fold molar excess to FlhBC by direct injection. Wild 
type FlgE GRM peptide bound to FlhBC with a Kd of around 10 µM (Figure 3.4B). This 
is a stronger interaction than that reported for full length FlgD binding to FlhBC, which 
has a Kd of 39 µM (86). The peptides containing variant FlgE GRMs, with either 
conservative or non-conservative replacements of either the first or fifth GRM 
residues, were unable to bind FlhB in a range measurable by ITC, corroborating the 
in vivo data previously presented that showed these mutations impaired hook subunit 
export (Figure 3.4C-F). 
 
3.4 Early subunits bind transiently to FlhBC 
The FlgE GRM peptides bound FlhBC with a Kd approximately four-fold lower than full-
length FlgD. Additional peptides were designed for all the early subunits to measure 
the Kd upon binding to FlhBC using ITC. We hypothesized that the Kd between early 
subunits and FlhBC determines subunit export order (Figure 3.5A and 3.6A). All 
peptides save for the FlgC and FlgD GRM peptides were easily resuspended in 
deionised water (MilliQ). FlgD GRM peptide later went into solution when diluted into 
a Tris-salt buffer, whilst FlgC GRM peptide required the addition of 10% v/v dimethyl 
sulfoxide (DMSO, Sigma). 
 
The early subunit GRM peptides bound to FlhBC with micromolar affinities, ranging 
from approximately 5 to 45 µM. The hook subunit GRM peptide, FlgE, and the 
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Peptide Sequence
FlgE KSGTASFADMFAGSKVGLG
FlgE F39K KSGTASKADMFAGSKVGLG
FlgE F39A KSGTASAADMFAGSKVGLG
FlgE F43K KSGTASFADMKAGSKVGLG
FlgE F43A KSGTASFADMAAGSKVGLG
A
Figure 3.4 Single residue changes in a FlgE GRM peptide abolish binding to
FlhBC
(A) Table of synthetic peptides used in the ITC studies with FlhBC. Both protein and 
peptide were kept in degassed 50 mM Tris, pH 7.4 150 mM NaCl buffer at 25°C in 
preparation for ITC. 
(B) ITC trace of FlhBC titrated with FlgE wild type. The heat of dilution of FlgE wild 
type peptide in buffer was subtracted from FlhBC titrated with FlgE wild type to 
generate the best fit line.
(C-F) ITC traces of FlhBC titrated with FlgE GRM mutant peptides.
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E F
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F43A
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F43K
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F39K
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Peptide Sequence
FlgE KSGTASFADMFAGSKVGLG
FlgD LQSSFLTLLVAQLKNQD
FliK KTTGSAEDFLALLAGALGAD
FlgE
FlgD FliK
Figure 3.5 Hook subunits bind with varying affinities to FlhBC
(A) Table of synthetic flagellar rod peptides used in the ITC studies. Both protein and
peptide were kept in degassed 50 mM Tris, pH 7.4 150 mM NaCl buffer at 25°C in
preparation for ITC.
(B-D) ITC traces of FlhBC titrated with hook subunit GRM peptides. The heat of dilutions
for peptide in buffer was subtracted from FlhBC titrated with each peptide to generate
the best fit line. The GRM peptides used in each experiment are listed on each trace.
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Peptide Sequence
FliE THSQSTVSFAGQLHAALDR
FlgB YQARDIDFASELKKVMVRG
FlgC YRAKQVVFQVDAAPGQATGG
FlgF NASTPGFRAQLNALRAV
FlgG KRQRAVFEDLLYQTIRQ
FliE
Figure 3.6 Rod subunits bind with varying affinities to FlhBC
(A) Table of synthetic flagellar rod peptides used in the ITC studies. Both protein and
peptide were kept in degassed 50 mM Tris, pH 7.4 150 mM NaCl buffer at 25°C in
preparation for ITC.
(B-F) ITC traces of FlhBC titrated with rod subunit GRM peptides. The heat of dilutions
for peptide in buffer was subtracted from FlhBC titrated with each peptide to generate
the best fit line. The GRM peptides used in each experiment are listed on each trace.
FlgC GRM peptide was measured in the presence of 10% v/v DMSO.
A
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 secreted molecular ruler GRM peptide, FliK, have Kd’s of intermediate strength, 
between 10 and 15 µM (Figure 3.5B and 3.5D). The FlgD peptide, the hook cap, binds 
with a Kd of 38.8 µM, in line with the reported Kd for full-length FlgD (Figure 3.5C). The 
strongest binders were those of the proximal rod subunit GRM peptides, FliE and FlgB, 
which both share a similar affinity for FlhBC (Figure 3.6B and 3.6C). The distal rod 
subunit GRM peptides, FlgF and FlgG, are weaker binders by approximately eight- 
and five-fold, respectively (Figure 3.6E and F). All told, there is roughly a ten-fold 
difference across the Kd’s of all early subunit GRM peptides (Figure 3.7). 
 
3.5 How might FlgC be exported 
Notably, the GRM peptide for the FlgC proximal rod subunit did not bind to FlhBC in a 
magnitude measurable by ITC. This peptide was relatively hydrophobic and 
precipitated in the ITC experimental buffer. For this reason, buffer supplemented with 
10% v/v DMSO was used to keep the FlgC GRM peptide in solution, but still no binding 
to FlhBC could be observed in that experiment (Figure 3.8A). FlgB GRM peptide in 
buffer with 10% v/v DMSO was also titrated against FlhBC and the heat of binding was 
measured by ITC as a control to measure any effect of DMSO on peptide-FlhBC 
binding. The Kd was altered slightly in this experiment, from 5.6 µM to 9.6 µM, but 
binding was still observed (Figure 3.8B). That data indicate that DMSO does not 
substantially weaken subunit binding to FlhBC. 
 
Is the FlgC GRM not important for swimming motility? First, a sequence alignment of 
FlgC from seven species was performed to compare putative FlgC GRM sequences 
(Figure 3.9A). The closely related E. coli, S. typhimurium, and Y. enterocolitica all 
showed similar GRM sequences. As expected, the first phenylalanine of the GRM was 
also highly conserved across all species in the alignment. The phenylalanine of FlgC 
GRM of B. subtilis appears later in the protein sequence, at residue 60, compared to 
other species and is followed by a leucine in the fifth position. A. fabrum also has a 
leucine in the fifth position of the FlgC GRM. B. burgdorferi and A. aeolicus shared a 
valine in the fifth position (Figure 3.9A). 
 
FlgC GRMs vary slightly across species, but the enteric organisms all share an alanine 
in the fifth position. When the fifth residue of the FlgE GRM was mutated into alanine 
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FlgD
FlgE
FliK
FlgG
FlgF
FlgC
FlgB
FliE
Kd μM
38.80
10.80
15.96
31.80
48.56
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5.60
5.72
Figure 3.7 Rod and hook subunits bind transiently to FlhBC
Summary of dissociation constants of GRM peptides binding to FlhBC using ITC. Subunits are
listed in order of final assembly, starting from FliE up to FlgD, and colour-coded to refer to the
rod and hook structure. FliK is an exported subunit that is not assembled into the final structure.
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Figure 3.8 DMSO does not substantially affect the FlhBC-GRM interaction as measured
by ITC
(A) ITC trace of FlhBC titrated with FlgC GRM peptide in the presence of 10% v/v DMSO. The
heat of dilutions for peptide in buffer was subtracted from FlhBC titrated with FlgC to generate
the best fit line. The Kd could not be determined from this data, suggesting that ITC cannot
measure the interaction between the FlgC peptide and FlhBC.
(B) ITC trace of FlhBC titrated with FlgB GRM peptide in the presence of 10% v/v DMSO. The
heat of dilutions for peptide in buffer was subtracted from FlhBC titrated with FlgB to generate
the best fit line. The Kd was recorded as 9.6 µM in the presence of DMSO. The Kd for the FlgB
GRM peptide-FlhBC interaction without DMSO is 5.6 µM.
FlgB
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Figure 3.9 The conserved phenylalanine of the FlgC GRM is important for cell motility
(A) Sequence alignment of the proximal rod protein FlgC from selected species with the
proposed GRM coloured red. Possible second GRM sites are coloured blue. Sequences were
acquired from UniProt and aligned with Clustal Omega using default settings. Aquifex aeolicus
strain VF5; Salmonella enterica serovar Typhimurium strain LT2; Escherichia coli strain K12;
Yersinia enterocolitica; Borrelia burgdorferi strain ATCC 35210; Agrobacterium fabrum strain
C58; Bacillus subtilis strain 168.
(B) Complementation of SJW1103ΔflgC transformed with pBAD18amp plasmids carrying flgC
wild type and GRM mutants on swimming motility agar (0.25% agar) with 0.002% L-arabinose
after incubation for 18 hours at 30°C. Vector is empty pBAD18amp. GRM swap is FlgC
carrying the GRM sequence from FlgB (FASEL) rather than its native sequence (FQVDA).
(C) Dominance of SJW1103 transformed with pBAD18amp plasmids carrying flgC wild type
and GRM mutants on swimming motility agar (0.25% agar) with 0.2% L-arabinose after
incubation for four hours at 37°C. Vector is empty pBAD18amp.
A
C Dominance in SJW1103
B Complementation of SJW1103ΔflgC
Aquifex
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E. coli
Yersinia
Borrelia
Agrobacterium
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38DGTPFNRLVPVFEAVENLEDPSE 
45KQVVFQVDAAPGQATGGVKVASV
45KQVVFQVNAAPGAATGGVKVADV
45KQVVFQVAAQPGQETGGVRVAQI
45QRIIFAPRVNNPYWKGPFIPDYL
47KTVTFGSELDHVSGVERVKVKKL
56KGESFSSILNSQMSGSGNAGNGV
FlgC GRM
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 in the previous experiments, cells expressing this variant could still swim and FlgE 
subunit export was only minimally affected. This mutation was unable to bind FlhBC, 
however, suggesting that FlgC may be exported through another mechanism. 
 
Recombinant pBAD18amp plasmids encoding FlgC GRM variants under the control 
of the PBAD promoter were constructed to test whether the FlgC GRM was necessary 
for motility. Cells expressing wild type Salmonella flgC off the plasmid could 
complement the loss of flgC from the chromosome, but cells expressing an alanine 
replacement of the conserved phenylalanine in the FlgC GRM (F49A) were not as 
motile (Figure 3.9B), the cells only weakly swimming. Interestingly, cells expressing a 
flgC variant where the flgC GRM was replaced with the GRM from flgB 
(FQVDA®FASEL), was as motile as wild type FlgC (Figure 3.9B). Recombinant 
plasmids with these flgC variants were also introduced into wild type Salmonella to 
test whether they were dominant over wild type flgC. No dominance effect could be 
seen (Figure 3.9C). 
 
I hypothesised that FlgC may natively be co-exported with FlgB as prior results have 
suggested an interaction between the two subunits (132, 133). Recombinant pTXBI 
plasmid was constructed to co-express HexaHis-3xFLAG-tagged FlgB and FlgC, 
which was directly fused to the intein-chitin binding domain found on the plasmid. FlgB 
expression was under the control of the vector-encoded T7 promoter, while FlgC was 
expressed under its native promoter found immediately upstream of flgC at the end of 
flgB. This allowed for high expression, but also maintained the ratio of FlgB:FlgC 
expression found in the cell. 
 
Three expression conditions were tested (Figure 3.10A). In all cases, protein was 
induced by the additional of 1 mM IPTG to the culture as described in Materials and 
Methods. HexaHis-3xFLAG-FlgB expressed well under all conditions, with overnight 
growth at 20°C optimal. FlgC-inteinCBD, however, was only produced when 
expression cultures were grown overnight at 20°C (Figure 3.10A). This latter condition 
was selected for future protein expression. 
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Figure 3.10 FlgB and FlgC were co-expressed but could not be co-purified
(A) Overnight, low temperature incubation was optimal for FlgB and FlgC co-expression. Co-
expression of HexaHis-3xFLAG-FlgB and FlgC-inteinCBD from the pTXBI vector (NEB). Three
conditions were tested, all with 2YT medium and induction with 1 mM IPTG. Cells grown at
30°C and 37°C with 200 rpm shaking were induced at A600 1.0 and protein expression was
carried out for 4 hours. Cells grown at 20°C with 200 rpm shaking were induced at A600 1.0 and
protein expression was carried out for 20 hours. Whole cell fractions (1 ml) were collected by
centrifugation and diluted 1:500 in SDS loading buffer based on culture density as measured by
absorbance at 600nm. Mouse anti-FLAG M2 (Sigma) antibody was used to detect FlgB and
mouse anti-CBD (NEB) was used to detect FlgC. Secondary infrared antibody, donkey anti-
mouse (Li-Cor), was used to detect the primary antibodies. Samples were imaged using a Li-
Cor Odyssey CLx and Image Studio Lite (Li-Cor).
(B) FlgB and FlgC could not be purified from a nickel column. The cell pellet containing
expressed recombinant protein was resuspended in 20 mM Tris-HCl, pH 8.0 buffer with 20 mM
imidazole and 150 mM NaCl. Cells were lysed using a cell disruptor at 30k psi and the soluble
fraction was collected by centrifugation. Co-purification of HexaHis-3xFLAG-FlgB and FlgC-
inteinCBD was attempted on a 1 ml HisTrap Excel column (GE Healthcare) attached to a
BioLogic FPLC (Bio-Rad). Soluble protein was loaded using 0.5 ml min-1 flow rate. Elution
fractions A1-A5 (1 ml each) were collected by eluting bound protein with 300 mM imidazole.
Samples (0.1 ml) were diluted 1:2 in SDS loading buffer and analysed by immunoblotting.
Mouse anti-FLAG M2 (Sigma) antibody was used to detect FlgB and mouse anti-CBD (NEB)
was used to detect FlgC. Secondary infrared antibody, donkey anti-mouse (Li-Cor), was used
to detect the primary antibodies. Samples were imaged using a Li-Cor Odyssey CLx and Image
Studio Lite (Li-Cor).
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 Both proteins were soluble in the purification buffer. To test whether FlgB and FlgC 
may interact in vitro, I attempted to co-purify the proteins using a nickel column 
attached to an FPLC. A low flow rate was used to minimise column pressure and not 
break any interaction between the two proteins. Only FlgB was recovered from 
fractions eluted off the nickel column using buffer supplemented with 300 mM 
imidazole. FlgC did not bind the column or FlgB and was only found in the flow-through 
fraction (Figure 3.10B). This data suggests that FlgC may not interact with FlgB, or 
does so too weakly to be observed by co-purification using the described method. 
 
3.6 Subunit binding may cause conformational changes of FlhB 
FlhBC was previously shown to form crystals that could be solved with atomic 
resolution using standard X-ray crystallography techniques (192). Three different 
buffer screens were created (Figure 2.2 and 2.3) to grow FlhBC with and without GRM 
peptide to determine the atomic contacts between early subunit GRM and the surface-
exposed hydrophobic binding pocket. Screens GT2 and GT3 were optimised based 
on the success of protein crystallisation in screen GT1. Peptide was added at five-fold 
molar excess to protein to encourage co-crystallisation. Crystals were first observed 
after 1 week incubation. 
 
Many wells showed extensive precipitation, but protein crystals similar to those 
previously reported were seen in the presence of all peptides used (Figure 3.11A) 
(237). Upon moving them to cryostorage, it was observed that the presence of the 
GRM peptide had weakened the FlhBC crystals compared to crystals in the absence 
of GRM peptide. Crystals were analysed by Dr. Philip Hinchliffe using beamline I24 at 
Diamond Light Source UK. Dr. Hinchliffe also performed the data analysis generated 
from X-ray diffraction and generated the PyMol structure of the resulting unbound 
FlhBC (Figure 3.11B). 
 
Only one crystal returned a near-atomic resolution structure (at 4.0 Å). This crystal, 
grown in the presence of FlgE GRM peptide, did not show any additional density 
compared to the published structure for FlhBC, suggesting that the FlgE GRM peptide 
had not co-crystallised with the protein. Since crystallography was not possible with 
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Figure 3.11 Crystallisation of FlhBC
(A) FlhBC protein crystal in buffer containing a five-fold molar excess of FlgE GRM peptide at
10x magnification using a stereomicroscope.
(B) Near-atomic resolution structure of unbound FlhBC resolved to 4.0 Å. No additional
election density was uncovered, suggesting the FlgE GRM peptide had not bound FlhBC
during co-crystallisation. Dr. Philip Hinchliffe analysed the crystals using beamline I24 at
Diamond Light Source UK and performed the molecular replacement to generate the
structure.
A
B
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 FlhBC and the GRM peptides, the decision was made to observe the effects of GRM 
peptide binding on FlhBC in solution as had been done with ITC. 
 
NMR spectroscopy was used to characterise the effect of early subunit binding on 
FlhBC (Figure 3.12). This allowed both protein and peptide to be kept in solution in 
physiologically relevant buffer. NMR spectroscopy was conducted and analysed with 
the assistance of Dr. Daniel Nietlispach, who helped plan the experiments and collect 
and process the data, and Dr. Yvonne Yu, who assisted with assigning the peaks to 
the FlhBC sequence. 
 
Briefly, isotopically labeled (15NH4Cl, Sigma) FlhBC was analysed using a Bruker 
800MHz NMR spectrometer with a cryoprobe to detect proton and 15N signals in the 
presence and absence of unlabeled peptide. Three peptides were chosen based on 
their final assembly location of their “parent” subunit in the flagellum and their affinity 
for the export gate. Additionally, the FlgE F39K GRM peptide variant (Figure 3.11B) 
and FlhBC containing a point mutation in the subunit binding pocket (FlhBC P287E) 
(Figure 3.16) were used as non-binding controls. 
 
To assign the peaks in the various spectra, nitrogen-15 and carbon-13 labeled FlhBC 
was studied using a Bruker 600MHz NMR spectrometer with a cryoprobe to detect 
proton, nitrogen-15, and carbon-13 signals. Peak assignment reached about 70% of 
total protein sequence, not including prolines as these residues are not visible in the 
nitrogen-15 spectrum because of the lack of a primary (1°) amide proton. 
 
It was noted that over the course of the week-long 3D experiments, a secondary 
cleavage site in FlhBC between residues D237 and P238 resulted in the movement and 
loss of some peaks. A non-autocleavable mutant of FlhBC, P238A, was developed and 
labeled with deuterium, nitrogen-15, and carbon-13 (Figure 3.12B). This mutant still 
autocleaved at the primary, and biologically relevant, site between residues N269 and 
P270 (193). This deuterated, dual labeled (15N and 13C) sample allowed further peaks 
to be assigned to the protein sequence, about 80% of the protein not including the 
prolines (Figure 3.13), allowing for a comparison between peptide-bound and unbound 
FlhBC. 
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200-300 µM FlhBC
in buffer
Isotopically labelled
15N or 15N/13C
2D sample (proton + 15N) to measure subunit-bound and unbound FlhBC states.
3D sample (proton/2H + 15N + 13C) to assign residues to signal peaks in spectra.
Figure 3.12 Overview of NMR experiments using FlhBC (residues 219-383, G383A)
(A) Concentrated FlhBC in 50 mM Tris-HCl, pH 7.4 buffer with 150 mM NaCl was carefully
pipetted into a thin-walled glass tube for use in a Bruker NMR spectrometer. Experiments
were run at 25°C. FlhBCN is coloured blue, FlhBCC is coloured yellow, and the primary
autocleavage site between residues N269 and P270 is coloured red with side groups shown.
FlhBC was purified as described in Figure 3.3.
(B) Immunoblot of different conditions for FlhBC expression. Whole cell samples of expressed
protein were analysed using mouse anti-CBD (NEB) and donkey anti-mouse infrared
secondary antibody (Li-Cor). Samples were imaged using a Li-Cor Odyssey CLx and Image
Studio Lite (Li-Cor). 2YT is wild type FlhBC expressed in 2x Yeast-Tryptone medium; M9 is
wild type FlhBC expressed in M9 minimal medium. The other samples were expressed in M9
minimal medium with 99% D2O. WT is wild type FlhBC. N269A and P238A, N269A are non-
autocleavable mutants of FlhBC.
A
B
cleaved FlhBC
uncleaved FlhBC
M9 99% D2O
46
kDa
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Figure 3.13 Assignment of FlhBC residues to peaks generated by NMR
(A) Peaks recorded by NMR spectroscopy were assigned to the primary sequence of FlhBC
before being mapped onto the atomic resolution structure of FlhBC. Red residues are
assigned to peaks in the NMR spectra, blue residues could not be assigned, and green are
prolines, which are not visible in proton and 15N (2D) SOFAST-HMQC spectra. Residues R354-
R360, E371-N380, and D382-A383 are assigned but not represented above as they are not a part of
the atomic resolution structure.
(B) 2D HMQC spectrum of unbound FlhBC with assigned residues labeled. X-axis is 1H signal
(ppm). Y-axis is 15N signal (ppm).
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 Wild type FlhBC was titrated stepwise with GRM peptide at an initial concentration of 
4.8 mM. Peptide was added in 50 µl increments until the FlhBC peaks no longer shifted. 
This corresponded to a final GRM peptide concentration of 550 µM. Titration with FlgE 
GRM peptide caused multiple chemical shift perturbations in FlhBC (Figure 3.14A), 
indicating either multiple binding events or a high degree of secondary effects caused 
by subunit peptide binding to FlhBC. The FlgE F39K GRM peptide caused little change 
in FlhBC, confirming the earlier ITC observation that the peptide cannot bind FlhBC in 
vitro (Figure 3.14B). 
 
Similar to the FlgE GRM peptide, both the FlgB GRM peptide (Figure 3.15A) and the 
FliK GRM peptide (Figure 3.15B) caused a high number of chemical shift perturbations 
in FlhBC. Although all three peptides caused shifts in similar residues, there were 
noticeable differences in the magnitudes and directions of the shifts. FlhBC P287E 
titrated with the FlgB GRM peptide showed few chemical shift perturbations across 
the protein (Figure 3.16). 
 
Chemical shift perturbations in FlhBC were compared by assigning residues across 
spectra from peptide-bound and unbound protein. The chemical shift perturbations 
observed in the unbound state (the reference spectrum) were subtracted from the 
chemical shift perturbations in the GRM peptide-bound state. The difference in shifts 
(Δδ) was analysed to identify residues that showed the greatest shift upon GRM 
peptide binding (Figure 3.17). 
 
For all wild type GRM peptides, FlhB Alanine341 (A341), a residue in the proposed early 
subunit binding pocket, showed the greatest chemical shift perturbations (over 0.4 
ppm) (86). For comparison, most FlhBC residues experienced less than a 0.05 ppm 
chemical shift perturbation upon GRM peptide titration and binding. Leucine344 (L344), 
also in the proposed early subunit binding pocket, showed large chemical shift 
perturbations, although often not as great as other residues (e.g. Isoleucine328 and 
Alanine338, residues not in the proposed binding pocket). Another member of the 
proposed early subunit binding site, Alanine286, showed only a small shift perturbation 
upon subunit binding. The final residue of the proposed early subunit binding site, 
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Figure 3.14 Wild type GRM peptides change the FlhBC environment
(A) Spectra overlay of FlhBC titration experiment with FlgE GRM peptide. Peaks in blue are
fully titrated, or bound, FlhBC, while peaks in red are unbound FlhBC. The x-axis is the 1H
signal, the y-axis is the 15N signal.
(B) Spectra overlay of FlhBC titration experiment with FlgE F39K GRM peptide. Peaks in blue
are bound FlhBC, while peaks in red are unbound FlhBC. The x-axis is the 1H signal, the y-axis
is the 15N signal.
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Figure 3.15 Wild type GRM peptides change the FlhBC environment
(A) Spectra overlay of FlhBC titration experiment with FlgB GRM peptide. Peaks in blue are
fully titrated, or bound, FlhBC, while peaks in red are unbound FlhBC. The x-axis is the 1H
signal, the y-axis is the 15N signal.
(B) Spectra overlay of FlhBC titration experiment with FliK GRM peptide. Peaks in blue are
bound FlhBC, while peaks in red are unbound FlhBC. The x-axis is the 1H signal, the y-axis is
the 15N signal.
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Figure 3.16 Mutating the proposed GRM binding pocket on FlhBC disrupts subunit-
FlhBC interactions
Spectra overlay of FlhBC P287E titration experiment with FlgB GRM peptide. Peaks in red are
fully titrated, or bound, FlhBC P287E, while peaks in blue are unbound FlhBC P287E. The x-axis
is the 1H signal in ppm, the y-axis is the 15N signal in ppm.
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Figure 3.17 Chemical shift perturbations in the 1H and 15N resonances experienced by
FlhBC residues when bound by GRM peptide
The title of each plot represents the GRM peptide used in that titration experiment. Peaks of the
proposed early subunit binding site are in red and purple, peaks experiencing greater than 0.1
ppm shift when bound by peptide are in gold. The chemical shifts (Δδ) are compound chemical
shifts for each backbone 1H-15N signal calculated as described in materials and methods.
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 Proline287, could not be detected by 2D NMR, so a chemical shift perturbation pattern 
was not determined. 
 
Residues near the proposed binding pocket also showed chemical shift perturbations 
greater than 0.1 ppm, but the perturbations are not limited to residues close to the 
subunit binding pocket in FlhBC. Two residues, Glutamate327 (E327) and Isoleucine328 
(I328), are located on the loop between FlhBC a-helices 3 and 4, on the face opposite 
the proposed binding pocket showed perturbations greater than 0.1 ppm. I328 showed 
chemical shift perturbations regardless of the peptide present, whereas E327 only 
showed shift perturbations upon binding with FliK and FlgE GRM peptide. Tyrosine268, 
a residue located on FlhBCN just before the autocleavage site, also showed chemical 
shift perturbations upon peptide binding, regardless of subunit used. Residues 
experiencing chemical shift perturbations greater than 0.1ppm were mapped onto the 
atomic resolution structure (Figure 3.18). 
 
FlhBC peak assignments in the peptide-bound state account for only 85-90% of known 
residue peaks assigned in the unbound reference FlhBC spectrum. Therefore, 
additional chemical shift perturbations near the proposed binding site or elsewhere on 
the protein could be possible. The majority of known chemical shift perturbations 
occurred around the proposed subunit binding site, particularly residues A341 and L344, 
and any further perturbations could reasonably be expected to be localised to the 
proposed binding site and surrounding area. So, it is likely that the data presented 
thus far provides robust coverage of subunit GRM peptide binding to FlhBC and 
confirms the FlhBC surface-exposed hydrophobic patch as the binding site for early 
subunits. 
 
A sequence alignment of FlhB and its homologues was conducted to determine how 
conserved the hydrophobic binding pocket might be (Figure 3.19). Alanine286, which 
did not experience great chemical shift perturbations upon early subunit binding, is the 
only binding pocket residue not well conserved, being replaced with leucine and valine 
in some species. Proline287 is found in all species and homologues sampled, including 
the FliR-FlhB fusion protein used by Clostridium difficile, but is invisible in 2D NMR 
and difficult to examine using this method. A341 is found in all species and homologues 
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Figure 3.18 Residues that experienced chemical shift perturbations greater than 0.1 ppm
in the 1H and 15N resonances upon subunit binding are mapped and labeled on the
FlhBC atomic resolution structure
(A) Surface view. FlhBCN is coloured blue, FlhBCC is coloured yellow. The surface-exposed
hydrophobic subunit binding pocket residues that experienced chemical shift perturbations
greater than 0.1 ppm are coloured red, while the other binding pocket residues are coloured
purple. Orange residues experienced chemical shift perturbations greater than 0.1 ppm in all
three titration experiments; cyan residues experienced chemical shift perturbations greater than
0.1 ppm in two of the three titration experiments. *P287 does not have an amide proton and
could not be detected in 2D NMR titration experiments.
(B) Ribbon view. FlhBCN is coloured blue, FlhBCC is coloured yellow. The surface-exposed
hydrophobic subunit binding pocket residues that experienced chemical shift perturbations
greater than 0.1 ppm are coloured red, while the other binding pocket residues are coloured
purple. Orange residues experienced chemical shift perturbations greater than 0.1 ppm in all
three titration experiments; cyan residues experienced chemical shift perturbations greater than
0.1 ppm in two of the three titration experiments; and green residues experienced chemical
shift perturbations greater than 0.1ppm in one of the three titration experiments.
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Figure 3.19 Sequence alignment of export gate component, FlhB, from selected species
The early subunit surface-exposed hydrophobic binding pocket of S. enterica is boxed, showing
conservation in other species and across T3SS. Green residues experienced chemical shift
perturbations when titrated with one peptide; blue residues experienced chemical shift
perturbations when titrated with two peptide; and orange residues experienced chemical shift
perturbations when titrated with three peptides. Only N380 experienced significant chemical shift
perturbations when titrated with the FlgE F39K peptide.
The FliR-FlhB fusion protein from Clostridium difficile has been truncated to remove most of the
FliR domain, which did not align to the other sequences. YscU and PscU are FlhB homologues
found in the injectisome. Sequences were acquired from UniProt and aligned with Clustal
Omega using default settings. Treponema pallidum (strain Nichols); Borrelia burgdorferi strain
ATCC 35210; Yersinia pestis; Pseudomonas aeruginosa (strain ATCC 15692); Helicobacter
pylori (strain ATCC 700392); Escherichia coli strain K12; Salmonella enterica serovar
Typhimurium strain LT2; Aquifex aeolicus strain VF5; Bacillus subtilis strain 168; Clostridium
difficile.
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 save for the FlhB found in the spirochetes. L344 is always a larger hydrophobic residue, 
sometimes being replaced with phenylalanine. This sequence alignment, along with 
recent findings in the injectisome T3SS, strongly suggests that this surface-exposed, 
hydrophobic early subunit binding pocket is conserved across all T3SSs (88, 89). 
 
3.7 Discussion 
The data described in this chapter highlight the importance of the early subunits’ GRM, 
especially the highly-conserved phenylalanine, and the environmental changes 
caused by early subunit binding to FlhBC. 
In vivo data investigating the deletion or mutation of the FlgE GRM (e.g. F39K, F43K 
labeled as FFKK in Figures 3.1 and 3.2) on subunit export and cellular motility suggest 
that the first and fifth residues of the GRM are the most important residues for early 
subunit binding to FlhBC and eventual subunit export. This isn’t surprising as these are 
the most conserved residues in the early subunit GRM across subunits and species 
(this study and 85). The middle three GRM residues, although not investigated in this 
study, vary greatly across subunits and species. What effects they may have on 
subunit export and cellular motility are currently unknown. I hypothesise that these 
residues are most important for the correct positioning of the first and fifth GRM 
residues when early subunit binds to FlhBC. Further experimentation on these 
residues may be necessary to determine structure of the GRM when bound to FlhBC 
and how these middle residues affect early subunit binding. 
 
ITC and NMR data corroborate the in vivo data on the importance of the FlgE GRM 
as the single replacement mutants (e.g. F39K and F43K) on synthetic GRM peptides 
were unable to bind to FlhBC or cause the chemical peak shifts seen with wild type 
peptide. None of the flgE GRM deletions or mutations were dominant when expressed 
in wild type Salmonella and assayed for swimming motility, suggesting that wild type 
FlgE can outcompete the FlgE GRM deletions or mutations in vivo probably due to 
their lack of strong binding to FlhBC. 
 
All early subunits binding affinities to FlhBC fall in the micromolar range, confirming 
that the interaction between FlhBC and the early subunits is transient. These affinities 
corroborate the previously observed binding affinity of early subunits and FlhBC (86, 
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 191). The FlgD and FliK GRM peptides bound FlhBC with similar affinities to full length 
FlgD or FliK, indicating that the subunit GRM peptides encompass the major binding 
site for FlhBC and that the GRM is primarily responsible for early subunit binding affinity 
to FlhBC. 
 
Not all the ITC experiments reached full saturation. Additionally, a few of the curves 
show unusual spikes or dips in the data. Some of the GRM peptides are difficult to 
maintain in solution due to the hydrophobicity of the GRM and surrounding sequence, 
so it is possible that some of the peptide aggregated and precipitated during ITC 
experiments. This would lower the concentration of peptide available for titration and 
impact the quality curves. All ITC experiments were repeated at least three times 
under the same conditions. Additional experiments may be necessary to take the 
peptide-FlhBC interaction to saturation and confirm the magnitude of the micromolar 
affinities reported here. 
 
The transient interaction between the export gate and early subunit may be important 
to keep subunits moving to the distal site of assembly, whether by a subunit chain or 
diffusion. If subunits were to dock tightly to FlhB prior to export, it would require more 
energy to pull subunits into the chain or require more energy to inject them into the 
channel (86, 99). This could slow subunit export and, ultimately, flagellum growth. 
Observations showing that flagellar growth rate is constant, regardless of length, have 
been challenged by other work showing that growth rate is length-dependent (99, 
172). These observations were conducted on the long filament and it is unknown 
whether the rate of HBB growth is constant or variable. The HBB structure is only 
about 100 nm in length, or the length of a fully stretched FlgE subunit, so it is unlikely 
that the subunit chain or diffusion growth rate is severely impacted by HBB length. 
Still, subunits strongly binding to the export gate would raise the energy barrier needed 
to export them, a costly enterprise for the cell. 
 
Why might early subunit GRM binding affinities for FlhB differ? There is a general 
trend between subunit export order and subunit GRM binding affinity to FlhBC, but, as 
the range is less than an order of magnitude, the correlation between subunit export 
order and binding affinity to FlhBC is weak. The binding affinities for the early subunit 
122
 GRM to FlhBC may also be a result of the final stoichiometry of each subunit in the 
early HBB structures. FlgE, the monomer, has one of the stronger binding affinities, 
and could outcompete FlgD and FliK to selectively bind FlhB to promote its own export. 
FliE also has a strong binding affinity for FlhB and must assemble before other rod 
subunits can. FlgB, the proximal rod subunit that assembles on FliE, shares a similarly 
strong binding affinity for FlhB. 
 
More work is needed to fully understand the role of early subunit GRM binding affinities 
for FlhB. Kinetics of early subunit-FlhBC binding, such as the on and off rates for early 
subunit binding, can be studied to determine how subunit-gate binding may influence 
subunit export order, if at all. NMR could be used to measure the dynamics of early 
subunit binding to FlhBC by observing the rate at which peaks shift and broaden in the 
GRM peptide-bound versus unbound FlhBC state. Other biophysical techniques could 
also be used to establish the reaction parameters, kon and koff, which may play a 
greater role than binding affinity in subunit export order. Finally, expression levels of 
each subunit prior to export are needed to put these affinities and reaction kinetics into 
context. Weaker binders may be better expressed and could then outcompete the 
stronger binders, for example, but it is difficult to conclude this based on available 
proteomic data. 
 
Intriguingly, FlgC is the only Salmonella early subunit to contain an alanine in the fifth 
GRM position, rather than a large hydrophobic residue. Although an affinity for FlgC 
GRM peptide to FlhBC could not be established using ITC, mutational analysis and 
swimming motility assays confirm the importance of the conserved phenylalanine in 
FlgC’s GRM. Mutating the conserved phenylalanine in the FlgC GRM creates a GRM 
similar to the previously described FlgE mutant FFAA, which was shown to have 
impaired export and to swim poorly when compared to wild type FlgE. Swapping the 
flgC GRM for the native GRM sequence from flgB did restore motility in a flgC null 
strain. As this GRM swap was not dominant in wild type Salmonella, this mutant adds 
further evidence that it is the presence of the first phenylalanine in the GRM that is of 
vital importance. 
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 The addition of DMSO to the buffer did help with FlgC GRM peptide solubility, but still 
no binding to FlhBC could be observed. This suggests the binding affinity for the FlgC 
GRM to FlhBC may be too weak to be measured by ITC. It is also possible that DMSO 
interfered with the putative hydrophobic interaction between the FlgC GRM peptide 
and FlhBC, but an ITC experiment using FlhBC and FlgB GRM peptide showed only a 
twofold increase in the binding affinity in the presence of DMSO (Figure 3.8). Local 
concentration of FlgC near the export machinery may be high enough to force an 
interaction between FlgC and FlhBC or other rod subunits may act as partner proteins 
for FlgC export, requiring less interaction between the FlgC GRM and FlhBC. In vitro 
work in this study between FlgB and FlgC suggests that these two rod subunits do not 
interact. This work did use an FPLC and a low flow rate to test interactions. Column 
pressure was closely monitored, but it is possible any interaction between FlgC and 
other rod subunits is too weak to be observed by co-purification using FPLC. Follow 
up work, such as protein pulldown assays that examine potential interactions, is 
needed. 
 
A sequence alignment of FlgC from seven different bacterial species emphasises the 
unusual nature of this GRM when compared to other subunits such as FlgE (Figure 
3.9A). The Salmonella FlgC GRM starts at residue 49, further downstream than in 
other subunits. The GRM is defined as an N-terminal secretion motif, but, in a protein 
of 134 amino acids, FlgC’s GRM is more centrally located than the GRM in FlgE or 
FliK. FlgB and FlgC are reported to be completely disordered in vitro, suggesting they 
may only adopt a fold once assembled into the flagellar rod (132). So, although the 
conserved phenylalanine occurs more centrally in FlgC, it will still be disordered and 
bind to FlhBC in preparation for export. 
 
The Gammaproteobacteria in the sequence alignment all have an alanine in the fifth 
GRM position, while the FlgC GRM in other species is either a leucine or valine 
Experiments using FlgC from Bacillus, Agrobacterium, or Borrelia species could be 
conducted to see if their variants with a more typical residue in the fifth position bind 
to FlhBC. If that is the case, it is possible the Gammaproteobacteria evolved other 
mechanisms for the export of FlgC, as discussed previously. Aquifex and Borellia are 
unusual in that they contain another phenylalanine downstream of the conserved FlgC 
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 GRM phenylalanine. The role this downstream phenylalanine may play in subunit 
export is unknown. 
 
Prior research is mixed on whether the rod proteins are dominant when overexpressed 
in wild type Salmonella. Minamino and colleagues saw no effect on wild type motility 
when overexpressing flgB, but did report a slight effect when expressing a mutant of 
fliE at 30°C (131). Hirano and colleagues reported an overexpression effect from all 
the rod proteins, including flgB, when expressed in wild type Salmonella (238), 
although flgB and flgC had less of an effect compared to other rod subunits. In both 
cases, the studies used pTrc99A, with the latter study using a further optimised 
plasmid called pTrc99AET (238). 
 
pTrc99AET is isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible, whereas the 
pBAD18amp plasmid used in this study to express flgC in Salmonella is inducible by 
L-arabinose. Siegele and Hu report that the addition of 1.33 mM L-arabinose, or 0.2% 
w/v arabinose, was enough to cause 89% of cells to express GFP, as rapidly as 15 
minutes post-induction, and concluding that the dark cells had lost the GFP plasmid 
(239). Starter cultures, used to inoculate the swimming motility agar, contained wild 
type Salmonella carrying the pBAD18amp plasmid with and without the flgC GRM 
variants were first incubated to an A600 of 1.0 in the presence of 0.02% w/v arabinose 
to induce protein expression. Therefore, the pBAD18amp plasmids should have 
already been producing protein before inoculation on agar containing the higher 
arabinose concentration. It is then likely that the differences in overexpression can be 
explained by the difference of induction systems used. 
 
Further work is clearly needed to unpick the importance of the phenylalanine residue 
to export or assembly of FlgC and the impact of the alanine in the fifth GRM position. 
In vivo experiments, such as cell fractionations after osmotic shock, could be used to 
study the ultimate fate of the FlgC GRM mutant, F49A, as export or assembly deficient 
to establish the importance of the phenylalanine. Furthermore, in the native FlgC 
GRM, the fifth position alanine may be insufficient to establish contacts with the 
binding pocket on FlhBC, allowing only for the phenylalanine to contact the binding 
pocket, if the phenylalanine were required for export. The middle three residues of the 
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 FlgC GRM may also play a greater role in navigating the alanine to the binding pocket 
or keeping the phenylalanine in closer proximity to the binding pocket. 
 
Co-crystallisation of GRM peptide with FlhBC was unsuccessful, only returning a near-
atomic resolution structures of unbound FlhBC. We did observe a minor difference in 
the atomic resolution structure of FlhBC from the published structure. A part of the 
FlhBCN a-helix presented as a random coil in the structure presented in this chapter 
(Figure 3.11B). Because our structure could only be resolved to 4.0 Å, while the 
published structure was resolved to 2.45 Å, this minor structural difference is most 
likely due to the poorer resolution in our analysis than caused by any peptide binding 
(192). 
 
Co-crystallisation was attempted concurrently with the ITC experiments, so affinity 
measurements between subunit GRM peptides and FlhBC were not completed when 
the crystal screens were conducted. Later screens were attempted that decreased the 
molar excess of peptide to FlhBC while increasing the overall FlhBC concentration but 
these failed to crystallise. The transient interactions observed via ITC may be too weak 
to accommodate co-crystallisation between peptide and FlhBC. Further experiments 
could see unbound FlhBC protein crystals soaked in peptide and cryoprotectant prior 
to freezing. Crystallisation with the early subunit peptides covalently fused to FlhBC or 
co-crystallisation between FlhBC and peptide fused to a partner protein are also 
possibilities given the ability to purify FlhBC in high yields. 
 
The use of NMR to study subunit binding proved fruitful, although there were 
complications along the way. The FlhBC 3D spectra recorded have fairly discrete 
peaks and it looked easy to assign residues to the spectra. Assignments took longer 
than anticipated, however, for several reasons. Firstly, a region of overlapping peaks 
proved to be a central part of FlhBC, rather than the disordered termini. As these peaks 
overlapped, it is possible some residues were masked by other, stronger signals. This 
may also explain why certain discrete peaks could not be assigned to the FlhBC 
sequence as masked residues could disrupt sequential assignment. Secondly, the 
high number of prolines in the protein caused some difficulty. Because prolines do not 
possess an amide bond in a polypeptide, they do not produce an amide proton signal 
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 and are therefore hidden in 2D NMR experiments using a probe for 1H and 15N. FlhBC 
has 13 prolines, roughly 8% of the protein. This makes sequential assignment of peaks 
to the amino acid sequence difficult in proline-rich regions. Deuterated FlhBC was used 
to push assignments further than proton-labeled FlhBC allowed. The deuterated 
sample did allow peak assignments covering roughly 80% of the protein, not including 
prolines, enabling robust comparison across the bound and unbound FlhBC states. 
 
The proposed binding pocket identified by Evans and colleagues was corroborated by 
NMR in this study (86). The FlhB sequence alignment confirms that this binding pocket 
is well conserved across species. Proline287 of the binding pocket is well conserved 
across all species and homologues sampled. Although this residue could not be seen 
in the 2D NMR experiments, and so its contribution to subunit binding is left 
undetermined, its conservation suggests that it is important to at least the makeup of 
the binding pocket. 
 
Alanine286, one of the four proposed residues and the least well conserved, did not 
experience a large chemical shift perturbation upon GRM peptide binding. It is unlikely, 
then, that this residue interacts with early subunits or is altered once subunit binds. 
This alanine could be merely a structural feature to form the surface-exposed 
hydrophobic binding pocket on FlhBC’s surface. 
 
Alanine341 and Leucine344, both well conserved residues, appear to be involved directly 
in early subunit binding. Alanine341 experiences the greatest chemical shift 
perturbations in the presence of all three GRM peptides, with Leucine344 experiencing 
smaller perturbations. Combining the data from the NMR titration data with from the 
early subunit export and motility assays suggests that Alanine341 directly interacts with 
the conserved phenylalanine of early subunit GRM. Leucine344 may also interact with 
the phenylalanine, interact with the fifth hydrophobic GRM residue, or serve to stabilise 
the interaction between Alanine341 and the early subunit GRM phenylalanine. 
 
Surrounding residues, such as Lysine283, may move away from the binding pocket 
upon early subunit binding as the hydrophobic residues would no longer need to be 
shielded from the hydrophilic environment. Lysine283 could also act as a clamp, of 
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 sorts, to hold subunit into the binding pocket via a salt bridge or polar interaction with 
residues near the GRM. Residues more distant from the binding pocket probably 
experience chemical shift perturbations as a secondary effect of subunit binding 
causing rearrangement to the binding pocket structure. As both Glutamate327 and 
Isoleucine328 are located on the loop immediately prior to a-helix4, their chemical shift 
perturbations may result as the loop is repositioned to allow the binding pocket to 
accommodate early subunit. 
 
That a tyrosine located on FlhBCN also experienced chemical shift perturbations is 
interesting. No other residues on FlhBCN experienced such perturbations, nor did any 
near the autocleavage site on FlhBCC. The tyrosine’s side chain does not protrude 
toward the binding pocket in the atomic resolution structure. In fact, the side chain is 
surface-exposed on another face of FlhBC distant from the binding pocket. Does this 
tyrosine play a greater role in early subunit recognition and binding? Or does this 
tyrosine need to move to accommodate early subunit binding to the binding pocket? 
Future work could investigate why a residue on FlhBCN was strongly affected by early 
subunit binding. 
 
Residues not found in the published atomic resolution structure did experience 
chemical shift perturbations upon binding in the presence of FlgB and FliK GRM 
peptide. These residues are primarily located in the last 30 residues of FlhBC, the C-
terminal disordered tail region. Current NMR data are not robust enough to calculate 
the location or fold of these residues. Future work could seek to determine the 
structure and relevance of these disordered residues to subunit export. 
 
Another line of inquiry could be to replicate these experiments using the non-
autocleavable, early-locked gate, FlhBC N269A. This variant of FlhBC can interact with 
early subunits, but does not allow for the switch in assembly phases. Does it share 
similar features to wild type FlhB? Or does autocleavage give FlhB the needed 
flexibility to properly recognise and interact with early subunits? 
 
We can now conclude that early subunits interact transiently with FlhBC at a surface-
exposed hydrophobic binding pocket, providing strong evidence that the hydrophobic 
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 residues on FlhBCC directly interact with the GRM. But further work is needed to 
understand this fully. For instance, how does the conserved phenylalanine interact 
with the conserved binding pocket on FlhBC, particularly Alanine341 and Leucine344? 
Do residues experiencing large chemical shift perturbations move out of the way to 
allow the protein to accommodate subunit? What do the differences in magnitude and 
direction of peak shifts mean? Do early subunits cause slightly different conformations 
in FlhBC and is this a result of accommodating each subunit or may this impose export 
order on the early subunits? 
 
Work presented thus far has studied the interactions between early subunits and 
FlhBC. But this is only one of FlhB’s roles in controlling flagellar subunit export and 
assembly. One early subunit, FliK, is more than an exported early subunit. In tandem, 
FliK and FlhB are responsible for the export specificity switch at the fT3SS that leads 
to late subunit expression and export. The next chapter will explore this vital role of 
FlhB and seeks to provide clarity to the as of yet unsolved mechanism underlying the 
switch. 
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 Chapter 4 
The loss of a domain activates the 
export specificity switch at FlhB 
 
4.1 Introduction 
Much of the work investigating the export specificity switch concentrates on two key 
elements – the secretion of FliKN and the autocleavage of FlhBC (105, 126). Fewer 
studies have investigated why the autocleavage of FlhBC is important to the switching 
mechanism and how FliKC and FlhBC may interact to cause the switch. 
 
Mizuno and colleagues found an acidic loop conserved across FliK and its SctP 
homologues. Their modeling suggests that the acidic residues of the loop are only 
able to access basic residues on the surface of FlhBC post-autocleavage and they 
proposed that these loops trigger the switch at FlhBC (203). Their hypothesis went 
untested, however, until follow-up work from the Aizawa group where they identified 
other residues in the loop, Leucine-Arginine-Leucine, that they suggest are important 
to the switch. Using a combination of electron microscopy and motility assays, they 
concluded that these three residues upstream of loop 2 were important to the switch 
by stabilising the core folded domain of FliKC where the T3S4 is located and not by 
interacting with FlhBC (240). 
 
Currently, genetic evidence is strongest for the role of FliKC in triggering the switch. 
Scanning deletions of ten residues and truncations of FliKC resulted in a failure of the 
fT3SS to switch properly, leading to the polyhook or polyhook-filament phenotype 
(202, 204). Structural data was not available at the time, but now it is clear that these 
mutations remove large chunks of structured domains. Their deletion possibly 
destablises the rest of the C-terminal structure, again pointing to the importance of 
structural stability over any residue in particular. 
 
In the Yersinia injectisome, chemical shift perturbations in the early subunit export 
gate were only observed by NMR spectroscopy upon titration with the molecular ruler 
disordered linker and C-terminal T3S4 domains. The SctPC T3S4 domain on its own 
did not cause any chemical shift perturbations in SctUC, hinting that there is no direct 
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 interaction between the T3S4 and export gate (89). Rather than suggesting a direct 
interaction between FliKC and FlhBC to trigger the switch, these data in combination 
strongly suggest a role of the specific structure of FliKC in triggering the switch, 
although it is unclear how. 
 
McMurry and colleagues investigated the binding kinetics of FliK to wild type and non-
autocleavable FlhBC. They found that FliK bound to FlhBC with micromolar affinity 
(188). This agrees with my ITC data presented in the previous chapter which shows a 
micromolar affinity between FliK’s GRM and FlhBC. Their reported affinity was twofold 
stronger (Kd ~15 µM vs Kd ~8 µM) than the affinity I measured. The difference in 
affinities could be due to a difference in technique (ITC vs surface plasmon resonance) 
or their use of full length FliK instead of short peptides meant to study the GRM in 
isolation (188). 
 
The lack of biochemical data on interactions between FliKC and FlhBC is not surprising. 
FliK/SctP has a relatively disordered N-terminus and linker region that could not be 
studied with techniques such as NMR and no atomic level resolution structure exists 
for these domains. The structured, “ball-like” FliKC domain only represents about 20% 
of the protein (203). This makes FliK a difficult protein to study. FlhBC, on the other 
hand, is quite stable and easier to study. 
 
The structure of autocleaved FlhBC revealed a core of four b-strands surrounded by 
four a-helices. The conserved NPTH autocleavage loop sits between two b-strands, 
b1 and b2 (192). These four b-strands seem to form a b-sheet that holds the two 
polypeptides together post-autocleavage with stabilising contributions from core-
facing residues of the a-helices. Disrupting these interactions and destablising the 
structure of FlhBC is enough to restore functionality in an export specificity switch-
deficient FlhB variant (241). Other suppressor mutations in FlhBC that partially 
overcome the effective loss of FliK were previously identified (242, 243). In all cases, 
these mutations were found on the C-terminal cytoplasmic domain of the early subunit 
export gate (FlhBCC/SctUCC). Most mutations resulted in a radical change of residue 
side chain biochemistry, such as a charged side chain becoming an aromatic 
hydrophobic side chain, although truncations of FlhBCC were also observed (242, 243). 
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 These mutations were mapped onto the Yersinia early subunit export gate, SctU 
(YscU), and were able to partially restore effector molecule secretion (244). 
Accordingly, we have dubbed these mutations the “autonomous switchers” for their 
ability to trigger the export specificity switch in the absence of the molecular ruler. 
 
Notably, these early subunit export gate mutants are more stable than the wild type 
protein, resulting in less efficient autocleavage (190). This reduced rate of 
autocleavage could explain why these mutants are only able to partially restore the 
wild type switching phenotype in the absence of the molecular ruler, although further 
work in this area is needed. These mutations are valuable tools to study the 
interactions between FlhBCN and FlhBCC and, ultimately, the export specificity switch 
in isolation from FliK. 
 
Data presented in this chapter describes the role of FlhB autocleavage in the export 
specificity switch and suggest the switch is only triggered after a major structural 
change at FlhBC. I will also discuss, briefly, how FliK may cause this change. 
 
4.2 FlhBCN does not adopt a native fold in solution 
To investigate how non-covalent interactions stabilise autocleaved FlhBC, 
recombinant plasmids carrying FlhBCN and FlhBCC C-terminally fused to the intein-
chitin binding domain (inteinCBD) were constructed. Protein was purified as described 
in the Materials and Methods. 
 
Although a higher molecular weight band than expected for background inteinCBD 
was seen with immunoblotting, the fusion protein was too small to be full length 
FlhBCC. Only inteinCBD could be detected by immunoblotting and staining with 
Coomassie R250 post DTT-mediated cleavage (Figure 4.1A). This expression was 
repeated after the plasmid was reconfirmed by sequencing, but FlhBCC was not 
recovered. 
 
In contrast, FlhBCN expressed well and could be purified (Figure 4.1B). Before further 
attempts to purify FlhBCC were made, FlhBCN was analysed using circular dichroism 
(CD). The protein was scanned from 260 nm to 200 nm to determine what secondary 
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Figure 4.1 Independent expression and purification of FlhB cytosolic domains
(A) FlhBCC-inteinCBD expressed in E. coli C41 and purified on chitin resin. Left panel is a
Coomassie R250 stained 15% polyacrylamide gel, right panel is an immunoblot using mouse
anti-chitin binding domain (anti-CBD) (New England Biolabs) to detect FlhBCC-inteinCBD fusion
protein and remaining inteinCBD. Bound resin is chitin resin bound with the FlhBCC-inteinCBD
fusion protein, Elution post-DTT is the eluate after DTT cleavage, and Resin post elution is
protein bound to the resin after elution of the cleaved product. Samples were imaged using a
Li-Cor Odyssey CLx and Image Studio Lite (Li-Cor).
(B) Purified FlhBCN was dialysed at 4°C overnight into sodium phosphate (NaPO4), pH 7.4
buffer with 100 mM NaCl for use with circular dichroism (CD). Pure FlhBCN after dialysis is
shown stained with Instant Blue Coomassie stain. CD scanning data from 260 nm to 200 nm at
25°C of FlhBCN showing the mean residue ellipticity before and after a thermal melt at 95°C. 133
 structure, if any, it possessed in isolation from FlhBCC. FlhBCN was subsequently 
incubated at 95°C before being returned to 25°C for a second scan from 260 nm to 
200 nm to test FlhBCN’s ability to refold after heat denaturation (Figure 4.1B). 
 
Thermal melt and subsequent CD scan strongly suggest that FlhBCN does not adopt 
its native predominantly a-helical structure on its own in solution. The data is unclear 
as to what structure FlhBCN may adopt in solution, but it suggests that FlhBCN forms 
soluble, super-stable aggregates impervious to heat denaturation. Because neither 
FlhBCC expressed appropriately nor did FlhBCN adopt its native structure, further 
experiments investigating both proteins independently in vitro were not completed. 
 
4.3 The autonomous switcher mutants surround the FlhBC b-sheet 
Williams and colleagues identified a set of suppressor point mutations in FlhB that 
could overcome the effective loss of FliK to trigger the export specificity switch (243). 
These suppressor mutations, dubbed the autonomous switchers, are all located on 
FlhBCC (Figure 4.2A). Many of the suppressor mutations are found in the hydrophobic 
core of FlhBC surrounding the b-sheet, which has been proposed to contribute to 
holding the two FlhBC domains together post-autocleavage (Figure 4.2B) (241). The 
b-sheet comprises four b-strands – one from FlhBCN and three from FlhBCC. 
 
Some of the suppressor mutations introduce charged residues into the core of the 
protein or introduce larger hydrophobic residues into the core, potentially causing a 
rearrangement of the core. Others abolish non-covalent interactions, like hydrogen 
bonds, that could be important to holding the two polypeptides together post-
autocleavage at the fT3SS. Finally, some of these mutations may alter the structure 
of FlhBCC, resulting in different and perhaps weaker interactions between FlhBCC and 
FlhBCN. I sought to investigate the role of these mutations in auto-cleaved FlhBC 
structural stability. 
 
Williams and colleagues found little effect of the FlhB autonomous switcher mutations 
on cellular motility in the presence of FliK. I set out to identify mutations which, when 
introduced together, may also cause the greatest structural instability in FlhBC. I 
hypothesised these joint mutations would result in greater defects of cellular motility 
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Figure 4.2 Suppressor mutations in FlhB, dubbed the “autonomous switchers”, that can
overcome the loss of FliK
(A) Autonomous switcher mutants are only found in FlhBCC. Figure adapted from Williams et al.,
1996.
(B) Autonomous switcher mutants mapped onto the atomic resolution structure of Salmonella
FlhBCC. The K351Stop and W353Stop mutants are not mapped to the structure. Tryptophan 353
represents the end of the folded structure as determined by X-ray crystallography, so these
nonsense mutations are not shown. Insertion and frame shift mutations are likewise not shown.
that they are effectively nulls and therefore are all functionally
equivalent.
DISCUSSION
FliK plays a central role in the control of hook length and
the initiation of filament assembly (9, 19, 29). Polyhook mu-
tants are defective in both hook length control and filament
assembly (Hlc2 Fil2), whereas polyhook-filament mutants are
defective only in the former process (Hlc2 Fil1). In the ac-
companying paper (15) we suggested, on the basis of its amino
acid sequence, that FliK might have a two-domain (or possibly
a three-domain) structure. We also raised the question of
whether these domains might correspond to different functions
within the overall process of hook and filament assembly. Here
we report the analysis of many mutations responsible for both
polyhook and polyhook-filament phenotypes.
Polyhook mutations in FliK are usually severe ones. It is
clear from this study and previous ones (19, 29) that the poly-
hook phenotype is the null phenotype for FliK. Nonetheless,
we were surprised that almost all of the mutations that gave
rise to the polyhook phenotype were severe ones, resulting in
the loss of large stretches of sequence and often generating
frameshifted sequence. Only in the C-t rminal region (the last
120 or so amino acids) did relatively minor mutations (for
example, a 2-amino-acid insertion in strain SJW154) severely
affect both hook length control and filament assembly.
The results of the intragenic suppressor analysis provide a
ready explanation for the absence of missense mutants that fail
to control hook length. Missense mutations (just like moderate
in-frame deletions) throughout the first two-thirds of the gene
either would have had no effect or at most would have caused
the polyhook-filament phenotype. Cells carrying such muta-
tions would therefore have been motile and would have been
eliminated by our selection criterion, resistance to the flag-
ellotrophic phage x (32). However, missense mutations at
some codons in the C-terminal sequence of FliK might cause
the polyhook phenotype, and a more extensive search might
yield examples of these.
Intragenic suppression requires restoration of the C termi-
nus of FliK. Given the severity of the original mutations, how
is it possible to recover function by intragenic suppression?
The answer is by restoring the C-terminal region of the pro-
tein, either by correcting frameshifts by introducing compen-
sating frameshifts, or by changing nonsense mutations to mis-
sense ones. The importance of the C-terminal region is
underscored by the fact that whenever the first mutation lay in
that region, it was in essentially all cases unsuppressible intra-
genically. The only examples of suppression that we encoun-
tered were one in which a 1-base insertion occurred at the site
of the original 1-base deletion and one in which a nonsense
mutation was converted to a missense mutation.
In many cases restoration of the C-terminal region was
achieved at the cost of considerable damage to the N-terminal
and central regions. This indicates that these regions are rel-
atively tolerant of change, with the degree of restoration of
function depending on the extent and position of the compen-
sating event. Thus, the replacement of 22 amino acids of nat-
ural sequence in the central region by 15 amino acids of frame-
shifted sequence (MY3112) (Table 2) gave close to wild-type
flagellar morphology and motility behavior. We also found
stretches of sequence in the N-terminal region that were dis-
pensable, but they were typically much shorter, e.g., the re-
placement of 5 amino acids at residues 31 to 35 by 4 residues
of frameshifted sequence (MY3001).
When damage to the N-terminal region was very extensive
(for example, with the deletion of 131 amino acids starting
from codon 27 in pAW40 [Fig. 7c]), not only was hook length
control lost but filament assembly was initiated poorly, and so
the mean extent of flagellation was greatly reduced.
The nature of extragenic suppressors in FlhB. All of the
extragenic suppressors lay in flhB. The 15 independent muta-
tions that we observed all lay towards the 39 end of the gene
and so would produce defects in the predicted cytoplasmic
C-terminal domain of the integral membrane protein that it
encodes (Fig. 8). Our data confirm and extend those of Kut-
sukake et al. (19), who identified two suppressor mutations in
the C-terminal sequence of FlhB.
The lack of allele specificity of suppression (19; also this
work) fails to provide evidence for direct protein-protein in-
teraction between FliK and FlhB, but it does not argue against
it either, in view of the severity of the fliK mutations being
suppressed (and also the severity of the suppressing flhB mu-
tations in many instances). If polyhook mutants with point
mutations in the 39 end of fliK can be isolated, the issue of
allele specificity may be worth reexamining.
The most striking feature of the extragenic pseudorevertants
was their poor ability to swarm compared with many of the
intragenic pseudorevertants. This poor ability appears to be
due to t e fact t at they are not only completely defective in
hook length control but also poorly competent to initiate fila-
ment assembly (9, 19; also this work). However, the same flhB
mutations cause only mild defects in a wild-type fliK back-
ground. This implies that they do not significantly affect the
early stages of flagellar assembly, whereas the spontaneous
first-site flhB mutants that have been isolated have a much
more severe phenotype, being unable to proceed beyond as-
sembly of the MS ring (16). The latter point is presumably the
reason why we did not observe suppressor mutations causing
extensive truncations of FlhB or missense mutations except
near the C terminus.
FliK does not conform to a simple hook length control
versus filament assembly model. We now examine the data in
terms of the two-domain two-function hypothesis. In its sim-
plest form, this hypothesis would predict that mutations in one
domain would result in failure of one function and mutations
FIG. 8. Extragenic suppressors in flhB of polyhook first-site mutations in fliK.
The predicted topology of FlhB, an integral membrane protein, is shown (22).
All of the suppressing mutations were found in the predicted C-terminal cyto-
plasmic domain of the protein. Note that missense mutations were encountered
further from the C terminus than were frameshift or nonsense mutations. Con-
version of the natural termination codon to a sense codon results in addition of
a 48-residue sequence to the terminus. Mutations at the two residues indicated
by asterisks have also been noted by Kutsukake et al. (19).
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 in the presence of FliK. I also hypothesised that these joint mutations could be used 
to model the export specificity switch. 
 
Serine274 (S274) and Arginine302 (R302) are mutated into phenylalanine and proline, 
respectively, in the mutants identified by Williams and colleagues (Figure 4.3). S274 
lies downstream of the autocleavage site on b-strand2 (Figure 4.3A). R302 sits in the 
center of a-helix2 (Figure 4.3B), which a proline residue could disrupt. Mutations of 
either of these residues may alter autocleavage efficiency, therefore affecting the 
timing of the subunit specificity switch, or post-autocleavage structure, possibly 
resulting in a loss of FliK-mediated switching. Additionally, the side chains of the polar 
serine residue and charged arginine are within 4 Å of one another in the native FlhBC 
structure (Figure 4.3C), suggesting they may form a weak hydrogen bond that may be 
part of core stability. The autonomous switcher mutations abolish this hydrogen bond. 
 
4.4 Two autonomous switcher mutations are better than one, but not as good 
as wild type 
To be able to detect FlhBCC in the cell, my colleague, Owain Bryant, engineered a 
strain of Salmonella enterica serovar Typhimurium SJW1103 with a C-terminal 
3xFLAG tag on FlhBCC expressed under native chromosomal control (FlhBCT3xFLAG). I 
then introduced five sets of mutations of FlhBC into this strain using double lambda 
red recombinase-mediated recombination to engineer additional strains as described 
in section 2.7.1 (Figure 4.4A). A non-autocleavable variant of FlhB, FlhB N269A, was 
engineered to serve as a negative control for in vivo experiments. 
 
The effect on the cell’s ability to swim of the FlhB autonomous switcher mutations in 
the presence of FliK was measured. The addition of a 3xFLAG tag to FlhB had little 
effect on swimming motility as cells expressing FlhBCT3xFLAG showed equivalent 
swimming motility to SJW1103 (Figure 4.4B). Cells expressing the autonomous 
switcher mutations individually had a slight swimming motility defect, but these cells 
swam comparatively to wild type (approximately 90% wild type swimming motility). 
Cells expressing the double autonomous switcher mutant (S274F, R302P) had a greater 
effect on motility, only about 60% as motile as wild type cells (Figure 4.4B). 
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Figure 4.3 The autonomous switcher mutants selected for further study
(A) Autonomous switcher mutant S274F mapped onto the atomic resolution structure of
Salmonella FlhBCC. S274 sits on the β-strand immediately downstream of the autocleavage site.
Its polar side chain sits in the core of the protein. The residues in red are the autocleavage site
between N269 and P270.
(B) Autonomous switcher mutant R302P mapped onto the atomic resolution structure of
Salmonella FlhBCC. R302 sits in the middle of α-helix2, facing both the core and the surface of
the protein, and above the autocleavage site. The residues in red are the autocleavage site
between N269 and P270.
(C) Autonomous switcher mutant S274F, R302P mapped onto the atomic resolution structure of
Salmonella FlhBCC. The double replacement mutation moves these two residues 1.4 Å closer to
one another.
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Figure 4.4 Autonomous switcher mutations have a slight effect on the motility
phenotype and flagellin export
(A) List of SJW1103 strains used in motility and export assays.
(B) Motility assays of SJW1103flhbCt3xFLAG variants. Strains were inoculated on swimming
motility agar (0.25% w/v agar) and were incubated for 4 hours at 37°C.
(C) Immunoblot of export assay measuring FliC expression (cell) and export (supernatant) of
SJW1103flhbCt3xFLAG variants at A600 1.0. The cell sample was collected from 1 ml of culture.
The supernatant sample was filtered, cell-free supernatant from 1 ml of culture that was TCA
precipitated to collect exported protein. Samples were diluted 1:100 and 1:50 in SDS buffer for
cell and supernatant samples, respectively. All samples were standardised to A600. FliC was
detected using a 1:5000 dilution of Difco Salmonella H antiserum i (Becton, Dickinson and
Company). Samples were imaged using a Li-Cor Odyssey CLx and Image Studio Lite (Li-Cor).
Strain Characteristic
SJW1103 flhB
WT FLAG flhBCT3xFLAG
N269A
flhBCT3xFLAG N269A,
non-cleavable variant
PANA flhBCT3xFLAG P238A N269A, non-cleavable variant
S274F flhBCT3xFLAG S274F
R302P flhBCT3xFLAG R302P
S274F, R302P flhBCT3xFLAG S274F, R302P
A
B
C
cell
supernatant FliC
FliC46
kDa
46
kDa
138
 How might the double autonomous switcher mutant affect the cell’s ability to swim? 
These mutations, which are known to affect FlhB’s ability to autocleavable, may impair 
the expression and export of flagellin (FliC) by mistiming the export specificity switch. 
Cells expressing wild type FlhB and FlhBCT3xFLAG expressed and exported similar 
levels of FliC, as expected based on their ability to swim (Figure 4.4C). Cells carrying 
the double S274F, R302P mutant expressed slightly lower levels of FliC, which resulted 
in decreased export, although the effect is not great (Figure 4.4C). This small decrease 
in flagellin expression and export may explain the defect in motility, but the data 
suggest the cell can recover. 
 
While cells expressing the non-autocleavable flhB N269A variant could not swim, they 
expressed low levels of fliC and were able to export FliC into the supernatant. This is 
surprising as past reports have shown the flhB N269A mutant incapable of exporting 
FliC (193). FlhB does possess a known secondary autocleavage site between D237 
and P238, although this site is not known to be biologically relevant (193). P238 was 
mutated along with N269, resulting in the “PANA” strain. This flhB PANA mutant is 
totally autocleavage deficient and should not switch from early to late subunit export. 
FliC expression and export was greatly reduced in the PANA strain (Figure 4.4C). 
 
The double autonomous switcher mutant showed minor phenotypic effect in the 
presence of FliK. To test its effect on swimming motility and flagellin export without 
FliK, FliK was effectively deleted by replacement of the fliK gene with a kanamycinR 
cassette (Figure 4.5A). In past work, the autonomous switcher mutants were 
evaluated in strains expressing a C-terminal truncation of FliK (residues 1-300), not 
enough to cause the export specificity switch but still enough for FliK secretion (243). 
Here, the full fliK gene was replaced with the kanamycinR cassette, leaving only the 
extreme 5’ and 3’ gene sequence to allow for native operon control. 
 
Cells expressing the individual autonomous switcher mutants swam poorly in the 
absence of FliK (Figure 4.5B). Cells expressing the double autonomous switcher 
mutant showed greater swimming motility (Figure 4.5B); however, they did not swim 
near as well as wild type Salmonella with FliK. Cells expressing the individual and 
double autonomous switcher mutants all took 20 hours before motility could be 
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Strain Characteristic
ΔfliK
WT FLAG
ΔfliK::KanR
flhBCT3xFLAG
ΔfliK
S274F
ΔfliK::KanR
flhBCT3xFLAG S274F
ΔfliK
R302P
ΔfliK::KanR
flhBCT3xFLAG R302P
ΔfliK
S274F, R302P
ΔfliK::KanR
flhBCT3xFLAG S274F, R302P
A
B
Figure 4.5 Two autonomous switcher mutations are better than one
(A) List of SJW1103 strains used in motility and export assays.
(B) Motility assays of SJW1103ΔfliK::KanR flhbCt3xFLAG variants. Strains were inoculated on
swimming motility agar (0.25% w/v agar) and were incubated for 20 hours at 37°C.
(C) Immunoblot of export assay measuring FliC expression (cell) and export (supernatant) of
SJW1103ΔfliK::KanR flhbCt3xFLAG variants at A600 1.0. The cell sample was collected from 1 ml
of culture. The supernatant sample was filtered, cell-free supernatant from 1 ml of culture that
was TCA precipitated to collect exported protein. Samples were diluted 1:100 and 1:50 in SDS
buffer for cell and supernatant samples, respectively. All samples were standardised to A600.
FliC was detected using a 1:5000 dilution of Difco Salmonella H antiserum i (Becton, Dickinson
and Company). Samples were imaged using a Li-Cor Odyssey CLx and Image Studio Lite (Li-
Cor).
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 observed. At this stage, wild type Salmonella cells would have overtaken the entire 
motility plate and, therefore, was not included in these long-term experiments. As 
expected, cells expressing wild type flhB were unable to overcome the loss of FliK, 
displaying some outward growth after 20 hours but no signs of swimming motility 
(Figure 4.5B). 
 
Cells expressing the flhB double autonomous switcher mutant in the absence of FliK 
showed low levels of FliC expression and export (Figure 4.5C). The assay evaluated 
fliC expression at A600 1.0, or about three hours of growth. As it takes cells expressing 
the double autonomous switcher mutant around 20 hours to swim in the absence of 
FliK, it is not surprising that FliC expression and export is weak at an early stage of 
growth. Further work is needed to evaluate FliC expression and export in the double 
autonomous switcher mutant after 20 hours of growth. 
 
Based on swimming motility and FliC export assays, it is clear the FlhB double 
autonomous switcher mutant has a greater effect on the cell than individual 
autonomous switcher mutants. How might these mutations impact flagellar subunit 
export and assembly? Might they mistime the switch by disrupting the FlhBC structure? 
 
4.5 Autonomous switcher mutants are less stable in vitro 
Four autonomous switcher mutations were cloned into the pTXBI expression vector to 
study the effects of the mutations on FlhBC stability in vitro. The four mutations were 
as follows – S274F, R302P, S274F R302P combined, and W353T. W353T was constructed 
to mimic the W353Stop mutation that excludes the last 30 residues of FlhBC (residues 
354-383). Wild type FlhB and non-autocleavable FlhB N269A were also included in the 
stability study. All variants of FlhBC expressed well and could be purified using the 
inteinCBD system (Figure 4.6A). 
 
CD experiments were planned and conducted with Dr. Katie Kemplen. Dr. Kemplen 
analysed the data using KaleidaGraph to generate graphs and fit the equation 
provided in the Materials and Methods to the CD thermal melt data. Wild type FlhBC 
was initially scanned using CD from 260 nm to 200 nm at 25°C and 35°C. The protein 
showed a slightly greater signal at 35°C, not unexpected as Salmonella’s preferred 
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Figure 4.6 Autonomous switchers mutants do not have substantial structural
differences from wild type FlhBC
(A) FlhBC W353T tagged with inteinCBD purified on chitin resin following method described in
materials and methods. Samples were run on 15% SDS-PAGE and stained with Instant Blue
coomassie stain. Purified protein was dialysed at 4°C overnight into 20 mM sodium phosphate
(NaPO4), pH 7.4 buffer with 100 mM NaCl for use with CD. Post-cleavage represents FlhBC
W353T after cleavage from the inteinCBD. Pure protein is FlhBC W353T after dialysis. Panels on
the right are the pure protein inputs used in CD. All FlhBC variants were purified and dialysed in
the same manner.
(B) Scanning thermal melts of wild type FlhBC from 260 nm to 200 nm. Temperature was
increased by 10°C and allowed to equilibrate for 10 minutes before scanning FlhBC again.
FlhBC was completely unfolded at 75°C and did not refold as temperature was lowered.
(C) CD scanning data from 260 nm to 200 nm of FlhBC variants. Autocleaved FlhBC (WT), non-
autocleaved FlhBC (N269A), FlhBC S274F, and FlhBC W353T show similar structure based on
scans. FlhBC R302P does show a shift in the curve around 208 nm, suggesting a different
structure to other FlhB variants. 142
 growth temperature is 37°C. Wild type FlhBC was further scanned in intervals of 10°C, 
up to 95°C, to unfold the protein. After the melt at 95°C, FlhBC was incubated at 65°C 
and then 25°C to investigate if it could refold as it was returned to room temperature. 
The CD signal for wild type FlhBC began to weaken at 55°C and reached its lowest 
signal around 75°C, suggesting the protein is fully denatured around this temperature. 
The CD signal never recovered as the temperature was lowered, indicating that FlhBC 
cannot refold on its own once unfolded by heat denaturation (Figure 4.6B). 
 
Each of the FlhB variants were scanned from 260 nm to 200 nm at 25°C to determine 
if they were structurally similar. Most of the variants returned a similar curve as wild 
type, autocleavable FlhBC (Figure 4.6C). This indicates that some of the individual 
mutations do not have a major effect on FlhBC structure. One autonomous switcher 
mutant, R302P, showed a shift around 208 nm in the CD curve. Although it is not 
possible from the CD data recorded to conclude what structural differences exist 
between wild type FlhBC and FlhBC R302P, this shift suggests there is some structural 
change between these two variants. Based on the signal and the location of the point 
mutation, it is possible that the observed difference is due to a change in a-helix2. 
 
Unfortunately, the double autonomous switcher mutant, S274F R302P, precipitated out 
of solution when dialysed against the CD experimental buffer (20mM sodium 
phosphate, pH 7.4, 100 mM NaCl) at 4°C (Figure 4.7). Because this protein was 
unstable in buffer suitable for circular dichroism (CD), it could not be studied further in 
these experiments. 
 
The in vitro stability of each FlhB variant was determined by CD at 222 nm and 
measuring the melting temperature of the protein by increasing the experimental 
temperature from 25°C to 95°C in 1°C intervals. Each variant was also studied for the 
ability to refold by decreasing temperature from 95°C to 25°C in 1°C intervals after an 
incubation step at 95°C. Wild type and non-autocleavable FlhBC had similar melting 
temperatures near 80°C (Figure 4.8A and 4.8B). Non-autocleavable FlhBC was slightly 
more thermostable, which is not surprising as the protein possesses an additional 
(covalent) peptide bond. 
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Figure 4.7 The double autonomous switcher mutant was not stable in buffer suitable for
CD
FlhBC S274F, R302P tagged with inteinCBD purified on chitin resin. Samples were run on 15%
SDS-PAGE and stained with Instant Blue coomassie stain. After purification in 40 mM Tris, pH
7.4 buffer with 1 M NaCl, protein was dialysed at 4°C overnight into 20 mM sodium phosphate
(NaPO4), pH 7.4 buffer with 100 mM NaCl for use with CD. The double autonomous switcher
mutant was unstable in the low-salt sodium phosphate buffer used for CD and precipitated out
of solution. Therefore, this mutant could not be analysed further by CD.
144
R302P
Tm 329.9 K 
(56.75°C)
Temperature (K)
El
lip
tic
ity
 (m
de
g)
S274F
Tm 340.2 K 
(67.05°C)
Temperature (K)
El
lip
tic
ity
 (m
de
g)
W353T
Tm 347.54 K 
(74.39°C)
Temperature (K)
El
lip
tic
ity
 (m
de
g)
N269A
Tm 353.9 K
(80.75°C)
Temperature (K)
El
lip
tic
ity
 (m
de
g)
FlhBC
Tm 352.7 K
(79.55°C)
Temperature (K)
El
lip
tic
ity
 (m
de
g)
Figure 4.8 FlhBC autonomous switcher mutants alter its thermal stability
(A-E) Thermal melts of FlhBC variants from 298.15 K (25°C) to 368.15 K (95°C) measured at
222 nm by CD. Proteins were subsequently cooled to 298.15 K (25°C), but no refolding was
observed as previously shown for wild type FlhBC (Figure 4.6B).
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 Unlike the non-autocleavable FlhB variant, a single autonomous switcher mutation 
was enough to substantially decrease the melting temperature of FlhB. S274F was 
12°C less stable (Figure 4.8C). R302P was 23°C less stable than wild type FlhBC 
(Figure 4.5D). The W353T mutant was about 5°C less stable than wild type FlhBC 
(Figure 4.8E). The loss of thermal stability among the autonomous switcher mutants 
indicates that these mutations are disrupting the FlhBC polypeptides, even if they are 
not radically changing the folded structure. 
 
Structural changes caused by these autonomous switcher mutations were studied by 
attempting to crystallise FlhBC R302P using the crystal screens in section 2.20. FlhBC 
R302P was chosen as the CD data suggested it may be structurally different from wild 
type FlhB and it had the most severe effect on FlhBC melting temperature. FlhBC R302P 
failed to crystallise in the three screens used to crystallise FlhBC successfully. Further 
investigation of the structural differences between FlhBC and the autonomous 
switchers is needed to study how these point mutations effect the structure of FlhBC. 
 
4.6 Autonomous switcher mutants are less stable after autocleavage in vivo 
The autonomous switcher mutants proved to be less stable in vitro than autocleavable, 
wild type FlhB and non-autocleavable FlhB. Do these mutations have a similar effect 
on FlhB stability in the cell? To observe FlhB stability in vivo, Salmonella DfliK::KanR 
cells expressing 3xFLAG-tagged wild type FlhB, 3xFLAG-tagged non-autocleavable 
FlhB N269A, and a 3xFLAG-tagged FlhB double autonomous switcher mutant were 
grown to late log and stationary phase as measured by A600. Wild type FlhBC has 
completely autocleaved by late log stage as detected by the single FlhBCC CT3xFLAG 
band and a lack of a corresponding full length FlhB Ct3xFLAG (uncleaved) band (Figure 
4.9). This FlhBCC CT3xFLAG band is observed in both late log and stationary phases. The 
non-autocleavable FlhBC, by contrast, has not autocleaved, as is expected, since only 
a full-length band for FlhBCT3xFLAG was observed (Figure 4.9). 
 
The double autonomous switcher mutant shows inefficient autocleavage in vivo by 
late log stage, but is fully autocleaved by stationary phase. A band for FlhBCC Ct3xFLAG 
cannot be seen either in late log phase or in stationary phase for the double 
autonomous switcher mutant (Figure 4.9). This suggests that FlhBCC is unstable after 
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Figure 4.9 In vivo stability of FlhB in late log and stationary phase
The box shows where the FlhBCC band should appear. Salmonella Typhimurium ΔfliK::KanR
cells with C-terminally FLAG tagged flhB variants were grown in LB broth with kanamycin 50
µg ml-1 until an A600 of 1.0 for late log phase and A600 1.5-2.0 for stationary phase. Whole cell
samples were collected and standardised to A600. Samples were analysed by immunoblotting
using mouse anti-FLAG M2 antibody (Sigma) and donkey anti-mouse infrared antibody (Li-
Cor). Samples were imaged using a Li-Cor Odyssey CLx and Image Studio Lite (Li-Cor).
FlhBCN was not detected with antibody in these experiments.
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 autocleavage as a result of the double autonomous switcher mutations and agrees 
with the previous in vitro findings that these mutations destabilise FlhB. 
 
4.7 FliK leads to the loss of FlhBCC from the membrane 
The autonomous switcher mutations destabilised FlhBC in vitro and in vivo in the 
absence of FliK. They hint that the role of FliK in the export specificity switch might be 
to destabilise the non-covalent interactions that bind FlhBCC to the rest of FlhB. To test 
this hypothesis, whole cell samples and small scale fractionation experiments at late 
log phase (A600 1.0) were carried out with cells expressing 3xFLAG-tagged wild type 
and non-autocleavable FlhBC in the presence and absence of FliK. FlgN, a soluble 
cytoplasmic protein, was used as a control for the fractionation experiments. 
 
Wild type FlhBC is completely autocleaved in late log phase whether FliK is present or 
not in whole cell samples. Thus, FliK doesn’t seem to have much of an effect on FlhB 
autocleavage (Figure 4.10). In the absence of FliK, a distinct FlhBCC Ct3xFLAG band can 
be seen in the whole cell samples as previously noted (Figure 4.10). The presence of 
FliK leads to a 2.4-fold loss of the FlhBCC Ct3xFLAG band (Figure 4.10). This result is 
statistically significant (p-value= 0.006) across four biological replicates. 
 
Fractionation experiments in the presence of FliK were used to determine what might 
happen to FlhBCC after it dissociates. The FlhBCC band does not appear in the 
periplasmic fraction, which is not surprising (Figure 4.11B). The FlhBCC band does 
appear in the cytosol fraction, but so does non-autocleaved FlhB (N269A), suggesting 
the cytosol fraction was slightly contaminated with insoluble and membrane protein 
(Figure 4.11C). The insoluble fraction, which contains membrane and insoluble 
cytoplasmic protein, mimics what is seen in the whole cell fraction, where FlhBCC is 
decreased 2.4-fold in the presence of FliK (Figure 4.11A and Figure 4.11D). FlhB is a 
transmembrane protein, so it is reasonable to suggest that FlhBCC is lost from the 
membrane before being degraded by proteases. These data support that hypothesis. 
Alternatively, FlhBCC might be too unstable to be detected after dissociation from FlhB. 
 
The separation of fractions was not as clean as desired as all fractions contained some 
FlgN, although it was mostly detected in the cytosol fraction as expected. Very little 
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Figure 4.10 FlhBCC dissociates from FlhB in a FliK-dependent manner
2.4 fold less FlhBCC is observed when FliK is present. Salmonella Typhimurium wild type and
ΔfliK::KanR cells with C-terminally FLAG tagged flhB variants were grown in LB broth until an
A600 of 1.0. 1 ml whole cell samples were collected and standardised to A600. Samples were
analysed by immunoblotting using mouse anti-FLAG M2 antibody (Sigma) and donkey anti-
mouse infrared antibody (Li-Cor). FlhBCN was not detected with antibody in these
experiments. The relative amount of FlhBCC with standard error of the mean was calculated
from four biological replicates and analysed using a Li-Cor Odyssey CLx and Image Studio
Lite (Li-Cor). The relative amount of FlhBCC in WT FLAG samples was always counted as 1.0.
* indicates that the p-value < 0.05.
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Figure 4.11 FlhBCC disappears from the membrane
Salmonella Typhimurium wild type and ΔfliK::KanR cells with C-terminally FLAG tagged flhB
variants were grown in 10 ml LB broth until an A600 of 1.0. 1 ml whole cell samples were
collected and fractionated using osmotic shock. Samples were Samples were analysed by
immunoblotting using mouse anti-FLAG M2 antibody (Sigma) and rabbit anti-FlgN. Donkey
anti-mouse and donkey anti-rabbit infrared antibody (Li-Cor) were used as secondary
antibodies. Samples were imaged using a Li-Cor Odyssey CLx and Image Studio Lite (Li-Cor).
Panels beneath each blot show the amount of FlgN, a soluble, cytoplasmic flagellar subunit, in
each sample.
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 FlgN appeared in the periplasmic fraction, confirming that osmotic shock used to 
separate periplasm contents from the cell was successful overall. The presence of 
FlgN in the insoluble fraction could indicate that it started to aggregate, but is more 
probably a result of the slow centrifuge speed (17,000 xg) used to separate the 
fractions. 
 
After dissociation, FlhBCC does not appear elsewhere in the cell as assayed by 
fractionation. Past reports suggest that Yersinia SctUCC contains a possible secretion 
signal and is secreted after the export specificity switch is complete (198, 199). A 
secretion assay using 100 ml of culture was conducted to see if FlhBCC was secreted 
after being removed from the membrane. Wild type Salmonella expressing FlhB and 
FliK was grown to an A600 of 1.0. Although wild type FlhB did not autocleave fully by 
this stage, a FlhBCC band was observed in the whole cell. No corresponding FlhBCC 
band was detected in the supernatant, suggesting that FlhBCC is not secreted after its 
removal from the membrane (Figure 4.12). 
 
4.8 How might FliK lead to the loss of FlhBCC from FlhB 
The data suggest that FlhBCC dissociates from the rest of FlhB in a FliK-dependent 
manner and that the autonomous switcher mutations mimic the role of FliK in the 
export specificity switch. How might FliK cause the dissociation between FlhBCC and 
FlhB? Evidence for a direct interaction between the FliK T3S4 domain and FlhBCC is 
weak, so a few hypotheses were tested to determine how this FliK-dependent loss of 
FlhBCC may occur. 
 
Firstly, full-length FliK was expressed in E. coli C41 to determine if FliK could cause 
FlhBCC to dissociate from FlhB in vitro. E. coli C41 cells were resuspended in buffer 
and lysed to collect the soluble fraction containing FliK. Pure FlhBC Ct3xFLAG (1 µM) was 
incubated with both C41 soluble lysate expressing empty pET15b vector and C41 
soluble lysate containing full-length FliK. Samples were collected at different time 
points and analysed by immunoblotting to detect any loss of FlhBCC. No loss of FlhBCC 
could be observed in vitro after 180 minutes, approximately the same length of time 
as the in vivo cell-based assays that originally showed the FliK-dependent loss of 
FlhBCC (Figure 4.13). 
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Figure 4.12 FlhBCC is not secreted after dissociation from FlhB
Salmonella Typhimurium wild type cells with C-terminally FLAG tagged flhB variants were
grown in 100 ml LB broth until an A600 of 1.0. Cells of 1 ml broth culture were collected for
whole cell samples. Supernatant samples were TCA precipitated from remaining 99 ml of
culture. Samples were analysed by immunoblotting using mouse anti-FLAG M2 antibody
(Sigma) and donkey anti-mouse infrared antibody (Li-Cor). Samples were imaged using a Li-
Cor Odyssey CLx and Image Studio Lite (Li-Cor). FlhBCN was not detected with antibody in
these experiments.
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Figure 4.13 FliK does not cause the loss of FlhBCC in vitro
Immunoblot of in vitro assay of purified FlhBC Ct3xFLAG (input) incubated for 0, 30, 90, and 180
minutes at 25°C with C41 soluble lysate ± HexaHis-FliK. Left panel is the C41 empty vector
soluble lysate control. FlhBC Ct3xFLAG was detected with mouse anti-FLAG M2 antibody.
HexaHis-FliK was detected with mouse PentaHis antibody (Qiagen). Donkey anti-mouse
infrared antibody (Li-Cor) was used to detect primary antibodies. Samples were imaged using a
Li-Cor Odyssey CLx and Image Studio Lite (Li-Cor).
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 This in vitro experiment failed to demonstrate that the loss of FlhBCC was FliK-
dependent, unlike the in vivo experiment that showed a 2.4-fold loss of FlhBCC in the 
presence of FliK. Minamino and colleagues used genetic analysis to conclude that 
FliK residues 300-350 and 401-405 are required for the export specificity switch, the 
so-called T3S4 domain (202). Residues 300-350 correspond to the central globular 
FliKC domain (203). Recombinant plasmid (pBAD18amp) carrying FliK270-405 was 
constructed to test whether this T3S4 domain alone could interact with FlhB to cause 
the export specificity switch. 
 
Salmonella Typhimurium DfliK::FRT cells expressing fliK270 induced with 0.02% w/v L-
arabinose did not swim at 37°C, while cells expressing wild type fliK could complement 
swimming motility in the same conditions (Figure 4.14A). That was unsurprising given 
previously reported results that fliKC was not enough to complement swimming motility 
(204). 
 
Along with Dr. Kemplen, I planned and performed a pulldown experiment to test 
whether FliK270 might interact with pure FlhBC. These experiments were performed 
with HexaHis-tagged FliK and FliK270 immobilised on nickel resin. Resin-bound FliK 
and FliK270 were then incubated with purified, untagged FlhBC. FlhBC bound to the 
empty nickel agarose resin, but bound more greatly to FliK and FliK270 (Figure 4.14B). 
FlhBC bound to FliK and FliK270 in equal amounts, suggesting FliK270 is able to form a 
stable complex with FlhBC. This is one of the first biochemical results to show a direct 
interaction between FliKC and FlhBC. The high amount of background FlhBC binding 
to nickel-NTA resin, however, makes these results difficult to analyse conclusively. 
That, coupled with the lack of motility from the FliK270 construct, made this a less 
attractive truncation to study. Attention was returned to full-length FliK. 
 
The autocleavage of FlhBC leaves a surface-exposed proline residue at the start of 
FlhBCC. We hypothesised that FliK may act as a proline aminopeptidase and remove 
this proline residue to begin to destabilise FlhBC. L-proline p-nitroanilide 
trifluoroactetate salt mimics a free N-terminal proline residue. In the presence of a 
proline aminopeptidase, L-proline will be cleaved from the p-nitroanilide, resulting in a 
colourimetric change that can be measured at 405 nm. 
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Figure 4.14 The FliK T3S4 domain alone can not cause the switch, but can bind to FlhBC
(A) fliK270 is not able to recover motility in a SJW1103ΔfliK::FRT strain. pBAD18amp served as
the empty vector control. Protein expression was induced with 0.02% w/v L-arabinose for four
hours at 37°C.
(B) FliK270 binds FlhBC. The left most band, labeled “background”, is FlhBC binding to empty
nickel-NTA resin. HexaHis-FliK and HexaHis-FliK270 were purified on nickel-NTA resin (Qiagen)
and washed with 10 CV. A sample of FliK bound on resin was taken to serve as the “input”.
Pure FlhBC was then added to the remaining resin. The FliK-FlhBC complex was washed with 5
CV and proteins were boiled from the resin. Samples were analysed by immunoblotting using
PentaHis antibody (Qiagen) and anti-FlhBC antibody. Samples were imaged using a Li-Cor
Odyssey CLx and Image Studio Lite (Li-Cor).
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 Purified FliK was incubated with 1 mM L-proline p-nitroanilide trifluoroactetate at 20°C 
or 50°C for 30 minutes. C41 pET15b soluble lysate in PBS was used as the positive 
control as E. coli has native proline aminopeptidases. The reaction was stopped with 
the addition of acetic acid. Each sample was analysed at A405. The C41 pET15b 
soluble lysate had the greatest aminopeptidase activity at 20°C. Incubating the 
solutions at 50°C resulted in about a twofold loss of enzymatic activity. After 30 
minutes incubation, FliK showed no effect on L-proline p-nitroanilide trifluoroactetate 
at either 20°C or 50°C (Figure 4.15). Therefore, FliK is most likely not a proline 
aminopeptidase. 
 
Finally, Mizuno et al 2011 proposed that the acidic loops of FliKC may interact with the 
basic surface of FlhBC and result in the export specificity switch (Figure 4.16A). There 
are two acidic loops in FliKC – loop 2 and loop 3. Loop 2 contains a highly conserved 
sequence LxPx1x2LG, where x1 and x2 are acidic residues (glutamic acid in 
Salmonella). Loop 3 also contains two acidic residues (aspartic acid in Salmonella), 
although these are not as well conserved (203). 
 
These acidic residues were mutated to glycines to maintain loop structure while 
altering local chemistry (acidic to hydrophobic residues). The loss of these acidic 
residues showed no effect on complementation of swimming motility in a fliK null 
Salmonella strain. Cells expressing these fliK variants swam comparably to fliK null 
Salmonella cells expressing wild type fliK from recombinant plasmid (Figure 4.16B). 
This agrees with previously reported results that were published after these 
experiments were conducted (240). The combination of these results strong suggest 
the acidic loops are not involved in the export specificity switch, although they may still 
bind FlhBC’s basic surface. This was not investigated in this study. 
 
The goal of these experiments was to figure out how FliK may cause FlhBCC to 
dissociate from the rest of FlhB through direct interactions or enzymatic activity. What 
these experiments suggest is that FliK’s role in the export specificity switch appears 
to be more complicated than a simple interaction. FliKC is stable, but presumably must 
be unfolded for export through the very narrow rod and hook channel. Does this 
unraveling expose binding sites covered in the structured C-terminal domain? That 
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Figure 4.15 FliK is not a proline aminopeptidase
Proline aminopeptidase activity assay measured at A405 with 1 mM L-proline p-nitroanilide. PBS
and Tris-saline buffer (“Buffer”) served as absorbance blanks for assay. FliK in Tris-saline buffer
is purified HexaHis-FliK in buffer at 6 µM. C41 soluble lysate in PBS (“C41”) at 20°C is counted
as 1.0 relative enzymatic activity.
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Figure 4.16 The acidic loops in FliKC are not responsible for causing the switch
(A) The core, structured domain of FliKC contains two α-helices, a β-sheet made up of four β-
strands, and several loops. Some of these loops are acidic. FliKC loop 2 contains two glutamate
(E) residues; FliKC loop 3 contains two aspartate (D) residues. A proposed model of FliKC acidic
loop 2 binding to a basic cleft on FlhBC post-autocleavage is shown. Figure adapted from
Mizuno et al., 2011.
(B) Complementation of SJW1103ΔfliK::FRT transformed with pBAD18amp plasmids carrying
fliK wild type and acidic loop mutants on swimming motility agar (0.25% w/v agar) with 0.02%
w/v L-arabinose after incubation for four hours at 37°C. Vector is empty pBAD18amp.
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 remains possible, and future work, proposed in the following discussion, should seek 
to address this question. 
 
4.9 Discussion 
FlhBC rapidly autocleaves into two cytosolic domains at the NPTH loop, with a half-life 
of approximately five minutes (190). These two domains, FlhBCN and FlhBCC, can be 
co-purified in 1:1 stoichiometry, hinting that the non-covalent interactions holding the 
two domains together must be relatively strong. CD data investigating the melting 
temperature of autocleavable FlhBC and non-autocleavable FlhBC show that the 
protein is quite stable in either state, happy to exist as two tightly associated domains 
or one covalently-attached polypeptide with no discernable change in structure. 
 
But, although structural work has provided evidence of possible non-covalent links 
between the two domains, an affinity between the FlhBCN and FlhBCC domains has not 
been established. FlhBCC was difficult to purify on its own, meaning that biophysical 
methods such as isothermal titration calorimetry (ITC) were not possible. FlhBCN could 
be purified without its FlhBCC partner domain. CD analysis showed that the protein did 
not adopt the expected, majority a-helical fold it shows when in association with FlhBCC 
in the published atomic resolution structure. The unusual structure of FlhBCN in 
isolation from FlhBCC makes studying the two domains separately difficult without the 
use of large tags, experiments which were not attempted in this study. In vivo, the 
deletion of FlhBCC from the chromosome can be partially rescued by overexpression 
from recombinant plasmid (190), suggesting that FlhBCN can adopt its native fold either 
while connected to the transmembrane domain of FlhB or upon association with the 
FlhBCC polypeptide in the cytosol. Because FlhBCC could not be purified without a large 
protein tag in this study, I did not attempt to mix FlhBCN and FlhBCC to see if the two 
domains could re-associate in vitro. 
 
Since separating the two domains proved to be unfruitful, the autonomous switcher 
mutants were investigated as models to study the effect of the export specificity switch 
on the stability of FlhBC. The two autonomous switcher mutations selected for this 
study, S274F and R302P, are structurally critical based on analysis of the atomic 
resolution structure. S274 is located on b-strand2 downstream of the primary 
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 autocleavage site. R302 is centrally located in a-helix2. These residues may also form 
a weak hydrogen bond in the core of the protein since they are at the limit that 
hydrogen bonding usually occurs. This may be one of the secondary, non-covalent 
bonds that hold FlhB together post-autocleavage. 
 
CD analysis reveals that the autonomous switcher mutants are structurally similar to 
wild type FlhB, with one exception (FlhBC R302P). The loss of the proposed hydrogen 
bond between S274 and R302 did not seem to have a major effect on FlhB’s structure. 
It is difficult, then, to say what contribution this hydrogen bond makes on core 
arrangement. Presumably, it is one of many non-covalent bonds that keep the two 
polypeptides in association after autocleavage. 
 
As previously discussed, changing R302 into a proline could damage a-helix2 and lead 
to local unfolding, potentially exposing the core to the aqueous solution and therefore 
causing a major rearrangement of the folded domains to shield hydrophobic residues. 
This was the only variant of FlhBC that showed a shift in the CD data, indicating that 
some structural rearrangement had occurred. Unfortunately, it is not possible to 
analyse this shift further to determine what structural changes did occur. 
Crystallisation of FlhBC R302P was attempted, but crystals did not grow. Future work 
might purify FlhBC R302P and attempt other methods in solution or additional crystal 
screen conditions to characterise the structural changes caused by this point mutation. 
 
Individually, the autonomous switcher mutants S274F and R302P have minor effects on 
the cell’s ability to swim, both in the presence and absence of FliK. When combined 
as a double autonomous switcher mutant, however, these mutations are better able 
to rescue the swimming motility phenotype in the absence of FliK. These cells are 
inefficient swimmers, unable to outcompete wild type Salmonella, and only weakly 
express and export FliC. 
 
This inefficient swimming is probably caused by a mistimed export specificity switch 
in the absence of FliK that results from sporadic autocleavage. The double 
autonomous switcher mutant undergoes inefficient autocleavage as observed in vivo, 
triggering the export specificity switch too early or too late. If the switch occurred too 
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 early, a filament could begin to assemble too early. If the switch were delayed for too 
long, a filament may assemble on what would now be an elongated polyhook 
structure. In either case, the cell would not be able to swim as the short hook or long 
polyhook would not rotate and transfer torque efficiently. 
 
Once the mutant FlhB does autocleave, the structural instability caused by the double 
autonomous switcher mutations results in the loss of FlhBCC. What do these results 
tell us about the effect of the double autonomous switcher mutant on flagellar 
assembly? The double autonomous switcher mutations may serve to disrupt the 
interactions between FlhBCN and FlhBCC post-autocleavage just well enough to allow 
for the assembly of some competent flagella in a minority of cells, resulting in some 
rescue of the swimming phenotype in the absence of FliK. 
 
Motility assays with the FlhB double autonomous switcher mutant in the presence or 
absence of FliK were conducted at 37°C to compare to the other FlhB variants. But 
the double autonomous switcher mutant was shown to be unstable during dialysis into 
low-salt buffer at 4°C (Figure 4.7). Future investigation could perform motility assays 
at higher temperatures, such as 42°C, to determine if this improves the cell’s ability to 
swim. I hypothesise that the higher incubation temperature would lead to an earlier 
loss of the mutated FlhBCC from FlhB by promoting more rapid autocleavage of the 
double autonomous switcher mutant and then to a more efficient export specificity 
switch. 
 
Williams and colleagues reported that cells with the autonomous switcher mutations 
swam slower than wild type, but ultimately produced motility rings on semi-solid agar 
similar to wild type. They measured these rates and ring sizes based only on the 
effective loss of FliK. In their strains, FliK was truncated to residues 1-300, out of the 
405 residues in wild type FliK (243). In this study, the swimming rates of cells with 
autonomous switcher mutations were not measured, but the ring size is not near 50% 
of wild type Salmonella cells after 20 hours, which would have taken up the plate rather 
than swim just 30 mm as cells with the double autonomous switcher mutant did. The 
difference here could be the effective loss of FliK via a C-terminal truncation in the 
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 Williams strains versus the near complete replacement of FliK with a kanamycinR 
cassette in the strains used in this study. 
 
So, what effects may the autonomous switcher mutants have on FlhBC? The in vitro 
data show that the mutations greatly compromise the protein’s thermal stability, with 
the exception of W353T. W353T mimics a nonsense mutation by eliminating the last 30 
residues of FlhBC. Interestingly, these residues are not present in the atomic resolution 
structure, suggesting they are not well structured. Many of them are, however, 
assigned in the NMR spectra recorded for FlhBC and could adopt secondary structure 
in solution. The minor loss of thermal stability in the W353T mutant could be a result of 
the loss of this solution structure, lowering the energy barrier it takes to unfold the 
protein. These last 30 residues may also provide additional contacts between FlhBCN 
and FlhBCC by acting as a hinge between the two domains. The importance of these 
residues should be studied further to elucidate what role they may play in the protein’s 
properties. 
 
S274F has a greater effect than W353T on decreasing the melting temperature of FlhBC. 
Replacing serine with phenylalanine removes a smaller, polar residue for a larger, 
aromatic one, but the phenylalanine would most likely stay confined to the protein’s 
core. It may push out on the surrounding residues, particularly R302 on a-helix2, and 
force them to adopt a slightly different conformation. This rearrangement and loss of 
a hydrogen bond may be what causes the decreased stability. 
 
R302P results in the greatest decrease of the FlhB melting temperature that we could 
measure. Not only does a hydrophobic residue replace a surface exposed, charged 
residue, but prolines are known to break a-helices. The full effect of this mutation on 
a-helix2 structure is unknown and should be studied further, but it is reasonable to 
suggest that the addition of a proline at least serves to destabilise the local region, 
remove a hydrogen bond partner, and increase the hydrophobicity on FlhBC’s surface. 
This mutation almost certainly results in a greater structural change than S274F, which 
would explain its greater effect on thermal stability. 
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 The double autonomous switcher mutant, S274F R302P, was not stable in the low-salt 
buffer needed for CD, either at 4°C or 25°C. The CD buffer (20 mM sodium phosphate 
buffer, pH 7.4, 100mM NaCl) was selected to minimise the background absorbance 
of buffer components during the CD experiments while maintaining FlhBC structure 
and approximating physiological conditions as much as possible. All other variants of 
FlhBC were stable in this buffer, so it is doubtful that the buffer caused the double 
autonomous switcher mutant to precipitate out of solution during dialysis. The double 
mutant was stable in the high salt (1 M NaCl), tris buffer used to purify proteins fused 
to the inteinCBD tag. The extra ionic charges in the high salt buffer may serve to 
stabilise the mutated FlhBC’s structure. 
 
What may happen with the double autonomous switcher mutant during dialysis? 
Unlike when the two domains are separately purified, and FlhBCN was shown to be 
super stable in solution, the two domains were expressed and purified in vitro 
simultaneously for the CD experiments. This should allow FlhBCN to adopt its native 
fold with the now unstable FlhBCC prior to or during autocleavage. As the double 
autonomous switcher mutant is stable in high salt, these two domains must stably 
interact long enough to be recovered after overnight cleavage from the expression 
inteinCBD tag. Once the salt concentration of the buffer was lowered though, FlhBCC 
would begin to destablise and could be pulling FlhBCN out of solution with it. This may 
explain why both domains can be seen in the precipitate. 
 
In vitro stability is one matter. In vivo, where the protein exists in the crowded cell 
environment, is another. The addition of a 3xFLAG tag to the C-terminus of FlhB allows 
for the tracking of FlhBCC’s fate in the cell. Under wild type conditions without FliK, and 
therefore the absence of an export specificity switch, FlhB autocleaves completely by 
late log phase, leaving a strong FlhBCC band. The double autonomous switcher mutant 
does not have a corresponding FlhBCC band in late log phase, but the protein has not 
completely autocleaved yet, as evidenced by the larger molecular weight band 
corresponding to the non-autocleavable variant of FlhB. This corroborates prior 
findings that these mutations lead to inefficient cleavage via an unknown mechanism 
(190). 
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 The double autonomous switcher mutant has completely autocleaved once the cells 
have reached stationary phase. No FlhBCC band for the double autonomous switcher 
mutant was detected at this stage either, even though such a band could still be 
detected for wild type FlhB. This in vivo finding complements what we see in vitro. The 
double autonomous switcher mutant expressed well in the cell, but, once 
autocleavage occurred in an environment with low salt, like what might be found in a 
Salmonella cell, FlhBCC is not stable enough to maintain tertiary and secondary 
structure and is degraded in the cell. 
 
The autonomous switcher mutants, especially the double autonomous switcher 
mutant, reveal the first clues about the downstream effects of FlhB autocleavage in 
the export specificity switch. These mutations destabilise FlhBC and ultimately cause 
the loss of FlhBCC from the rest of FlhB. Why might that be important? Early subunits 
bind to a surface-exposed hydrophobic pocket on FlhBCC. Without this domain, early 
subunits would not have an export gate at the fT3SS. FlhB must autocleave, then, to 
allow for the proper timing of FlhBCC dissociation that leads to competent flagella. 
 
This same effect is seen with wild type FlhB, but only in the presence of FliK. In the 
presence of FliK during log phase, FlhBCC starts to disappear. This change is not great, 
only a 2.4-fold difference, but this is probably due to the nature of flagella assembly in 
Salmonella. Salmonella is peritrichous, with many flagella at different stages of 
assembly per cell. In the wild type environment, it is possible this staggered assembly 
means that FlhBC has not yet switched at all of the fT3SS machines. The immunoblots 
analysed a population of cells, further complicating the picture by capturing both 
phases of flagellar assembly across a large population. Regardless, these results 
suggest that wild type FlhBCC dissociates from FlhB at the membrane in a FliK-
dependent manner. 
 
If two copies of FlhB are present at the fT3SS, it may mean one FlhB has “switched” 
while the other has not. This could explain why FliK is secreted intermittently through 
hook assembly. Hook length must be tightly controlled, but the range can still fall within 
10% of average length (55 ± 6 nm). Two copies of FlhB could account for this range if 
both FlhBCC’s would need to dissociate to trigger the switch.  
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 Although YscUCC is shown to be secreted (198), we could not find similar evidence 
using 100 ml cultures of Salmonella expressing FlhBCt3xFLAG. We hypothesise that the 
export specificity switch activated by FliK simply leads to the loss of FlhBCC from the 
membrane. After dissociation, FlhBCC is either too unstable to be detected or is 
degraded by cellular proteases. Larger scale cultures may need to be studied to 
conclude if FlhBCC is secreted or not as it may also be unstable in the environment 
and, therefore, not detected by the anti-FLAG M2 antibody. 
 
How FliKC may interact with FlhBC to trigger the dissociation of FlhBCC remains an 
open question. Genetic evidence is plentiful in both the flagellum and injectisome 
T3SSs and supports the hypothesis that FliKC/SctPC is the export specificity switch 
domain (202). Much of the current biochemical and biophysical evidence for FliK’s role 
in the switch uses full length protein and does not isolate this domain. This is 
problematic as FliK and SctP share N-terminal recognition motifs which bind FlhB and 
its homologues (86, 88, 89). 
 
A few hypotheses of how FliK might cause the loss of FlhBCC were tested in this study. 
In 2011, Mizuno and colleagues proposed that two acidic loops found in the folded 
domain of FliKC may interact with the very basic surface of FlhBC (203). The result of 
the motility assay, where acidic residues in loops 2 and 3 were mutated to glycines, 
does not support the Mizuno hypothesis (Figure 4.16). This was confirmed by the 
corresponding author of the Mizuno paper at a recent T3SS conference and in a follow 
up publication measuring motility and hook length (240). It is now proposed that the 
conserved hydrophobic residues of loop 2 are critical for maintaining FliKC structure 
and, ultimately, for the export specificity switch. That hypothesis was not followed up 
in this study. 
 
Biochemical and biophysical studies on full length FliK make it impossible to 
differentiate N-terminal and C-terminal interactions. Evans and colleagues showed 
that FliK could still bind to FlhBC in vitro, albeit very weakly, when its gate recognition 
motif is deleted (86). We attempted to use a FliKC truncation that includes the residues 
identified by genetic analysis as critical for the switch but does not include the N-
terminal ruler and disordered linker domains of FliK. This truncation, FliK270, was not 
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 motile but was able to bind FlhBC in vitro. The lack of motility makes this truncation 
less desirable than a truncation which is export deficient but still activates the switch 
(204). For this reason, I focused on other hypotheses. But this truncation provides a 
valuable tool for follow-up investigations to study any direction interactions between 
the FliK T3S4 and FlhBC. 
 
Cell-based assays do suggest that FlhBCC dissociates from FlhB in a FliK-dependent 
manner. What about in vitro? To study this, C41 (DE3) soluble lysate from large scale 
expressions with empty recombinant plasmid or recombinant plasmid with full length 
FliK was incubated with FlhBCt3xFLAG. It was decided to use FliK soluble lysate with 
protease inhibitors to avoid purifying full length FliK, which often purifies with many 
breakdown products. Maintaining full length FliK in solution would more accurately 
simulate the cellular environment as well. 
 
No loss of FlhBCC could be detected in this assay, but that may be due to two aspects 
of the experiment. The first, FliK was not as well expressed in the soluble fraction as 
expected. FlhBCt3xFLAG (1 µM) was used to allow for detection, but this is much greater 
than the expected concentration of FlhB inside a cell. Future experiments should strive 
to increase the concentration of FliK while reducing the amount of FlhB used. Purifying 
FliK and incubating it, and its breakdown products, with FlhB may be another way to 
increase the amount of FliK used. 
 
The second flaw of the experiment is a lack of pulling force. FliK, as an exported 
subunit, would cross the cell envelope and fold in the external environment. Assuming 
a direct interaction between FliKC and FlhBCC, the force generated by FliK folding in 
the environment may serve to pull FlhBCC off from the rest of FlhB. Presumably, based 
on what we know of FlhB and FlhBCC interactions, this force would need to be strong 
enough to unravel at least a b-sheet. Furthermore, if FliK diffuses out of the cell rather 
than join a rate-constant subunit chain, the length of the hook would add a temporal 
component to the switch, as proposed by Erhardt and colleagues (142). For an 
immature, short hook, FliKN would start folding before FliKC could interact with FlhBCC 
and dissociate it from the rest of FlhB. Once the hook has reached a mature length, 
the diffusion of FliKN would be long enough to give FliKC the time to interact with 
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 FlhBCC. Once folding occurs, and the pulling force on FlhBCC grew strong enough, 
FlhBCC would then be pulled from the rest of FlhB. This model requires that FliKC and 
FlhBCC interact, which has yet to be settled convincingly. 
 
Future studies must be conducted to conclude how FliKC interacts with FlhBCC. That 
full length FliK interacts with FlhBCC is not in question, but many have assumed that 
FliKC must interact with FlhBCC based on the weight of genetic evidence that FliKC is 
critical to the switch. The simplest answer is that FliKC does interact with FlhBCC, as 
suggested by the pulldown presented in this study using FliK270, but that this 
interaction is not strong enough on its own to lead to the export specificity switch. A 
combination of biophysical techniques, evaluating the magnitude of the possible 
interaction between FliKC and FlhBCC, and biochemical techniques such as scanning 
deletions in the FliKlinker and FliKC domains could confirm important residues that may 
explain how FliK causes the dissociation of FlhBCC from the rest of FlhB. These 
variants of FliK should include a deletion of the FliK GRM to eliminate any possibility 
of background binding via the N-terminal secretion signal. 
 
Until a direct interaction between the FliK T3S4 domain and FlhBC is conclusively 
shown, the prospect of another protein partner continues to be alluring. Based on 
kinetic data of FliK interactions with wild type and autocleavable-deficient FlhB and 
the results presented here, other proteins may play in a greater role in the export 
specificity switch than previously believed. Evidence points to FlhA or Flk in 
Salmonella, but there could also be unknown interactions that transmit the switching 
signal from FliK to FlhBC (191). These additional protein partners should be studied 
alongside FlhB and FliK while monitoring FlhBCC dissociation. 
 
167
 Chapter 5 
Concluding remarks 
 
5.1 Early subunit interactions with FlhBC 
Early subunits bind transiently to their export gate, FlhB (Figure 3.7). This lowers the 
forces and energy needed to remove subunit from the gate, allowing for rapid transit 
to the distal site of assembly. Export order of early subunits does not appear to be 
imposed entirely by affinity of their gate recognition motif (GRM) for the export gate, 
but, when subunits are separated into the two early substructures, there is a trend 
between subunit affinity for the export gate and export order. The earliest rod subunits, 
FliE and FlgB, bind with the greatest affinity while later rod subunits have weaker 
affinities. Furthermore, the hook subunit, FlgE, binds with a greater affinity than either 
the hook cap, FlgD, or the molecular ruler, FliK. Affinity of the GRM for the export gate 
may then be a result of both rough order of required assembly, as with FliE and FlgB 
needing to be exported and assembled first, or the number of subunits required for 
proper assembly, as would be the case with FlgE needing to outcompete FlgD and 
FliK to assemble a mature hook. 
 
FlhBC contains a surface-exposed hydrophobic binding pocket, which is highly 
conserved across both species and FlhB/SctU homologues (Figure 3.19). This 
alignment, and the data presented here and in past publications, reinforces the 
importance of the interaction between early subunit GRM and the binding pocket on 
FlhB/SctU (86, 88, 89). Two residues in the binding pocket are of greatest importance 
based on chemical shift perturbations observed by NMR – Alanine314 and Leucine344. 
The other two residues identified in this binding pocket, Alanine286 and Proline287, may 
serve to contribute to the general hydrophobic environment but do not appear to be 
important in binding in either this or past studies. The caveat here being, of course, 
that prolines do not appear in 2D NMR probing for 1H and 15N, so P287 may have an 
unknown role in subunit binding. This is less likely, though, as the residues nearest 
Alanine286 and Proline287 do not experience chemical shift perturbations like the 
residues nearest Alanine314 and Leucine344 do, strongly suggesting that the early 
subunit GRM contacts Alanine314 and Leucine344. 
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 NMR allowed for greater coverage of the FlhB amino acid sequence than 
crystallography did, especially in the C-terminal tail. Residues in this tail, which is 
missing from the atomic resolution structure, do experience chemical shift 
perturbations upon subunit binding. What role these residues play in subunit binding 
remains unknown. A solution structure could be solved and compared to the available 
atomic resolution structure to investigate differences in how FlhB crystallises and how 
it might fold in a cell-like environment. 
 
Two of the autonomous switcher mutations are C-terminal tail truncations that match 
the cutoff of the atomic resolution structure folded domains (Lysine351 and 
Tryptophan353). Could this C-terminal tail have some role in stablising the interaction 
between FlhBCC and FlhB? NMR also allows for molecular dynamic measurements, 
data not collected in this study. These data could provide greater clarity in how FlhBCC 
and FlhB interact post-autocleavage by measuring how dynamic certain residues are. 
GRM peptide could also be added to monitor the change in dynamics after subunit 
binding and autonomous switcher mutations could be engineered in to observe how 
they affect individual residues. This information, in combination with a solution 
structure of FlhBC, should help to explain the role of the C-terminal tail in early subunit 
binding and the export specificity switch. 
 
How early subunit GRM sits in the binding pocket, and what structure it adapts while 
bound to the FlhB export gate, remain open questions. Is the GRM a helix while bound 
to FlhBC or is it completely unfolded by the time it associates with FlhBC? How might 
the middle three residues, which vary greatly across subunits, contribute to GRM 
structure and binding? These questions can be investigated with techniques already 
known to work well with FlhB and early subunits such as in vivo cell- or population-
based assays, ITC, and NMR. This data would also help to design novel therapeutic 
antagonists to subvert this interaction, leading to impaired flagellum or injectisome 
assembly. As both the GRM and subunit binding pocket are conserved across 
species, it is possible that therapeutics targeting both type III secretion systems in a 
range of pathogens could be found. Limiting cellular motility or the injection of effector 
molecules into the host cell could be a major step in treating some of the world’s 
greatest bacterial threats. 
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 5.2 A model for the flagellar export specificity switch 
The results from this study provide evidence for the conclusion of the export specificity 
switch, namely the loss of FlhBCC from the rest of FlhB, demonstrating why 
autocleavage of FlhBC is vital to the switch. Data from this study and from others 
strongly support that the early subunit binding pocket is located on FlhBCC. Once 
FlhBCC is removed from the FlhB export gate, the early subunits no longer have a gate 
to bind in preparation of export. How does the model for the switch look now? FliK is 
exported after interacting with FlhBCC via the FliK GRM. The unfolded N-terminus of 
FliK can then measure the nascent hook. If the hook is too short, the folding of the FliK 
N-terminus in the external environment pulls the rest of FliK from the export machinery 
without triggering the switch. But, if the hook has reached a mature length of 55 nm ± 
6 nm, FliK will have the necessary time to trigger the loss of FlhBCC and lead to the 
export specificity switch (Figure 5.1). 
 
This switch, presumably irreversible, means that the export machinery located at the 
base of that specific flagellum should now predominately export late subunits, starting 
with FlgM and continuing to filament export and assembly. Whether early subunits are 
still exported, especially in peritrichous organisms such as Salmonella, is difficult to 
discern due to staggered assembly of various flagella across a cell. But it is reasonable 
to assume that the export machinery moves permanently into late subunit export 
mediated by chaperone-subunit complexes and the FlhA export gate. 
 
Data presented here suggest that the loss of a FlhB domain is FliK dependent, but 
how FlhBCC is removed by FliK from the rest of FlhB remains unclear. There is a wealth 
of genetic evidence on the importance of FliKC and its injectisome homologues to the 
export specificity switch, but biochemical data remains unclear and sparse. Further 
biochemical and biophysical analysis is needed to conclude how FliKC may activate 
the switch at FlhBC, whether by direct interaction or the mediation of another protein. 
What about systems that lack FliK/SctP? What serves to trigger the loss of 
FlhBCC/SctUCC in these T3SSs? These systems may have evolved different 
mechanisms to cause the loss of FlhBCC/SctUCC, such as less stable FlhBCC and 
FlhBCN interactions. They could also help uncover other T3SS subunits that may be 
involved in triggering the loss of FlhBCC/SctUCC. 
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Figure 5.1 A proposed model for the export specificity switch at the fT3SS after the
autocleavage of FlhB
FliK is secreted through the rod and hook after first binding to FlhBCC via the GRM.
(A) If FliKN measures a short hook, the N-terminus begins to fold in the environment and pulls
FliKC out of the cell before causing the switch.
(B) If FliKN measures a mature hook, FliKC has enough time to cause FlhBCC to dissociate from
the rest of FlhB via an unknown mechanism, triggering the switch. The loss of FlhBCC
eliminates the export binding site for rod and hook subunits. The fT3SS will begin to secrete
FlgM, leading to the expression of flagellin, and begin late subunit export and assembly.
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 Ongoing work in the Fraser lab also seeks to investigate whether FliK joins the subunit 
chain or is a chain breaker and exports via diffusion, which should help settle the 
question of temporal regulation of the export specificity switch. If FliK is a member of 
the constantly moving subunit chain, the pulling force generated by FliK as it folds in 
the environment would need to be enough to pull FlhBCC from FlhB, either directly or 
via another unknown protein. 
 
Secretion of SctUCC in the Yersinia injectisome is thought to be important to activate 
the export specificity switch in the injectisome (198). I could find no evidence that 
FlhBCC is secreted, although the loss of a subunit binding site is consistent. I 
hypothesise that FlhBCC is too unstable to maintain structure without FlhBCN and is 
quickly degraded by cellular proteases after dissociation. This observation highlights 
a key difference between the flagellar and injectisome T3SS. Furthermore, the loss of 
Yersinia SctUCC to activate the export specificity switch was not shown to be SctP-
dependent, although the evidence suggests that this is the case (198). 
 
The flagellar and injectisome export machinery may diverge slightly on the export 
specificity switch mechanism, the loss of the early subunit binding site on 
FlhBCC/SctUCC is a critical junction between export phases shared by both systems. 
The loss of FlhBCC/SctUCC should continue to be studied in other organisms, but 
current data strongly supports that this mechanism is one shared across type III 
secretion systems. 
 
Whether used to move through an environment or to associate with hosts as 
pathogens or symbionts, type III secretion systems are a powerful tool utilised by many 
bacteria. Ordered export by type III secretion machines is one of the most elegant 
examples of multi-step precision control that combines gene expression, subunit 
export from the cell, and protein subunit assembly into the nascent nanomachine. FlhB 
plays a critical role in imposing order onto subunit export. It serves not only as the 
export gate for early subunits but also to ensure the fT3SS switches export specificity 
at the appropriate time by sacrificing part of itself. Although the exact mechanism of 
the export specificity switch remains unclear, the work presented here contributes new 
pieces to our understanding of how biological nanomachines operate. 
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 Appendix A 
 
A1.1 Reagents, buffers, and media 
All buffers and media were sterilised by filtration or autoclaving. 
Name Composition 
Luria-Bertani (LB)-Lennox broth 1% w/v tryptone 
0.5% w/v NaCl 
0.5% w/v yeast extract 
LB-Lennox agar 1% w/v tryptone 
0.5% w/v NaCl 
0.5% w/v yeast extract 
1.5% w/v agar 
Motility agar 0.25% w/v Bacto-agar 
1% w/v tryptone 
0.5% w/v NaCl 
2x Yeast Tryptone (2xYT) broth 1.6% w/v tryptone 
1.0% w/v yeast extract 
0.5% w/v NaCl 
Super optimal broth with catabolite repression (SOC) 2% w/v tryptone 
0.5% w/v yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM D-glucose 
M9 minimal medium 0.5% w/v D-glucose (Carbon-13, all 6 carbons labeled 
(13C6), 99% atom 13C, as needed) 
0.1% w/v NH4Cl (Nitrogen-15 labeled, 99% atom 15N, 
as needed) 
42.3 mM Na2HPO4 
22 mM KH2PO4 
8.6 mM NaCl 
5 mM MgSO4 
0.1 mM CaCl2 
4 µM ZnSO4 
1 µM MnCl2 
0.7 µM H3BO3 
0.7 µM CuSO4 
2 µM FeCl3 
Sterile water to 1 L 
M9 minimal medium with D2O and deuterated glucose Same as above, but sterile water was replaced with 
100% D2O (Sigma Aldrich) as needed. D-Glucose was 
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 replaced with 0.5% w/v D-glucose, 13C6-1,2,3,4,5,6,6-
deuterium7, 99% atom 13C, 97% deuterium (Sigma 
Aldrich) as needed. 
Buffer A 20 mM Tris-HCl, pH 8.0 
1 M NaCl 
20% v/v glycerol 
2 mM EDTA 
Buffer B 50 mM Tris-HCl pH 7.4 
150 mM NaCl 
Buffer C 20 mM sodium phosphate buffer, pH 7.4 
100 mM NaCl 
Buffer D 20 mM Tris-HCl, pH 7.4 
500 mM NaCl 
20 mM imidazole 
Buffer E 20 mM Tris-HCl, pH 7.4 
500 mM NaCl 
300 mM imidazole 
Buffer F 20 mM Tris-HCl, pH 8.0 
150 mM NaCl 
20 mM imidazole (300 mM for co-elution) 
Buffer G 20 mM Tris-HCl, pH 7.4 
150 mM NaCl 
SDS loading buffer, 2x 100 mM Tris-Hcl, pH 8.8 
4% w/v sodium dodecyl sulfate (SDS) 
20% v/v glycerol 
0.2% w/v Bromophenol Blue 
140 mM b-mercaptoethanol (bME) 
SDS running buffer, 1x 192 mM glycine 
25 mM Tris-HCl, pH 8.3 
0.1% w/v SDS 
Transfer buffer, 1x 10 mM 3-(Cyclohexylamino)-1-propanesulfonic acid 
(CAPS), pH 11 
10% v/v methanol 
Tris-Acetate-EDTA (TAE) buffer, 1x 40 mM Tris-HCl, pH 8.5 
20 mM acetic acid 
1 mM EDTA 
Phosphate buffered saline (PBS), 10x 1.37 M NaCl 
27 mM KCl 
100 mM Na2HPO4 
18 mM KH2PO4 
water to 1 L, pH 7.4 
Phosphate buffered saline with 0.05% Triton X-100 
(PBST), 1x 
1x PBS 
0.05% Triton X-100 
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 A1.2 Oligonucleotides 
Name Description & 
Restriction Site 
Destination
Plasmid 
Sequence (5’®3’) Length 
T7For Sequencing primer pTXBI and 
pET15b 
TAATACGACTCACTATAGGG 20 
T7Rev Sequencing primer pTXBI and 
pET15b 
GCTAGTTATTGCTCAGCGGTGG 22 
pTXBI 
inteinRev 
Sequencing primer pTXBI GATGTCGGCGATGCGTAC 18 
pBADFor Sequencing primer pBAD18amp GATTATTTGCACGGCGTCACACTTT
GCTATGC 
32 
pBADRev Sequencing primer pBAD18amp CTGCGTTCTGATTTAATCTGTATCA
GGCTG 
30 
FliKFor NheI, Ribosome 
binding site (RBS) 
from pET15b 
pBAD18amp GCTATTGCTAGCAGGAGAGCCCAA
ATGATCACCCTGCCCCAACTGATC 
48 
FliK270For NheI, RBS (from 
pET15b) 
pBAD18amp GCTATTGCTAGCAGGAGAGCCCAA
ATGGAATGGCAGCAAACGTTCAGT 
48 
FliK405 
StopRev 
XbaI pBAD18amp GCATACTCTAGATTAGGCGAAGATA
TCCACTGCGCC 
36 
FliKFor NdeI pET15b GCTATTCATATGATCACCCTGCCCC
AACTG 
30 
FliK270For NdeI pET15b GCTATTCATATGGAATGGCAGCAAA
CGTTC 
30 
FliK405 
StopRev 
BamHI pET15b GCATACGGATCCTTAGGCGAAGAT
ATCCACTGC 
33 
FliKE297G
E298GFor 
Overlap extension 
mutagenesis primer 
pBAD18amp CGATTGCATCCGGGCGGCTTAGGT
CAGGTG 
30 
FliKE297G
E298GRev 
Overlap extension 
mutagenesis primer 
pBAD18amp CACCTGACCTAAGCCGCCCGGATG
CAATCG 
30 
FliKD309G
D310GFor 
Overlap extension 
mutagenesis primer 
pBAD18amp TCGCTCAAGCTGGGCGGCAATCAG
GCGCAG 
30 
FliKD309G
D310GRev 
Overlap extension 
mutagenesis primer 
pBAD18amp CTGCGCCTGATTGCCGCCCAGCTT
GAGCGA 
30 
FliK717For For replacement of 
FliK with 
KanamycinR 
pWRG717 
(template) 
AAACCCGAATGATCACCCTGCCCC
AACTGATCACCACCGATACCGAGG
GTTTTCCCAGTCACGAC 
65 
FliK717Rev For replacement of 
FliK with 
KanamycinR 
pWRG717 
(template) 
CAAAGCGTGGAAAAGACGCGGATA
ATCATGCTACCTCTGGCGTTATGCT
TCCGGCTCGTATGTTG 
65 
FlhBFor211 NdeI pTXBI GCTATTCATATGTTCCAGATCTTTA
GCCACCTG 
33 
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 FlhBFor219 NdeI pTXBI GCTATTCATATGAAATTACGCATGT
CGCGGCAG 
33 
FlhBFor270 NdeI pTXBI GCTATTCATATGCCGACGCACTATT
CCGTGGCG 
33 
FlhBcc 
G_ARev 
SapI pTXBI GGTGGTTGCTCTTCCGCACGCATC
AGTATTCTTCTCGTT 
39 
FlhBcnRev SapI pTXBI GGTGGTTGCTCTTCCGCAGTTAGT
GACAATGACGTCCGC 
39 
FlhBcc 
W353TRev 
SapI pTXBI GGTGGTTGCTCTTCCGCAGGTGCG
TTTAAGCTGCCAGAC 
39 
FlhBc 
N269AFor 
Overlap extension 
mutagenesis primer 
pTXBI GTCATTGTCACTGCGCCGACGCAC
TATTCC 
30 
FlhBc 
N269ARev 
Overlap extension 
mutagenesis primer 
pTXBI GGAATAGTGCGTCGGCGCAGTGAC
AATGAC 
30 
FlhBc 
P238AFor 
Overlap extension 
mutagenesis primer 
pTXBI AGCGAAGGCGATGCGCATGTTAAG
GGC 
27 
FlhBc 
P238ARev 
Overlap extension 
mutagenesis primer 
pTXBI GCCCTTAACATGCGCATCGCCTTC
GCT 
27 
FlhB 
S274Ffor 
Overlap extension 
mutagenesis primer 
pTXBI ACGCACTATTTTGTGGCGCTG 21 
FlhB 
S274Frev 
Overlap extension 
mutagenesis primer 
 CAGCGCCACAAAATAGTGCGT 21 
FlhB 
R302Pfor 
Overlap extension 
mutagenesis primer 
 CTGCGCATTCCGGAGATCGGC 21 
FlhB 
R302Prev 
Overlap extension 
mutagenesis primer 
 GCCGATCTCCGGAATGCGCAG 21 
FlhBseqfor Flanking primer  GGACGACCTGCTGGACAGT 19 
FlhBseqrev Flanking primer  CGAGGATAAAAGCAGGTAGC 20 
FlgC 
717For 
For replacement of 
FlgC with 
KanamycinR 
pWRG717 
(template) 
GGACAGCCTTATCGCGCCAAACAG
GTGGTTTTTCAGGTGGACGCCAGG
GTTTTCCCAGTCACGAC 
65 
FlgC 
717Rev 
For replacement of 
FlgC with 
KanamycinR 
pWRG717 
(template) 
AATCACGCTGGCGACCTTTACCCC
GCCAGTGGCTTGACCCGGCGCTGC
TTCCGGCTCGTATGTTG 
65 
FlgC 
KnockinFor 
For replacement of 
KanamycinR 
cassette for scarless 
deletion of FlgC 
 AGGCATGATGAATGTGCTACAGGG
AGGAAACTAATCCGTGTAAAGGAG
GCGCGTATGTCTATTGCCGTAAATA
TGAATGA 
80 
FlgC 
KnockinRe
v 
For replacement of 
KanamycinR 
cassette for scarless 
deletion of FlgC 
 TCATTCATATTTACGGCAATAGACA
TACGCGCCTCCTTTACACGAATTAG
TTTCCTCCCTGTAGCACATTCATCA
TGCCT 
80 
199
 FlgC 
SeqFor 
Flanking primer to 
sequence FlgC and 
surrounding region 
 GTTTATTCCGGCGATAAC 18 
FlgC 
SeqRev 
Flanking primer to 
sequence FlgC and 
surrounding region 
 CTGCCGGTCGTCGTTTTGAC 20 
FlgC 
F49AFor 
Overlap extension 
mutagenesis primer 
 GCCAAACAGGTGGTTGCGCAGGTG
GACGCCGCG 
33 
FlgC 
F49ARev 
Overlap extension 
mutagenesis primer 
 CGCGGCGTCCACCTGCGCAACCAC
CTGTTTGGC 
33 
FlgC 
GRMswap 
For 
Overlap extension 
mutagenesis primer 
 CGCGCCAAACAGGTGGTTTTTGCC
AGTGAGTTAGCGCCGGGTCAAGCC
ACT 
51 
FlgC 
GRMswap
Rev 
Overlap extension 
mutagenesis primer 
 AGTGGCTTGACCCGGCGCTAACTC
ACTGGCAAAAACCACCTGTTTGGC
GCG 
51 
FlgCFor NheI, RBS (from 
pET15b 
pBAD18amp GCTATTGCTAGCAGGAGAGCCCAA
GTGGCGCTGTTAAACATTTTT 
45 
FlgC 
StopRev 
XbaI, with stop 
codon 
pBAD18amp GCATACTCTAGATTACTGGCCTAAT
GTCAGCGT 
33 
FlgE 
F39KFor 
Overlap extension 
mutagenesis primer 
 GGCATCAAAAGCCGATATGTTCGC
CGGT 
28 
FlgE 
F39KRev 
Overlap extension 
mutagenesis primer 
 CCGGCGAACATATCGGCTTTTGAT
GCC 
27 
FlgE 
F43KFor 
Overlap extension 
mutagenesis primer 
 GGCATCATTTGCCGATATGAAAGC
CGGT 
28 
FlgE 
F43KRev 
Overlap extension 
mutagenesis primer 
 CCGGCTTTCATATCGGCAAATGATG
CC 
27 
FlgEF39K 
F43KFor 
Overlap extension 
mutagenesis primer 
 GGCATCAAAAGCCGATATGAAAGC
CGGT 
28 
FlgEF39K 
F43KRev 
Overlap extension 
mutagenesis primer 
 CCGGCTTTCATATCGGCTTTTGATG
CC 
27 
FlgE 
F39AFor 
Overlap extension 
mutagenesis primer 
 GGCATCAGCGGCCGATATGTTCGC
CGGT 
28 
FlgE 
F39ARev 
Overlap extension 
mutagenesis primer 
 CCGGCGAACATATCGGCCGCTGAT
GCC 
27 
FlgE 
F43AFor 
Overlap extension 
mutagenesis primer 
 GGCATCATTTGCCGATATGGCGGC
CGGT 
28 
FlgE 
F43ARev 
Overlap extension 
mutagenesis primer 
 CCGGCCGCCATATCGGCAAATGAT
GCC 
27 
FlgEF39A 
F43AFor 
Overlap extension 
mutagenesis primer 
 GGCATCAGCGGCCGATATGGCGG
CCGGT 
28 
FlgEF39A 
F43ARev 
Overlap extension 
mutagenesis primer 
 CCGGCCGCCATATCGGCCGCTGAT
GCC 
27 
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 A1.3 Bacterial strains 
Note: The source of strains includes whomever constructed the strain and the method 
used to construct the strain. 
Strain Characteristic Source 
Salmonella enterica serovar Typhimurium strains  
JR501 For improved transformation of E. coli plasmids into 
Salmonella 
(245) 
SJW1103 Motile, phase-1 stable 
H1-I H2-enx-.off vh2- 
(58) 
SJW1103DflgD::KanR flgD-, KanamycinR
 
 L. Evans, (246) 
SJW1103DflgE::KanR flgE-, KanamycinR L. Evans, (246) 
SJW1103DfliK::FRT  fliK-, replaced with FLP recognition target (FRT) scar 
sequence 
N. Greene, (246) 
SJW1103DflgC flgC - This study, (221) 
SJW1103flhBCT3xFLAG flhB tagged with C-terminal 3xFLAG O. Bryant, (221) 
SJW1103flhBCT3xFLAG N269A flhB tagged with C-terminal 3xFLAG, N269A non-
autocleavable variant 
This study, (221) 
SJW1103flhBCT3xFLAG P238A 
N269A 
flhB tagged with C-terminal 3xFLAG, P238A N269A non-
autocleavable variant 
This study, (221) 
SJW1103flhBCT3xFLAG S274F flhB tagged with C-terminal 3xFLAG, S274F autonomous 
switching mutant 
This study, (221) 
SJW1103flhBCT3xFLAG R302P flhB tagged with C-terminal 3xFLAG, R302P 
autonomous switching mutant 
This study, (221) 
SJW1103flhBCT3xFLAG S274F 
R302P 
flhB tagged with C-terminal 3xFLAG, S274F R302P 
combined autonomous switching mutant 
This study, (221) 
SJW1103DfliK::KanR 
flhBCT3xFLAG 
flhB tagged with C-terminal 3xFLAG, fliK-, KanamycinR This study, (221) 
SJW1103DfliK::KanR 
flhBCT3xFLAG N269A 
flhB tagged with C-terminal 3xFLAG, N269A non-
autocleavable variant, fliK-, KanamycinR 
This study, (221) 
SJW1103DfliK::KanR 
flhBCT3xFLAG S274F R302P 
flhB tagged with C-terminal 3xFLAG, S274F R302P 
combined autonomous switching mutant, fliK-, 
KanamycinR 
This study, (221) 
Escherichia coli strains  
C41 (DE3) F- ompT gal dcm hsdSB (rB
- mB
-)  (247) 
XL-1 recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F ́ 
proAB lacIqZΔM15 Tn10  (T etr)]  
Laboratory stock 
DH10b F– Φ80lacZΔM15 Δ(lacZYA- argF)  U169 recA1 endA1 
hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1  
Laboratory Stock  
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 A1.4 Plasmids 
Note: All recombinant plasmids derived from parental vectors carry all features of the 
parental vector unless otherwise noted (e.g., all pTXBI constructs are C-terminally 
fused to the inteinCBD and expression is induced with IPTG). All genes originate from 
Salmonella enterica serovar Typhimurium strain SJW1103. 
Plasmid Characteristics Source 
pTXBI 6.7k base pairs, AmpicillinR, protein expression 
under IPTG-inducible T7 promoter, C-terminal 
fusion with Mxe intein/chitin binding domain 
(inteinCBD) via a cysteine residue 
New England Biolabs 
(NEB) 
pTXBI-FlhBC FlhBC domain, residues 219-383, G383A for 
better cleavage from inteinCBD 
(237) 
pTXBI-FlhBCN Residues 211-269 This study 
pTXBI-FlhBCC Residues 270-383, G383A This study 
pTXBI-FlhBC N269A G383A 
N269A to prevent autocleavage at primary site 
This study 
pTXBI-FlhBC P238A FlhBC domain, amino acids 219-383, G383A, 
P238A to prevent autocleavage at secondary site 
This study 
pTXBI-FlhBC P238A N269A G383A 
P238A and N269A to prevent autocleavage at 
primary and secondary site 
This study 
pTXBI-FlhBC P287E G383A, 
P287E to abolish early subunit binding 
This study 
pTXBI-FlhBC211 FlhBC domain, residues 211-383, G383A This study 
pTXBI-FlhBC211 N269A G383A 
N269A to prevent autocleavage at primary site 
This study 
pTXBI-FlhBC211 W353T G383A 
W353T to mimic autonomous switching mutant 
W353Stop 
This study 
pTXBI-FlhBC211 S274F G383A 
S274F autonomous switcher 
This study 
pTXBI-FlhBC211 R302P G383A 
R302P autonomous switcher 
This study 
pTXBI-FlhBC211 
S274F R302P 
G383A 
S274F R302P autonomous switcher 
This study 
pTXBI-FlhBCCT3xFLAG FlhBC domain, residues 211-383, C-terminal 
3xFLAG 
This study 
pTXBI-HexaHis-3xFLAG-FlgB-
FlgC 
HexaHis-3xFLAG-FlgB and FlgC (C-terminal 
fusion to inteinCBD). This plasmid allowed for 
co-expression of both recombinant proteins. 
FlgB under the vector T7 promoter and FlgC 
This study 
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 under the native Salmonella promoter found in 
FlgB. 
pBAD18amp 4.6k base pairs, AmpicillinR, protein expression 
under the control of the PBAD promoter of the 
araBAD operon 
(248) 
pBAD18amp-FlgEmid3xFLAG Residues 1-403 for expression in S. enterica, 3x 
mid-FLAG tag between residues 234 and 235. 
L. Evans 
pBAD18amp-FlgEDGRM Residues 1-38, 44-403, 3x mid-FLAG tag L. Evans 
pBAD18amp-FlgEF39K Point mutation- phenylalanine 39 to lysine, 3x 
mid-FLAG tag 
This study 
 
pBAD18amp-FlgEF43K Point mutation- phenylalanine 43 to lysine, 3x 
mid-FLAG tag 
This study 
 
pBAD18amp-FlgEF39KF43K Point mutation- phenylalanine 39 and 43 to 
lysine, 3x mid-FLAG tag 
This study 
 
pBAD18amp-FlgEF39A Point mutation- phenylalanine 39 to alanine, 3x 
mid-FLAG tag 
This study 
 
pBAD18amp-FlgEF43A Point mutation- phenylalanine 43 to alanine, 3x 
mid-FLAG tag 
This study 
 
pBAD18amp-FlgEF39AF43A Point mutation- phenylalanine 39 and 43 to 
alanine, 3x mid-FLAG tag 
This study 
 
pBAD18amp-FlgCwt Residues 1-134 for expression in S. enterica This study 
pBAD18amp-FlgCF49A Point mutation- phenylalanine 49 to alanine This study 
pBAD18amp-FlgCGRMswap GRM swap with native DNA sequence from FlgB This study 
 
pBAD18amp-FliKwt Residues 1-405 for expression in S. enterica This study 
pBAD18amp-FliK270 Residues 270-405 for expression in S. enterica This study 
pBAD18amp-FliKEEGG Residues 1-405 for expression in S. enterica, 
glutamic acid 297 and 298 to glycines 
This study 
pBAD18amp-FliKDDGG Residues 1-405 for expression in S. enterica, 
aspartic acid 309 and 310 to glycines 
This study 
pET15b 5.7k base pairs, AmpicillinR, IPTG-inducible T7 
promoter, N-terminal fusion of HexaHis-tag 
followed by thrombin cleavage site 
Novagen 
pET15b-FliKwt Residues 1-405 This study 
pET15b-FliK270 Residues 270-405 This study 
pWRG717 KanamycinR with I-SceI endonuclease 
recognition site 
R. Gerlach (update on 
Blank, Hensel, and 
Gerlach, 2011) 
pWRG730 ChloramphenicolR. Lambda red recombinase 
under a heat-shock inducible promoter. I-SceI 
endonuclease under a tetracycline inducible 
promoter. 
R. Gerlach (update on 
Blank, Hensel, and 
Gerlach, 2011) 
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 A1.5 Antibodies 
Antibody Host Dilution Source 
Penta×His Mouse, IgG, monoclonal 1:2000 Qiagen 
Anti-FLAG M2 Mouse, IgG1, monoclonal 1:5000 (for FlgEmid3xFLAG) 
1:1000 (for FlhBCt3xFLAG) 
Sigma Aldrich 
Anti-chitin binding 
domain (anti-CBD) 
Mouse, IgG, monoclonal 1:1000 NEB 
IRDye 680RD anti-mouse 
IgG 
Donkey 1:10000 Li-Cor 
IRDye 800CW anti-rabbit 
IgG 
Donkey 1:10000 Li-Cor 
Anti-FlhBC Rabbit, polyclonal 1:2000 F. Samatey 
Anti-FlgN Rabbit, polyclonal 1:2000 Fraser Lab 
Anti-FliC (Salmonella H 
Antiserum i) 
Rabbit, polyclonal 1:5000 Difco (Becton, Dickinson, 
and Company) 
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